BLBK041-Kim
August 19, 2008
16:45
Intracranial Atherosclerosis
Intracranial Atherosclerosis Edited by Jong S Kim, L...
283 downloads
1295 Views
6MB Size
Report
This content was uploaded by our users and we assume good faith they have the permission to share this book. If you own the copyright to this book and it is wrongfully on our website, we offer a simple DMCA procedure to remove your content from our site. Start by pressing the button below!
Report copyright / DMCA form
BLBK041-Kim
August 19, 2008
16:45
Intracranial Atherosclerosis
Intracranial Atherosclerosis Edited by Jong S Kim, Louis R Caplan and KS Lawrence Wong © 2008 Blackwell Publishing Ltd. ISBN: 978-1-405-17822-8
BLBK041-Kim
August 19, 2008
16:45
Intracranial Atherosclerosis Edited by Jong S Kim Department of Neurology University of Ulsan College of Medicine Asan Medical Center Seoul South Korea
Louis R Caplan Department of Neurology Beth Israel Deaconess Medical Center Boston Massachusetts USA
KS Lawrence Wong Department of Medicine and Therapeutics The Chinese University of Hong Kong Prince Wales Hospital Hong Kong People’s Republic of China
Foreword by Geoffrey A. Donnan Director, National Stroke Research Institute, Melbourne; and President, World Stroke Organization
A John Wiley & Sons, Ltd., Publication
BLBK041-Kim
August 19, 2008
16:45
C 2008 by Blackwell Publishing Ltd This edition first published 2008
Blackwell Publishing was acquired by John Wiley & Sons in February 2007. Blackwell’s publishing program has been merged with Wiley’s global Scientific, Technical and Medical business to form Wiley-Blackwell. Registered office: John Wiley & Sons Ltd, The Atrium, Southern Gate, Chichester, West Sussex, PO19 8SQ, UK Editorial offices: 9600 Garsington Road, Oxford, OX4 2DQ, UK The Atrium, Southern Gate, Chichester, West Sussex, PO19 8SQ, UK 111 River Street, Hoboken, NJ 07030-5774, USA For details of our global editorial offices, for customer services and for information about how to apply for permission to reuse the copyright material in this book please see our website at www.wiley.com/wiley-blackwell The right of the author to be identified as the author of this work has been asserted in accordance with the Copyright, Designs and Patents Act 1988. All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitted, in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, except as permitted by the UK Copyright, Designs and Patents Act 1988, without the prior permission of the publisher. Wiley also publishes its books in a variety of electronic formats. Some content that appears in print may not be available in electronic books. Designations used by companies to distinguish their products are often claimed as trademarks. All brand names and product names used in this book are trade names, service marks, trademarks or registered trademarks of their respective owners. The publisher is not associated with any product or vendor mentioned in this book. This publication is designed to provide accurate and authoritative information in regard to the subject matter covered. It is sold on the understanding that the publisher is not engaged in rendering professional services. If professional advice or other expert assistance is required, the services of a competent professional should be sought. The contents of this work are intended to further general scientific research, understanding, and discussion only and are not intended and should not be relied upon as recommending or promoting a specific method, diagnosis, or treatment by physicians for any particular patient. The publisher and the author make no representations or warranties with respect to the accuracy or completeness of the contents of this work and specifically disclaim all warranties, including without limitation any implied warranties of fitness for a particular purpose. In view of ongoing research, equipment modifications, changes in governmental regulations, and the constant flow of information relating to the use of medicines, equipment, and devices, the reader is urged to review and evaluate the information provided in the package insert or instructions for each medicine, equipment, or device for, among other things, any changes in the instructions or indication of usage and for added warnings and precautions. Readers should consult with a specialist where appropriate. The fact that an organization or Website is referred to in this work as a citation and/or a potential source of further information does not mean that the author or the publisher endorses the information the organization or Website may provide or recommendations it may make. Further, readers should be aware that Internet Websites listed in this work may have changed or disappeared between when this work was written and when it is read. No warranty may be created or extended by any promotional statements for this work. Neither the publisher nor the author shall be liable for any damages arising herefrom. Library of Congress Cataloging-in-Publication Data Intracranial atherosclerosis / edited by Jong S. Kim, Louis R. Caplan, K.S. Lawrence Wong. p. ; cm. Includes bibliographical references and index. ISBN 978-1-4051-7822-8 (hardcover : alk. paper) 1. Cerebral arteriosclerosis. 2. Cerebrovascular disease–Etiology. I. Kim, Jong S. II. Caplan, Louis R. III. Wong, K. S. Lawrence. [DNLM: 1. Intracranial Arteriosclerosis–diagnosis. 2. Intracranial Arterial Diseases–etiology. 3. Intracranial Arteriosclerosis–therapy. WL 355 I6144 2008] RC388.5.I58 2008 616.1 36–dc22 2008023246 A catalogue record for this book is available from the British Library. R Set in 9/11.5 pt Sabon by Aptara Inc., New Delhi, India Printed in Singapore by Fabulous Printers Pte Ltd 1
2008
BLBK041-Kim
August 19, 2008
18:35
Contents
List of contributors, vii Preface, xi Foreward, xiii
Epidemiology and risk factors 1 Anatomy of intracranial arteries, 3 David S Liebeskind and Louis R Caplan 2 Pathologic characteristics, 19 Xiang-Yan Chen and Mark Fisher 3 Epidemiology, 33 Philip Gorelick, Jinghao Han, Yining Huang and KS Lawrence Wong 4 Risk factors, 45 Kazuo Minematsu, Oh Young Bang and Toshiyuki Uehara
Stroke mechanism and clinical consequence 5 Stroke mechanisms, 57 KS Lawrence Wong, Louis R Caplan and Jong S Kim 6 Anterior circulation disorders, 69 Jong S Kim 7 Posterior circulation disorders, 83 Louis R Caplan, Pierre Amarenco and Jong S. Kim 8 Cognitive dysfunction, dementia and emotional disturbances, 100 Jae-Hong Lee, Alex E Roher, Thomas G Beach and Jong S Kim 9 Natural course and prognosis, 113 Juan F Arenillas, Louis R Caplan and KS Lawrence Wong
Diagnostic imaging studies 10 Vascular imaging, 127 Edward Feldman, Harry J Cloft, Mai Nguyen-Huynh and Avean McLaughlin 11 Application of magnetic resonance imaging, 135 Dong-Wha Kang and Jong S Kim 12 Transcranial doppler, 147 Qing Hao, KS Lawrence Wong and Andrei V Alexandrov
v
BLBK041-Kim
August 19, 2008
18:35
CONTENTS
Treatment 13 Antiplatelet therapy, 163 Sun U Kwon and Jong S Kim 14 Anticoagulation, 173 Fadi B Nahab and Marc I Chimowitz 15 Angioplasty and stenting, 181 Wei-Jian Jiang, Dae Chul Suh, Yongjun Wang and Thomas W Leung 16 Surgical therapy, 194 Chang Wan Oh and Jeong Eun Kim 17 Other miscellaneous treatments, 206 Christopher Chen, Jinghao Han and KS Lawrence Wong
Uncommon causes of intracranial arterial disease 18 Immunologic and vasoconstrictive disorders, 217 Min Lou and Louis R. Caplan 19 Arterial dissection, CNS infection and other miscellaneous diseases, 229 Jiann-Shing Jeng and Jong S Kim 20 Moyamoya disease, 246 Susumu Miyamoto, Jun C. Takahashi and Jong S. Kim Index, 259 Colour plates, 160
vi
BLBK041-Kim
August 19, 2008
16:45
List of contributors
Dr Andrei V Alexandrov MD
Dr Xiang-Yan Chen PhD
Department of Neurology University of Alabama at Birmingham Birmingham Alabama USA
Department of Medicine and Therapeutics The Chinese University of Hong Kong Prince Wales Hospital Hong Kong People’s Republic of China
Dr Pierre Amarenco MD
Dr Christopher Chen MD
Department of Neurology and Stroke Centre Bichat Hospital Paris France
Dr Juan F Arenillas MD, PhD Stroke Unit Department of Neurology Hospital Clinico Universitario University of Valladolid Valladolid, Spain
Dr Oh Young Bang MD, PhD Department of Neurology Sungkyunkwan University Samsung Medical Center Seoul South Korea
Department of Pharmacology Yong Loo Lin School of Medicine Singapore
Dr Marc I Chimowitz MBChB MUSC Stroke Center Department of Neurosciences Medical University of South Carolina Charleston South Carolina USA
Dr Harry J Cloft MD, PhD Department of Radiology Mayo Clinic Rochester Minnesota USA
Dr Geoffrey A. Donnan Dr Thomas G Beach MD, PhD Sun Health Research Institute Arizona USA
Dr Louis R Caplan MD Department of Neurology Beth Israel Deaconess Medical Center Boston Massachusetts USA
National Stroke Research Institute Department of Neurology Austin Health Professor of Neurology University of Melbourne World Stroke Organization
Dr Edward Feldman MD Department of Clinical Neurosciences Brown University School of Medicine Providence Rhode Island USA vii
BLBK041-Kim
August 19, 2008
16:45
LIST OF CONTRIBUTORS
Dr Mark Fisher MD
Dr Dong-Wha Kang MD, PhD
Department of Neurology University of California Irvine Medical Center Orange California USA
Department of Neurology University of Ulsan College of Medicine Asan Medical Center Seoul South Korea
Dr Philip Gorelick MD, MPH
Dr Jeong Eun Kim MD, PhD
Department of Neurology and Rehabilitation University of Illinois College of Medicine at Chicago Chicago Illinois USA
Dr Jinghao Han PhD Department of Medicine & Therapeutics Chinese University of Hong Kong Prince of Wales Hospital Hong Kong People’s Republic of China
Dr Qing Hao PhD Department of Medicine & Therapeutics Chinese University of Hong Kong Prince of Wales Hospital Shatin Hong Kong People’s Republic of China
Department of Neurosurgery Seoul National University College of Medicine Seoul South Korea
Dr Jong S Kim MD, PhD Department of Neurology University of Ulsan College of Medicine Asan Medical Center Seoul South Korea
Dr Sun U Kwon MD, PhD Department of Neurology University of Ulsan College of Medicine Asan Medical Center Seoul South Korea
Dr Jae-Hong Lee MD, PhD
Department of Neurology Peking University First Hospital Beijing People’s Republic of China
Department of Neurology University of Ulsan College of Medicine Asan Medical Center Seoul South Korea
Dr Jiann-Shing Jeng MD, PhD
Dr Thomas W Leung MD
Stroke Center and Department of Neurology National Taiwan University College of Medicine Taipei Taiwan
Department of Medicine and Therapeutics The Chinese University of Hong Kong Prince of Wales Hospital Hong Kong People’s Republic of China
Dr Yining Huang MD
Dr Wei-Jian Jiang MD Department of Neurology and Interventional Neuroradiology Beijing Tiantan Hospital The Capital University of Medical Sciences Beijing People’s Republic of China viii
Dr David S Liebeskind MD UCLA Stroke Center and Department of Neurology Los Angeles California USA
BLBK041-Kim
August 19, 2008
16:45
LIST OF CONTRIBUTORS
Dr Min Lou MD Department of Neurology The Second Affiliated Hospital of Zhejiang University School of Medicine Hangzhou Zhejiang People’s Republic of China
Dr Aevan McLaughlin MD Department of Clinical Neurosciences Brown University School of Medicine Providence Rhode Island USA
Dr Kazuo Minematsu MD, PhD Cerebrovascular Division Department of Medicine National Cardiovascular Center Suita City Osaka Japan
Dr Susumu Miyamoto MD, PhD Department of Neurosurgery National Cardiovascular Center Suita Osaka Japan
Dr Fadi B Nahab MD Emory Stroke Center Department of Neurology Emory University School of Medicine Atlanta Georgia USA
Dr Mai Nguyen-Huynh MD Department of Neurology University of San Francisco San Francisco California USA
Dr Chang Wan Oh MD, PhD Department of Neurosurgery
Seoul National University Bundang Hospital Seongnam Gyunggi-do South Korea
Dr Alex E Roher MD, PhD Longtine Center for Molecular Biology and Genetics Sun Health Research Institute Sun City Arizona USA
Dr Dae Chul Suh MD, PhD Department of Radiology University of Ulsan College of Medicine Asan Medical Center Seoul South Korea
Dr Jun C Takahashi MD, PhD Department of Neurosurgery National Cardiovascular Center Suita Osaka Japan
Dr Toshiyuki Uehara MD Department of Medicine National Cardiovascular Center Suita City Osaka Japan
Dr Yongjun Wang MD Department of Neurology Beijing Tiantan Hospital Beijing People’s Republic of China
Dr KS Lawrence Wong MD Department of Medicine and Therapeutics The Chinese University of Hong Kong Prince Wales Hospital Hong Kong People’s Republic of China ix
BLBK041-Kim
August 19, 2008
16:45
Preface
It reads in the literature that “extracranial atherosclerosis is an important cause of strokes while intracranial atherosclerosis is uncommon occurrence, accounting for 8–10% of strokes. However, it is more often seen in certain ethnic groups such as Asians, Blacks and Hispanics.” Whenever we read this, we cannot but feel weird. How many Asians, Black people and Hispanics are there in the world? As of March 2008, the world population had reached an estimated 6.65 billion, of which Asia and Africa accounted for over 60 and 12%, respectively, while Europe and North America accounted for only 11 and 8%, respectively. Although the location of cerebral atherosclerosis has not been reliably investigated in some parts of Asia, the dominance of intracranial atherosclerosis is well established in China, which alone comprises 20% of the world population. Therefore, our view is that the quote above should be revised as follows: “Intracranial atherosclerosis is the major cause of strokes worldwide. However, extracranial atherosclerosis is more often seen in certain ethnic groups, such as Caucasians.” Nevertheless, the literature has focused predominantly on extracranial atherosclerosis, largely neglecting intracranial atherosclerosis. Perhaps, there may be no other disease for which there is a greater discrepancy between the coverage of the literature and the real-world incidence than this example. To be sure, there are several reasons for this unusually large discrepancy. First, the literature in modern times has been dominated by scientists from North America and Northern Europe, who naturally focused on their main interest, extracranial atherosclerosis, while information from other countries has received less notice, especially when written in a local language. Second, extracranial carotid atherosclerosis has gained extra interest because endarterectomy has been a gold mine for vascular surgeons. By contrast, intracranial atherosclerosis remains technically inaccessible, attracting little attention from physicians. Finally, while diagnostic tools such as duplex scan can reliably assess the status of extracranial atherosclerosis, there have
been technical limitations to evaluate intracranial vessels until recently. With advances in imaging technologies such as magnetic resonance angiography, computed tomogrpahic angiography and transcranial Doppler, intracranial atherosclerosis is now more easily detected. In addition, advanced magnetic resonance imaging techniques, including diffusion-weighted magnetic resonance imaging, allow us to investigate stroke patterns and pathogenic mechanisms in patients with intracranial atherosclerosis. With the advent of these technologies, there has been a rapid accumulation of research papers that investigate pathology, risk factors, stroke mechanism, clinical syndrome, diagnosis and medical management of intracranial atherosclerosis. Furthermore, there have been remarkable developments in materials and technologies of stenting and angioplasty, while tools that help assess the cerebral perfusion, such as perfusion magnetic resonance imaging, single photon emission computed tomography or positron emission tomography, now enable us to select the patients who would benefit from bypass surgery. The aim of this book is to provide our readers with this ever-increasing knowledge on so far underinvestigated areas of intracranial atherosclerosis. This book, written by more than 30 experts in the field, is the first comprehensive textbook devoted to intracranial atherosclerosis. As such, we expect that this book will be of interest to physicians and researchers in diverse medical fields, including neurology, neurosurgery, radiology and rehabilitation medicine, who take care of stroke patients. Residents and students should also find this book interesting and stimulating. Although we extensively reviewed the currently available knowledge, we think that many important questions still remain to be investigated: Is the pathology of atherosclerosis really different between extraand intracranial arteries? Are the ethnic differences in the location of atherosclerosis related to differences in risk factors, genetic factor or still unknown factors? What would be the best medical therapy for patients with intracranial atherosclerosis? Who are the
xi
BLBK041-Kim
August 19, 2008
16:45
PREFACE
optimal candidates for revascularization therapy, such as angioplasty/stenting or bypass surgery? What is the ultimate clinical outcome in patients with intracranial atherosclerosis? Our hope is that this book will not only guide readers in their clinical practice but also stimulate them to be interested in and to perform research in the field of intracranial atherosclerosis aimed at solving these problems. By doing so, this book will ultimately contribute to the care of patients with intracranial atherosclerosis, the major cause of stroke worldwide.
xii
Finally, we express our sincere appreciation to all the contributors who took time out of their busy schedules to send us manuscripts, and also to Wiley-Blackwell for seeing this book through production. Without their help, this book could not have been brought to light.
Jong S Kim Louis R Caplan KS Lawrence Wong September 2008
BLBK041-Kim
August 19, 2008
16:45
Foreword
The editors have produced a superb book that aggregates for the first time all the information pertaining to intracranial atherosclerosis ranging from anatomy, pathology, and mechanisms through to epidemiology. This is particularly timely, given the recent increase in our understanding of this fascinating aspect of stroke medicine. Because it is a relatively infrequent cause of stroke in the West, probably only about 10%, compared to its major contribution to stroke in Asia (probably 30–60% of all strokes), it has occupied only a minor place in stroke medicine. However, with the emergence of Asia as a major academic driving force, the true place of intracranial atherosclerosis in the pantheon of stroke medicine worldwide is now being appreciated. Increasingly, stroke is being considered as a global problem that needs to be addressed by collaborative initiatives across racial and geographical borders. This book is a good illustration of this approach, with contributions from many different parts of the globe, both East and West. This is very much the philosophy of the World Stroke Organization that has a similar global approach to stroke as a clinical problem together with an awareness that more than half of the worlds’ strokes are occurring in Asian countries. To reduce
the unacceptable burden of stroke one of the major thrusts must be towards understanding stroke mechanisms in Asia so that adequate preventative measures can be instituted. This volume certainly contributes to this endeavor. Interestingly, the extent of the problem of intracranial atherosclerosis and a better understanding of its mechanisms have come up with the more recent advances in neuroimaging, including ultrasound. This book nicely puts this in context and should be a useful reference for those wishing to enter this cutting-edge area of research. No stone is left unturned with a nice chapter on rarer causes of intracranial arterial disease for those confronted with difficult individual cases. Indeed, the book is such that it should be accessible by all those interested in stroke ranging from medical students through to experts in the field. I wish you well in reading this volume. I found it interesting, informative, and addressing an important and emerging area of stroke. I am sure you will find the same. Geoffrey A. Donnan President, World Stroke Organization October 2008
xiii
BLBK041-Kim
August 12, 2008
19:56
Colour Plates
Plate 1.1
Plate 1.6
Intracranial Atherosclerosis Edited by Jong S Kim, Louis R Caplan and KS Lawrence Wong © 2008 Blackwell Publishing Ltd. ISBN: 978-1-405-17822-8
1
BLBK041-Kim
August 12, 2008
19:56
CHAPTER 10
A
B
Plate 2.2
A
B
Plate 2.3
Plate 5.2
2
BLBK041-Kim
August 12, 2008
19:56
COLOUR PLATES
Plate 5.4
Plate 6.5
3
BLBK041-Kim
August 12, 2008
CHAPTER 10
Plate 8.1
Plate 10.1
4
19:56
BLBK041-Kim
August 12, 2008
Plate 11.4
Plate 12.5
19:56
BLBK041-Kim
August 12, 2008
19:56
Plate 12.7
High frequency High frequency with irregular amplitude
Low frequency
Low frequency
Post-FFT spectrum
Pre-FFT time domain signal
M FS High frequency High intensity bi-directional low frequency signal
Post-FFT spectrum
Plate 12.8
Low frequency Pre-FFT time domain signal
BLBK041-Kim
August 12, 2008
19:56
COLOUR PLATES
Plate 15.1
7
BLBK041-Kim
August 12, 2008
19:56
CHAPTER 20
Rest
Plate 20.4
8
Acetazolamide i.v.
BLBK041-Kim
September 22, 2008
17:30
PART ONE
Epidemiology and risk factors
Intracranial Atherosclerosis Edited by Jong S Kim, Louis R Caplan and KS Lawrence Wong © 2008 Blackwell Publishing Ltd. ISBN: 978-1-405-17822-8
BLBK041-Kim
1
September 22, 2008
17:30
Anatomy of intracranial arteries David S Liebeskind and Louis R Caplan
Comprehensive knowledge of intracranial arterial anatomy forms the basis for consideration of intracranial atherosclerosis. Anatomy defines the location of such neurovascular lesions, delineates the extent and involvement of branching perforators, and consequently determines the effects on downstream perfusion. Anatomy is also intertwined with pathophysiology, as vessel morphology influences hemodynamic variables that promote plaque growth and vessel wall constituents may predispose to atherosclerotic involvement. Once an atherosclerotic plaque has formed, the arterial territories within the brain may shift, reflecting diminished perfusion beyond a stenosis and compensatory collateral flow via anastomoses from adjacent arterial sources.1 Simply stated, the anatomical features of these arteries or pipes and their perforators determine perfusion, penumbra, and the parenchymal consequences of brain ischemia. These intracranial vessels differ in anatomy from other circulatory beds in the heart or periphery, with only limited correlates noted in the comparative anatomy of intracranial arteries across species. Arterial anatomy adds to the complexity of neurological localization, providing a unique classification of neurovascular disorders. Consideration of intracranial arterial anatomy is most germane to clinical management where recognition of particular stroke syndromes influences treatment decisions. Identification of a culprit atherosclerotic lesion also hinges on anatomical details of the case. The historical perspective on characterizing anatomy of the intracranial arteries includes an ironic twist where only marginal advances regarding pathol-
ogy of these arterial segments have been made since the autopsy series performed hundreds of years ago, and angiography reigns as the definitive modality for defining these structures almost a century after its introduction. Pathology related to atherosclerotic involvement of the major intracranial arteries has largely eluded modern imaging techniques because of the small size of these vessels and the orientation of these segments that defy conventional imaging planes. Numerous noninvasive methods have been developed to image intracranial arterial anatomy,2 yet these modern vascular imaging techniques including transcranial Doppler ultrasound (TCD), computed tomographic angiography (CTA), and magnetic resonance angiography (MRA) are not as accurate as the gold standard of conventional or digital subtraction angiography (DSA).3 Recently, the advent of angioplasty and stenting for intracranial atherosclerotic disease has reinforced the importance of DSA, since arterial access is needed for treatment. Noninvasive imaging modalities such as TCD, CTA, and MRA each provide differing information regarding a balance of anatomical information, such as measures of the arterial lumen versus physiological data reflecting flow through a specific arterial segment and distal perfusion. DSA remains the prevailing method for evaluating vascular anatomy in the brain, although modifications such as threedimensional rotational angiography (Fig. 1.1) have allowed for expansion across numerous frames of reference. This introductory chapter considers the vascular anatomy of the major intracranial arterial segments supplying blood flow to the brain, emphasizing
Intracranial Atherosclerosis Edited by Jong S Kim, Louis R Caplan and KS Lawrence Wong © 2008 Blackwell Publishing Ltd. ISBN: 978-1-405-17822-8
3
BLBK041-Kim
September 22, 2008
17:30
CHAPTER 1
longitudinal connections develop, including the vertebral arteries that form with involution of the cervical intersegmental arteries. The embryologic development of the circle of Willis is also important to consider when these segments are recruited to later shunt blood flow due to stenosis or occlusions in the anterior or posterior circulations. Previously hypoplastic segments may be recruited and may progressively enlarge over time, whereas others involute because of disuse. The specific events characterizing the embryologic development of particular intracranial arteries are detailed below.
Fig 1.1 Three-dimensional rotational angiography illustrating the proximal segments of the anterior circulation, including bifurcation of the internal carotid artery (A) into the anterior carotid artery (B) and middle cerebral artery (C).
proximal segments where atherosclerotic lesions or stenoses are often noted. The extracranial segments of these vessels are not discussed and only marginal attention has been devoted to distal branches beyond the primary or secondary intracranial arterial divisions. For each artery, the chapter reviews embryologic development, basic morphology such as orientation and luminal dimensions, functional aspects such as perforators, territories, and collateral anastomoses, and common variants encountered in standard anatomy.
Embryology The arteries of the central nervous system originate from mesenchymal elements that coalesce to form channels that cover the surface of the neural tube. Over time, certain channels persist and enlarge to become principal conduits whereas others involute. A single ventral median artery forms, with paired or symmetrical branches that spread out in a circumferential pattern over the surface. A segmental pattern of blood flow predominates the 4- to 12-mm human embryo stage, arising from the branchial arches. Intracranial blood flow at this stage is distributed by the primitive trigeminal, otic or acoustic, and hypoglossal arteries. Early arterial blood flow is centripetal, extending from the periphery to the center. Beyond the 12-mm stage, 4
Arterial wall The majority of anatomical descriptions consider the cerebral vasculature as a mere conduit to supply and return blood through the brain, yet these vascular channels play an active role in the regulation of blood flow in the brain. The proximal segments of the intracranial arteries distribute flow to specific areas of the brain to match metabolic demand during development and for years thereafter. Cerebral perfusion depends on intraluminal pressure and downstream resistance. Because arterial blood pressure is so readily measured and commonly employed as a principal vital sign, the presumption is that cerebral blood flow is principally mediated by blood pressure. Most of the pressure head or arterial pressure gradient is lost before blood flow reaches the terminal branches feeding the cortical surface and deep regions of the brain. Resistance is directly modulated by these proximal arterial circuits and their vessel wall constituents, in addition to other biophysical factors and metabolic orchestration within the intracranial compartment. Unlike the peripheral vasculature, where precapillary sphincters mediate pressure gradients, the cerebral circulation lacks such structures and pressure gradients are modified in the arteries and arterioles of the brain. Flow is also readily shunted or equilibrated via unique anastomotic structures such as the circle of Willis. These features underscore the importance of recognizing the unique role of the proximal arterial circulation in the brain, not just as pipes for flow distribution, but as active physiological elements in metabolic homeostasis. The structural characteristics in the vessel wall that enable such functional capacity are therefore an important anatomical aspect to consider.
BLBK041-Kim
September 22, 2008
17:30
ANATOMY OF INTRACRANIAL ARTERIES
Several features distinguish intracranial arteries from arteries of similar caliber elsewhere in the body. Arteries in the brain have a well-developed internal elastic lamina with only a minimal degree of elastic fibers scattered in the media.4 Unlike arteries elsewhere throughout the body, the intracranial arteries do not have an external elastic lamina. Other distinctive features of the intracranial arteries include the presence of tight endothelial junctions with a relative paucity of pinocytic vesicles, and differing distribution of enzymes within the vessel wall. The adventitial layer is typically thin compared with the systemic arteries. In general, the cerebral arteries have a smaller wall-tolumen ratio than arteries elsewhere in the body.5 Overall, the intimal layer accounts for about 17% of total vessel wall thickness, with the media constituting 52% and adventitia only 31%.6,7 The arterial lumen is defined by the adjacent architecture of the vessel wall. Cerebral endothelial cells with tight junctions form a critical element of the blood–brain barrier.8 These endothelial cells are not fenestrated and the tight junctions bestow only selective permeability to this boundary, preventing exchange of numerous substances. This boundary is often referred to as the “blood–brain barrier.” Under pathophysiologic conditions, this selective permeability boundary may be deranged.9 The number of endocytotic vesicles is also limited compared with the endothelial lining of other vascular beds. Cerebral endothelial cells have a high concentration of mitochondria, denoting their active metabolic role and, possibly, their vulnerability to ischemia.10 Endothelial cells in cerebral arteries and arterioles play an active role in the regulation of hemodynamics. This capacity is partially related to the expression of a wide array of vasoactive substances, including endothelin and nitric oxide.11 The internal elastic lamina of intracranial arteries is fenestrated, with holes that vary in size according to the arterial segment.12 Beyond the endothelial layer, the cerebral arteries have protuberances at distal branching sites that also modulate flow. These structures have been variably defined as intimal cushions, bifurcation pads, or subendothelial protuberances. Underneath the luminal surface, these structures contain groups of smooth muscle cells arranged in irregular fashion, with intertwined collagenous fibrils and are encompassed by the split internal elastic membrane.13 Although the exact role of these structures in titration of arterial pressure has not been fully
elucidated, it appears that these structures help alter flow via fluid shear stress mechanisms. Fluid shear stress is a critical physiological variable both in the development of atherosclerosis and in compensatory arteriogenesis.14,15 A circumferential orientation of the smooth muscle cells at branching sites may be related to titration of arterial inflow resistance by acting via a sphincter-like mechanism. In normal intracranial arteries, smooth muscle cells make up 72% of the media, whereas this composition is radically altered under pathophysiologic conditions such as intracranial atherosclerosis or chronic hypertension.4 Age-related changes are found in the composition of the media. Autonomic nerves located in the tunica adventitia have connections with these subendothelial structures via intercellular smooth muscle cell contacts. Within the media, smooth muscle cells are generally oriented in a pattern circumferential to the lumen except at bifurcations.6 Adjacent collagen and elastin fibers run perpendicular to the smooth muscle layer or in parallel with the long axis of the vessel. The thin medial layer of intracranial arteries compared with systemic vessels is thought to be related to compliance differences associated with surrounding cerebrospinal fluid. The number of smooth muscle cell layers within the media diminishes distally. A basement membrane associated with the adjacent smooth muscle cells forms the framework for adjoining layers of the intima and adventitia. Nerve fibers approach the media from the adventitial layer. Within the adventitia, loose connective tissue surrounds autonomic nerve fibers and all vessel wall structures are enclosed by spindle-shaped fibrocytes. Once beyond the dura mater, the intracranial arteries have no vasa vasorum. The external surface of the intracranial arteries in these regions is in direct contact with surrounding cerebrospinal fluid. A rete vasorum in the adventitia is permeable to large proteins, allowing ingress or exchange with cerebrospinal fluid in the subarachnoid space.16 Characteristics of the intracranial arterial wall in humans typically consider the proximal intracranial arteries such as the middle cerebral artery (MCA) separately from much smaller intracerebral or pial arterioles. As the internal carotid artery (ICA) courses distally, there is progressive disappearance of the external elastic lamina. The MCA is a terminal continuation of the ICA with a gradual change in blood vessel wall characteristics of histopathology. The relative 5
BLBK041-Kim
September 22, 2008
17:30
CHAPTER 1
amounts of intima, media, and adventitia in the MCA are less than the equivalent amount per vessel size in the more proximal ICA. The MCA internal elastic lamina is thicker and partially fenestrated. Compared with similar sized extracranial arteries, the MCAs have less adventitia with less elastic tissue and few perivascular supporting structures, including an absence of vasa vasorum.17
Internal carotid artery Each ICA supplies approximately 40% of total perfusion to the brain. The ICA develops from the third primitive aortic arch. The distal cervical segment of the ICA arises from the junction of the distal aspect of this third primitive aortic arch with the dorsal aorta. The ICA arises from the common carotid artery in the neck, extending into the head at the skull base via the carotid canal (Fig. 1.2). There are three named segments of the intracranial ICA, including petrous, cavernous, and supraclinoid segments (Fig. 1.3). The petrous ICA extends for about 25–35 mm anteromedially from the skull base to the cavernous sinus.18 The shape of the petrous ICA varies depending on the development of the surrounding bony structures skull. Along this course, it bends anterior to the tympanic cavity near the apex of the petrous bone and traverses the posterior aspect of the foramen lacerum. The ICA crosses the membranes of the cavernous sinus, winding anteriorly and superomedially, then ascending vertically in a groove along the sphenoid bone and then passing along the medial aspect of the anterior clinoid process. On exiting the cavernous sinus, the ICA extends through the meninges to become the supraclinoid segment. The cavernous ICA typically averages 39 mm in length. The supraclinoid or cerebral ICA bends posteriorly and laterally between the oculomotor (III) and optic (II) nerves. Because of this sinuous course of the ICA, the cavernous and supraclinoid segments are often collectively referred to as the carotid siphon. Beyond the supraclinoid segment, the ICA terminates at the bifurcation into the anterior carotid artery (ACA) and MCA. This bifurcation is often referred to as the “carotid T” because of its shape or the “top-of-the carotid” because of its location. Along the course of the intracranial ICA, branching progressively increases with more distal locations.19 6
Fig 1.2 Gadolinium-enhanced magnetic resonance angiography depicting the course of the right internal carotid artery (ICA) from its extracranial origin at the carotid bifurcation (A), through the carotid canal at the skull base (B), to become the intracranial ICA (C).
Fig 1.3 Line drawing of the intracranial internal carotid artery, depicting the petrous (A), cavernous (B), and supraclinoid (C) segments.
BLBK041-Kim
September 22, 2008
17:30
ANATOMY OF INTRACRANIAL ARTERIES
The petrous segment gives rise to the caroticotympanic artery, supplying the tympanic cavity, and the pterygoid or vidian branch passing through the pterygoid canal.18 This vidian artery anastomoses with the internal maxillary artery. On occasion, the persistent stapedial branch of the petrous segment traverses a bony canal and continues as the middle meningeal artery.18 The cavernous portion, however, has far more tributaries including the meningohypophyseal trunk, the anterior meningeal artery, the artery to the inferior portion of the cavernous sinus, and the ophthalmic artery. The meningohypophyseal trunk further subdivides into diminutive branches that include the basal and marginal (artery of Bernasconi and Cassinari20 ) tentorial arteries, the inferior hypophyseal artery, and the dorsal meningeal artery. The inferolateral trunk arises from the inferolateral aspect of the cavernous ICA, supplying many small branches to the tentorium and trigeminal (V) nerve divisions. Collateral anastomoses between the ICA and the external carotid artery (ECA) are formed by the inferolateral trunk extending to the internal maxillary artery. The supraclinoid ICA also has numerous branches including the superior hypophyseal perforators to the anterior pituitary and stalk, posterior communicating artery (PCoA), and anterior choroidal artery (AChA) before bifurcating into the ACA and MCA.21 The two ACAs connect through the anterior communicating artery (ACoA) thus joining the left and right carotid circulations. The PCoA extends posteriorly to connect with the primary segment of the posterior cerebral artery, allowing collateral flow to pass between the anterior and posterior circulations.1 This vascular network, referred to as the circle of Willis (Fig. 1.4), plays a critical role in shunting blood flow between adjacent territories in the brain. At its origin, the PCoA often has a widened segment referred to as the infundibulum. The PCoA passes ventral to the optic tract, with perforators that supply the optic tract, posterior aspect of the chiasm, posterior hypothalamus, and anterior and ventral nuclei of the thalamus. In 15% of individuals, this vessel continues distally as the posterior cerebral artery.22,23 Great variability may be noted in the caliber of the PCoA, ranging from less than 1 mm to greater than 2 mm. The anatomy of the PCoA differs in various populations and in clinical conditions associated with ischemia.23,24 Hypoplasia or absence of the PCoA is
Fig 1.4 Line drawing of anastomotic connections at the circle of Willis, including the anterior communicating artery (A), the proximal or A1 segment of the anterior carotid artery (B), the posterior communicating artery (C), and the proximal or P1 segment of the posterior cerebral artery (D).
found in a minority of cases at autopsy, with bilateral hypoplasia in only 0.25% of individuals.22 The configuration and size of the PCoA also differs between rates gleaned from autopsy studies and angiography series. There are numerous variant configurations of the ICA, including its rare absence or hypoplasia. The amount of blood volume supplied to distal structures can vary depending on the caliber of the terminal ICA. The course of the ICA sometimes varies, coursing through the middle ear or bending towards the midline in a configuration termed kissing ICAs at the cavernous segments. Anomalous origins of the posterior fossa arteries from the ICA, including the superior cerebellar artery (SCA), anterior inferior cerebellar artery (AICA), or posterior inferior cerebellar artery (PICA), may also occur. Persistent fetal connections to the posterior circulation may involve the PCoA, trigeminal, otic or acoustic, hypoglossal, and proatlantal intersegmental arteries. The persistent trigeminal artery is the most common persistent embryonic connection (85%), arising from the cavernous ICA and joining the upper basilar artery.25 The persistent otic artery is very rare, connecting the petrous ICA with the basilar artery inferior to AICA. The persistent hypoglossal connects the distal cervical ICA with 7
BLBK041-Kim
September 22, 2008
17:30
CHAPTER 1
the distal vertebral artery. Intercavernous ICA collaterals may also allow for blood to flow laterally to either hemisphere.
Anterior choroidal artery The AChA arises from the posterior aspect of the ICA, about 2–4 mm distal to the origin of the PCoA and about 5 mm proximal to the carotid terminus.26 The AChA is relatively small, yet serves as an important landmark in delineating important structures at angiography.27 There are two segments of the AChA, including the cisternal and plexal segments. The AChA may have a single origin or may consist of several smaller vessels (4% of individuals).26,28 The AChA arises from the MCA or PCoA in 2–11% of individuals.28 Complete absence of the AChA has also been reported.27 The external diameter of this vessel is often only 0.5–1 mm, although a reciprocal relationship has been noted in the caliber of this vessel with the ipsilateral PCoA. The cisternal segment passes posteriorly from the lateral to medial aspect of the optic tract in close proximity to the posterior cerebral artery (PCA), extending for about 12 mm, extending to a total length of about 26 mm. The AChA gives off penetrating branches to the optic tract in this segment. As the AChA courses posteriorly it gives off penetrating branches to the globus pallidus and the genu and posterior limb of the internal capsule. Subsequent branches extend laterally to supply the medial temporal lobe cortex, hippocampal and dentate gyri, caudate, and amygdala. Medial branches supply the cerebral peduncle, substantia nigra, red nucleus, subthalamus, and ventral anterior and lateral nuclei of the thalamus. The AChA is the only branch of the ICA that supplies a portion of both the anterior and posterior circulation, although the midbrain and thalamic supply is very variable. More distally, the AChA extends through the choroidal fissure to become the plexal segment. The juncture of the AChA at the choroidal fissure is often referred to as the plexal point. The plexal segment then enters the choroid plexus near the posterior aspect of the temporal horn. Arterial supply of this segment includes the lateral geniculate body, optic radiations, and posterior limb of the internal capsule. The AChA anastomoses with lateral branches of the posterior choroidal artery, PCoA, PCA, and MCA.27,29 Variants include AChA origin from the PCoA or MCA. 8
Middle cerebral artery The MCA provides arterial blood flow to the largest extent of the intracranial circulation. The MCA is typically 75% of the caliber of the parent ICA.30 After diverging from the terminal ICA below the anterior perforated substance, it courses horizontally and slightly anteriorly to reach the sylvian fissure, where branches perfuse the frontal, parietal, and some extent of the temporal and occipital cortices (Fig. 1.5). The proximal or horizontal segment of the MCA averages around 15 mm in length yet may be as long as 30 mm.30 At younger ages, the M1 segment rises obliquely but this segment tends to course more inferiorly or anteriorly with increasing age later in life.31 Between the 7 and 12 mm (7 weeks) embryonic stage, small perforators that are precursors of the MCA may be seen arising from the ICA. The MCA is smaller than the AChA at these early stages and then grows larger. During the second month of fetal life, the sylvian
Fig 1.5 Schematic of the middle cerebral artery, illustrating the proximal segment or M1, lenticulostriate arteries (LSA), and bifurcation into M2, with downstream territories delineated between adjacent anterior carotid artery and posterior cerebral artery regions.
BLBK041-Kim
September 22, 2008
17:30
ANATOMY OF INTRACRANIAL ARTERIES
fissure develops as a groove over the cerebral hemisphere and the MCA grows within this depression. The MCA becomes enveloped in the sulcation of the cerebral cortex, following the growth of each specific brain region. The proximal or M1 division of the MCA provides lenticulostriate arteries that feed the globus pallidus, putamen, internal capsule, corona radiata, and caudate nucleus. This segment is typically around 2.5 mm in internal diameter.30 These end arteries originate from the M1 segment in almost perpendicular fashion to penetrate the brain parenchyma. The lateral lenticulostriates ascend for 2–5 mm posteromedially from the M1 and then course laterally and superiorly for an additional 9–30 mm to penetrate the internal capsule. The medial lenticulostriates generally arise from more proximal segments of the MCA or from distal reaches of the terminal ICA and proximal ACA.32–35 There is considerable variation in the relative distribution and origins of medial versus lateral lenticulostriate perforators. The arterial diameter of lateral lenticulostriates is typically greater than the medial lenticulostriate perforators. Overall, there are typically 5–17 lenticulostriate arteries, although all are barely identifiable at angiography.30 There are three principal patterns that have been described for the anatomy of the lenticulostriates.32–35 Grand et al.33 described a pattern where either one or more of the larger lenticulostriates arise just beyond the MCA bifurcation (49%), all arise proximal to the major bifurcation (39%), and a minority of cases where some of the larger perforators arise from the medial portion of the stem. According to Jain,34 54.1% originate from the MCA trunk, 25.6% from the division point, and 20.3% from one of the branches of the MCA. The lateral lenticulostriates supply the lateral portion of the anterior commissure, the putamen, the lateral segment of the globus pallidus, the superior half of the internal capsule, the adjacent corona radiate, and the body and head of the caudate nucleus. The medial lenticulostriates arise in perpendicular fashion to the parent MCA or ACA, yet bend in mesial fashion. The areas supplied by the medial lenticulostriates, including the prominent recurrent artery of Heubner, and the AChA are adjacent to the territories of the lateral lenticulostriates. The relative territorial extents are reciprocal in size and depend on the development of each of these arterial groups.32–35
The largest branch of the proximal MCA is the anterior temporal artery, extending from the middle of the proximal MCA and winding anteriorly and inferiorly. Although the configuration of the proximal MCA often varies, the vessel most often splits into two or more principal divisions near the sylvian fissure. Although prior studies have suggested symmetry in the morphology of bilateral MCAs, no clear correlations exist. The anterior and posterior divisions of the MCA extend into the sylvian fissure and spread out over the hemisphere. These cortical branches include the temporopolar, frontobasal, operculofrontal, precentral, postcentral, posterior parietal, angular, anterior temporal, middle temporal, and posterior temporal arteries. As the MCA branches loop over the insula in the sylvian fissure, they form the sylvian triangle, a landmark classically used to identify mass lesions on angiography. Terminal branches of the MCA form collateral anastomoses with the ACA and PCA.1 Variation in MCA anatomy is less common than variants in other intracranial arteries. Fenestration of the M1 segment occurs, and duplicated M1 segments may also arise from the ICA.36 Angiographic demonstration of MCA fenestration may be evident in approximately 0.26% of individuals.37 Yamamoto et al.38 described 14 accessory MCAs and seven duplicated MCAs in a series of 455 bilateral carotid angiographies. The M1–M2 junction is characterized by a bifurcation in 64–90% of individuals, trifurcation in 12–29%, and complex branching in isolated individuals.30 Some controversy has surrounded specific landmarks and associated classification of the MCA segments. Whereas many identify the segments of the MCA based on each successive branch point, others use a nomenclature that relates each of these MCA segments with a specific adjacent anatomical structure. For instance, some refer to the M2 origin at the initial bifurcation of the proximal or M1 MCA, whereas others identify the M2 segment as the arterial segment that overlies the insula.
Anterior cerebral artery The ACA develops from residual elements of the primitive olfactory artery at the terminus of the ICA. The paired primitive olfactory arteries from each side form a plexus in the midline that gives rise to the ACoA. During development, the ACA extends superiorly and 9
BLBK041-Kim
September 22, 2008
17:30
CHAPTER 1
Fig 1.6 CT angiography illustration of two different configurations in the anterior carotid artery (ACA) complex and anterior communicating artery (ACoA) anastomosis.
(A) A patent ACoA provides interhemispheric flow between left and right ACAs. (B) ACoA is absent, yet a prominent recurrent artery of Heubner (RAH) is demonstrated.
then posteriorly over the hemispheres in the midline whereas the remainder of the primitive olfactory artery regresses to become a small perforating vessel. The ACA is typically 50% of the caliber of the parent ICA.39 The internal diameter of the A1 is usually 0.9– 4 mm, with hypoplasia defined as a diameter less than 1 mm. The A1 segment measures 7–18 mm, with an average span of 12.7 mm.39 The ACA extends anteromedially between the optic chiasm (70% of individuals) or optic nerve (30% of individuals) and the anterior perforated substance to join the contralateral ACA through an anastomosis via the ACoA. The ACoA forms the anterior aspect of the circle of Willis, a critical route for collateral flow between the cerebral hemispheres. The ACoA is the shortest cerebral artery, measuring only 0.1–3 mm in length.39 The anatomy of the ACA–ACoA is variable (Fig. 1.6) with hypoplasia of different segments, including absence of the ACoA. Accessory routes, fenestrations, and other complex azygous connections between the proximal ACAs are also described. The proximal ACA or A1 segment gives off numerous perforating arteries that supply the adjacent optic nerves and chiasm inferiorly, and the hypothalamus, septum pellucidum, anterior commissure, fornix, and corpus striatum. These mesial lenticulostriate vessels often include a prominent recurrent artery of Heubner
that supplies the caudate head, putamen, and anterior limb of the internal capsule.40 The A2 segment begins at the juncture of the ACA with the ACoA and extends to the genu of the corpus callosum. The recurrent artery of Heubner arises from the A2 segment in 49–78% of individuals.39 The recurrent artery of Heubner may be a single vessel or can be represented by a number of parallel arteries. Beyond the proximal segment of the ACA, azygous connections allow for shunting of flow between the cerebral hemispheres. The ACAs course over the cerebral hemispheres in the interhemispheric fissure as paired vessels, with their distal extent typically determined by the corresponding anatomy of the PCAs. Subsequent divisions including the pericallosal and callosomarginal arteries divide to provide arterial supply to the corpus callosum and anteromesial cortices. Several variations in distal ACA anatomy have been described, including the observation that the left pericallosal artery is located more posteriorly than the corresponding rightsided vessel in 72%.41 Similarly, absence of the callosomarginal artery has been noted in 18–60% of cases studied.41 Cortical branches of the ACA include the orbitofrontal, frontopolar, callosomarginal, and pericallosal arteries. As the terminal portion of the ACA travels along the corpus callosum, its anterior pericallosal
10
BLBK041-Kim
September 22, 2008
17:30
ANATOMY OF INTRACRANIAL ARTERIES
branches form anastomoses with the posterior pericallosal branches of the PCA.41 Variant anatomy of the ACA most commonly includes hypoplasia or absence of the A1 segment (10% of individuals).39 Other variations may include anomalous origin of the ACA from the ICA, agenesis or accessory branches, direct connection of bilateral A1 segments, or other combinations that involve azygous orientation of distal ACA segments.
Vertebral artery The vertebral artery enters the skull at the level of C1 through the foramen magnum. The intracranial or intradural (V4) segment of the vertebral artery ascends anteriorly to the medulla, approaching the midline at the pontomedullary junction, where it meets the contralateral vertebral artery to form the basilar artery. The paired longitudinal arteries that form the arterial supply to the posterior circulation during early fetal development retain their proximal course as the vertebral arteries. The left vertebral artery is larger than the right 42% of the time, whereas the right is larger than the left 32% of the time. In the remainder of individuals, the vertebral arteries are equivalent in caliber. Vertebral artery hypoplasia is fairly common, often involving the right side. The frequency of this finding depends largely on the modality used to image the vessel, the size threshold used to define hypoplasia, and the study population, including healthy subjects or patients with ischemic stroke. Defining hypoplasia as ≤2 mm by ultrasonography, one group reported a frequency of 1.9% in 451 subjects.42 Among healthy subjects with a threshold of <3 mm, another group noted a frequency of 6% in 50 healthy subjects.43 Others have recently noted a frequency as high as 35.2% in 529 patients with ischemic stroke.44 Utilizing a luminal diameter threshold of 2.2 mm, prominent asymmetry in vertebral artery hypoplasia has also been described (7.8% on the right and 3.8% on the left) in 447 subjects.45 Differentiation of hypoplasia from a diseased arterial segment may be difficult to define on the basis of luminal dimensions alone. The configuration or compensatory enlargement of neighboring segments may provide clues to this distinction. Furthermore, definitions may vary considerably depending on the imaging technique employed. The vertebral artery may also terminate in the PICA rather than ex-
tend to the junction with the basilar artery. In such cases, the vertebral artery is generally smaller than the contralateral vertebral artery. The terminal vertebral artery yields several branches that supply the rostral end of the spinal cord and posterior inferior aspect of the cerebellum. Anterior and posterior spinal arteries extend from this segment. Each anterior spinal artery fuses with its counterpart, supplying the ventral medulla and rostral spinal cord. The posterior spinal arteries do not pair in the midline, but descend the spinal cord at the level of the dorsal roots. The posterior inferior cerebellar artery branches from the vertebral artery to supply the inferior aspect of the cerebellum.
Posterior inferior cerebellar artery The largest tributary of the vertebral artery is the PICA, arising 10–20 mm before the vertebrobasilar junction (Fig. 1.7).46 In 20% of individuals, the PICA arises from below the foramen magnum.47 During embryogenesis, the PICA may be evident as a larger branch of numerous arteries that extend posteriorly from the hindbrain in the 20–24 mm embryo stage.
Fig 1.7 Digital subtraction angiography of the posterior inferior cerebellar artery (PICA), showing proximal medullary segments and hemispheric tributaries.
11
BLBK041-Kim
September 22, 2008
17:30
CHAPTER 1
At later stages, this vessel continues to predominate, growing into the largest arterial offshoot. There are four segments of this vessel, including the anterior, lateral, posterior medullary, and supratonsillar PICA. The anterior medullary segment travels laterally near the inferior aspect of the olive of the medulla oblangata, continuing in a loop that courses between the cerebellum and medulla. Numerous perforating arteries extend from the first three segments of the PICA to supply anterior, lateral, and posterior aspects of the medulla. The PICA then extends posteriorly in the tonsillomedullary fissure adjacent to the glossopharyngeal (IX) and vagus (X) nerves. Beyond this point, the PICA curves over the cerebellar tonsil to become the supratonsillar segment extending further across the cerebellum as the medial and lateral terminal PICA branches. At the juncture of the posterior medullary and supratonsillar segments of the PICA, perforating vessels arise to feed the choroid plexus of the fourth ventricle. This choroidal point is used as a landmark to identify masses within the posterior fossa. Variations in PICA anatomy include hypoplasia or absence of this branch (10–20% of individuals), typically accompanied by a prominent ipsilateral anterior inferior cerebellar artery. Absence of the PICA is also accompanied by numerous medullary perforators that arise directly from the vertebral artery. Duplication of the PICA and double origin with distal arterial convergence of the PICA48 may occur. PICA–AICA connections and other anomalies may be seen, yet the specific frequencies of such anatomic configurations remain unclear. On occasion, both inferior cerebellar territories may be supplied by a bihemispheric PICA originating from one vertebral artery.49
Basilar artery The basilar artery extends from the confluence of the vertebrals near the pontomedullary junction to the terminal bifurcation as the PCAs at the level of the midbrain. During embryologic development, paired vessels on the ventral surface of the hindbrain fuse to form the basilar artery. Distal segments of these paired basilar arteries have connections with the ipsilateral ICA. Over time, the plexus formed by the paired basilar arteries fuses with progressive disappearance of fenestrations. The basilar artery is often tortuous or serpentine, with a straight course noted about 25% of the 12
Fig 1.8 Schematic of posterior circulation, demonstrating cerebellar arteries including superior cerebellar artery (SPA), anterior inferior cerebellar artery (AICA), and posterior inferior cerebellar artery (PICA).
time. Curvature of the basilar as it ascends has been associated with the presence of a wider contralateral vertebral artery, suggesting hemodynamic modeling. The length of the basilar artery is consistently 25–35 mm, irrespective of body size.50 The diameter is about 2.7– 4.3 mm at the proximal portion. The luminal diameter of the basilar artery tends to taper towards the distal end. The largest branches of the basilar artery include the anterior inferior cerebellar artery (AICA) and superior cerebellar artery (SCA) (Fig. 1.8). Numerous smaller perforators embrace the brainstem, coursing from the midline ventral aspect around the surface to the lateral dorsal surface, and diving deep into the substance of the brainstem between fiber tracts. These pontine perforators are grouped into medial and lateral subdivisions, often referred to as paramedian and circumferential arteries. Lateral pontine perforators extend to also supply the ventrolateral surface of the cerebellum, whereas the medial perforators perfuse midline structures of the midbrain. There is a somewhat downward trajectory of brainstem perforating arteries so that the most rostral portion of the basilar artery supplies penetrators to the pontine tegmentum. The internal auditory or labyrinthine artery may arise from the basilar to provide arterial blood flow to the cochlea, labyrinth, and facial (VII) nerve.51 Alternatively, this artery may arise as a branch of the AICA. Owing to the paired structure of posterior circulation arteries,
BLBK041-Kim
September 22, 2008
17:30
ANATOMY OF INTRACRANIAL ARTERIES
asymmetries or relative dominance of one artery such as the PICA, AICA, or SCA may occur. Contralateral cerebellar infarction may therefore result from occlusion or disease of one cerebellar artery. The frequencies of such patterns vary and are difficult to estimate, although the advent of MRI and MRA allows for systematic evaluation of such relatively subtle features. Terminal branches of the PICA, AICA, and SCA form anastomoses that allow for collateral flow to easily shift between their arterial territories.1,52
Anterior inferior cerebellar artery The AICA extends off of the basilar artery approximately one-third to halfway through its course.52 The AICA arises from the caudal third of the basilar 74% of the time.52 This artery is the smallest of the principal cerebellar arteries. During development, the AICA appears as one of the larger perforatoring vessels extending to the posterior aspect of the hindbrain. The AICA extends laterally and inferiorly, in close proximity to the abducens (VI) nerve. Similar to the lateral pontine perforators, it courses around the brainstem and then enters the cerebellopontine angle cistern along with the facial (VII) and vestibulocochlear (VIII) nerves. The AICA crosses the anteroinferior aspect of the cerebellum to supply the middle cerebellar peduncle, flocculus, and adjacent cerebellum. The AICAs supply a rather small variable portion of the anterior inferior cerebellum.53 The supply to the brachium pontis and flocculus is consistent. Numerous pontine perforators may arise from its proximal segment. The lateral branch runs across the cerebellum in the horizontal fissure. The medial branch of the AICA courses inferiorly to supply the biventral lobule. Similar to absence of the PICA, the AICA may be absent or hypoplastic and is typically accompanied by a prominent PICA. Variable infarct patterns may be noted in these regions of the posterior circulation, likely reflecting arterial configurations of the principal cerebellar arteries that may involve hypoplastic segments or anomalous anastomoses.53,54 Combined or multiple territorial infarcts such as the PICA and AICA or AICA and SCA may reflect dominant patterns of arterial supply originating from the vertebral and basilar arteries. Similarly, collateral anastomoses between these territories may provide sufficient arterial inflow to spare distal segments of a particular arterial territory. As individ-
ual anatomy is often studied only after the onset of stroke, the original arterial configuration and mechanistic events may only be surmised. Similarly, the frequency of specific arterial supply patterns may be difficult to ascertain in the healthy population as individuals are most often studied after presentation with potential neurovascular disorders.
Superior cerebellar artery The SCA also extends from the basilar in symmetric fashion, just proximal to the terminal bifurcation of the basilar into the proximal PCAs. SCA morphology is more consistent across individuals than other cerebellar branches.55 The SCA courses laterally below the oculomotor (III) nerve, passing around the cerebral peduncles and below the trochlear (IV) nerve.28 Numerous perforators extend from the proximal or ambient SCA to supply the adjacent pons and midbrain, whereas distal segments split into the lateral marginal and superior vermian branches. These divisions may also arise independently from the basilar artery or even the PCA. Duplication of the SCA is noted in 28% of individuals, with bilateral duplication in 10%.56 The SCA variably divides into medial SCA and lateral SCA branches. The lateral marginal SCA supplies the anterosuperior cerebellum, superior cerebellar peduncle, middle cerebral peduncle, and dentate nuclei. The superior vermian SCA supplies the superior cerebellar peduncle, tentorium, inferior colliculi, cerebellar hemispheres, and dentate nuclei. Anastomoses between this branch and the inferior vermian branch of the PICA allow for robust collateral perfusion across the cerebellar hemispheres.57
Posterior cerebral artery The PCA develops from fusion of several vessels that supply the mesencephalon, diencephalon, and choroid plexus in the fetus.58 These vessels stem from the terminal aspect of the PCoA at the distal end of the carotid circulation. The PCA most often then extends posteriorly to spread over the ipsilateral cortex, whereas the proximal connection with the PCoA regresses. In this common scenario, the primary arterial supply shifts to a source from the terminal basilar artery. In the remainder of individuals, the PCA supply continues 13
BLBK041-Kim
September 22, 2008
17:30
CHAPTER 1
Fig 1.9 Digital subtraction angiography illustrating posterior cerebral artery anastomosis with posterior communicating artery, thalamoperforators, and distal cortical branches.
from what has been termed a fetal PCoA. Variants of PCoA anatomy include a diverse range of caliber in this segment, complete agenesis, and anomalous origins of other vessels from this arterial segment.59 The PCA extends from the terminal portion of the basilar artery in the interpeduncular cistern, passing above the oculomotor (III) nerve to circle the midbrain above the tentorium (Fig. 1.9). As it passes through the peduncular, ambient, and quadrigeminal cisterns, numerous perforators supply adjacent structures.60 This pattern of arterial limbs includes paramedian perforators, short circumferential and long circumferential branches that typify the general structure of the major arterial territories in the posterior circulation. The perforating arteries from these segments range from 200 μm to 800 μm in diameter.60 The artery of Davidoff and Schechter extends from the P1 segment to supply part of the inferior surface of the tentorium. The midbrain receives arterial blood from the peduncular or P1 segment before posterior thalamoperforators arise. In the successive ambient segment, the thalamogeniculate arteries diverge to supply the lateral geniculate and pulvinar nuclei. Medial and lateral 14
branches of the posterior choroidal arteries extend from this portion of the PCA to supply the pineal gland, third ventricle, dorsomedial thalamus, pulvinar, lateral geniculate body, and choroid plexus.61 These distal posterior choroidal arteries form anastomoses with the AChA. These deep arterial territories composed of perforatoring arterioles that encompass the thalamus are often difficult to comprehend because of their complex configuration (Fig. 1.10).62 The P1 or proximal PCA serves as an important arterial segment in this configuration, with variable contributions from the basilar artery, PCoA, and AChA.63 These vessels have perforators that supply these critical structures at the juncture between the anterior and posterior circulations. The anterior thalamoperforating arteries consist of about 7–10 branches that arise from the superior and lateral surfaces of the PCoA.63 A larger branch, the premamillary artery, is often noted.64 This vessel courses from the posterior aspect of the PCoA, penetrates the hypothalamus and subsequently terminates in branches that supply the anterior and ventroanterior nuclei of the thalamus. Further posteriorly, the thalamus is
Fig 1.10 Schematic of the arterial supply to the thalamus, illustrating premamillary arteries (A), interpeduncular perforators (B), thalamogeniculate arteries (C), posterior choroidal arteries (PCoA) (D), and anterior choroidal artery (AChA) (E). PCA, posterior cerebral artery.
BLBK041-Kim
September 22, 2008
17:30
ANATOMY OF INTRACRANIAL ARTERIES
supplied by a combination of vessels arising from the posterior circulation. Interpeduncular branches from the basilar artery and P1 segment ascend superiorly to perfuse mesial aspects of the thalamus. More lateral aspects of the thalamus, including the ventroposteromedial and ventroposterolateral nuclei are supplied by the thalamogeniculate arteries.65 These typically consist of 3–5 small branches that penetrate the inferior aspect of the thalamus and also supply blood to the geniculate bodies.60 The most posterior reaches of the thalamus are supplied via the posterior choroidal arteries, arising from more distal aspects of the subcortical PCA. These posterior choroidal branches supply portions of the medial nuclei, habenula, and rostromedial pulvinar, and choroid plexus.66 The posterior choroidal arteries adjoin and overlap to some extent with distal reaches of the AChA, extending from the ICA to supply lateral and posterior regions of the thalamus. The PCA passes along the free edge of the tentorium to eventually reach the medial aspect of the occipital lobe. Further branching within the hippocampal fissure produces cortical divisions that course over the inferior and mesial aspects of the hemisphere. The cortical territories of the PCA are supplied via the anterior and posterior divisions, fanning out to follow the architecture of the cortical surface in these regions. Cortical branches of the PCA include the hippocampal, anterior temporal, middle temporal, posterior temporal, parieto-occipital, calcarine, and posterior pericallosal or perisplenial arteries.67 Anastomoses of the PCA allow for collateral flow into the MCA via the anterior and posterior temporal arteries and into the ACA via pericallosal divisions that arise from the quadrigeminal PCA.1
Conclusions Anatomy and physiology, or pathophysiology such as intracranial atherosclerosis, are inextricably linked. Knowledge of abnormal or pathological conditions such as intracranial atherosclerosis stems from detailed recognition of the normal or baseline pattern of vascular anatomy. The vascular anatomy of the intracranial arteries, at the level of the vessel wall and as a larger structure or conduit, is a reflection of physiology over time, from in utero stages through adult life. The embryologic development of these structures is
therefore pivotal, for understanding the flux of carotid supply to the hindbrain that ultimately determines PCoA morphology or for deciphering the complex pattern of evolving cortical architecture that shapes distal arterial territories. Variant anatomy may also be understood from this perspective, as persistence of embryologic variants typically reflects ongoing flow requirements. The unique characteristics of arteries at the base of the brain may help our understanding of atherosclerotic lesions that tend to afflict specific arterial segments. Replacement of smooth muscle cells in the arterial media with other cellular components or focal increases in fluid shear stress because of vessel morphology may hasten disease. Similarly, medical and endovascular therapeutic strategies may be refined through consideration of this unique anatomical system. Although much of the knowledge regarding intracranial arteries originates from pathology and angiography series over several centuries, evolving noninvasive techniques have rapidly expanded our perspective on these key arterial segments. As each modality provides a depiction that combines anatomy and flow physiology, it is important to interpret each image with a solid understanding of typical arterial anatomy. Ongoing studies that illustrate the anatomy and pathophysiology of these proximal arterial segments across modalities will help refine our knowledge of the interplay between vascular anatomy and cerebral blood flow. Such descriptions will likely extend far beyond the current standard of characterizing a vascular lesion solely based on the degree of luminal stenosis. Although distal arterial segments have not been emphasized in this chapter, collateral anastomoses at such sites may greatly influence disease management of intracranial atherosclerosis in the proximal intracranial arteries. Collateral flow should theoretically be inconsequential or nonexistent if an atherosclerotic lesion is not hemodynamically significant, determined by a critical threshold around 60–70%. Nevertheless, anecdotal descriptions relate findings of collateral flow with even slight or moderate stenoses. Future studies may help elucidate pivotal arterial factors far beyond the degree of stenosis, examining downstream influences on cerebral perfusion, artery-to-artery thromboembolic potential, amenability to endovascular therapies and stent conformation, or propensity for restenosis due to biophysical factors. 15
BLBK041-Kim
September 22, 2008
17:30
CHAPTER 1
References 1 Liebeskind DS. Collateral circulation. Stroke 2003; 34: 2279–2284. 2 Parmar H, Sitoh YY, Hui F. Normal variants of the intracranial circulation demonstrated by MR angiography at 3T. Eur J Radiol 2005; 56: 220–228. 3 Feldmann E, Wilterdink JL, Kosinski A, et al. The Stroke Outcomes and Neuroimaging of Intracranial Atherosclerosis (SONIA) trial. Neurology 2007; 68: 2099–2106. 4 Stehbens WE. Pathology of the cerebral blood vessels. St Louis, MO: CV Mosby 1972. 5 Walmsley JG, Canham PB. Orientation of nuclei as indicators of smooth muscle cell alignment in the cerebral artery. Blood Vessels 1979; 16: 43–51. 6 Walmsley JG. Vascular smooth muscle orientation in curved branches and bifurcations of human cerebral arteries. J Microsc 1983; 131: 377–389. 7 Walmsley JG. Vascular smooth muscle orientation in straight portions of human cerebral arteries. J Microsc 1983; 131: 361–375. 8 Farrall AJ, Wardlaw JM. Blood–brain barrier: ageing and microvascular disease – systematic review and metaanalysis. Neurobiol Aging (in press). 9 Bang OY, Buck BH, Saver JL, et al. Prediction of hemorrhagic transformation after recanalization therapy using T2∗ -permeability magnetic resonance imaging. Ann Neurol 2007; 62: 170–176. 10 Oldendorf WH, Cornford ME, Brown WJ. The large apparent work capability of the blood–brain barrier: a study of the mitochondrial content of capillary endothelial cells in brain and other tissues of the rat. Ann Neurol 1977; 1: 409–417. 11 McCarron RM, Chen Y, Tomori, T, et al. Endothelialmediated regulation of cerebral microcirculation. J Physiol Pharmacol 2006; 57 (Suppl 11): 133–144. 12 Hassler O. The windows of the internal elastic lamella of the cerebral arteries. Virchows Arch Pathol Anat Physiol Klin Med 1962; 335: 127–132. 13 Takayanagi T, Rennels ML, Nelson E. An electron microscopic study of intimal cushions in intracranial arteries of the cat. Am J Anat 1972; 133: 415–429. 14 Heil M, Eitenmuller I, Schmitz-Rixen T, Schaper W. Arteriogenesis versus angiogenesis: similarities and differences. J Cell Mol Med 2006; 10: 45–55. 15 Schaper W, Scholz D. Factors regulating arteriogenesis. Arterioscler Thromb Vasc Biol 2003; 23: 1143–1151. 16 Zervas NT, Liszczak TM, Mayberg MR, Black PM. Cerebrospinal fluid may nourish cerebral vessels through pathways in the adventitia that may be analogous to systemic vasa vasorum. J Neurosurg 1982; 56: 475–481.
16
17 Clower BR, Sullivan DM, Smith RR. Intracranial vessels lack vasa vasorum. J Neurosurg 1984; 61: 44–48. 18 Quisling RG, Rhoton AL, Jr. Intrapetrous carotid artery branches: radioanatomic analysis. Radiology 1979; 131: 133–136. 19 Allen JW, Alastra AJ, Nelson PK. Proximal intracranial internal carotid artery branches: prevalence and importance for balloon occlusion test. J Neurosurg 2005; 102: 45–52. 20 Frugoni P, Nori A, Galligioni F, Giammusso V. Further considerations on the Bernasconi and Cassinari’s artery and other meningeal rami of the internal carotid artery. Neurochirurgia (Stuttg) 1964; 108: 18–23. 21 Gibo H, Lenkey C, Rhoton AL, Jr. Microsurgical anatomy of the supraclinoid portion of the internal carotid artery. 1981; J Neurosurg 55: 560–574. 22 Alpers BJ, Berry RG, Paddison RM. Anatomical studies of the circle of Willis in normal brain. AMA Arch Neurol Psychiatry 1959; 81: 409–418. 23 Schomer DF, Marks MP, Steinberg GK, et al. The anatomy of the posterior communicating artery as a risk factor for ischemic cerebral infarction. N Engl J Med 1994; 330: 1565–1570. 24 Eftekhar B, Dadmehr M, Ansari S, Ghodsi M, Nazparvar B, Ketabchi E. Are the distributions of variations of circle of Willis different in different populations? Results of an anatomical study and review of literature. BMC Neurol 2006; 6: 22. 25 Uchino A, Kato A, Takase Y, Kudo S. Persistent trigeminal artery variants detected by MR angiography. Eur Radiol 2000; 10: 1801–1804. 26 Rhoton AL, Jr, Fujii K, Fradd B. Microsurgical anatomy of the anterior choroidal artery. Surg Neurol 1979; 12: 171–187. 27 Takahashi S, Suga T, Kawata Y, Sakamoto K. Anterior choroidal artery: angiographic analysis of variations and anomalies. AJNR Am J Neuroradiol 1990; 11: 719– 729. 28 Saeki N, Rhoton AL, Jr. Microsurgical anatomy of the upper basilar artery and the posterior circle of Willis. J Neurosurg 1977; 46: 563–578. 29 Morandi X, Brassier G, Darnault P, Mercier P, Scarabin JM, Duval JM. Microsurgical anatomy of the anterior choroidal artery. Surg Radiol Anat 1996; 18: 275– 280. 30 Gibo H, Carver CC, Rhoton AL, Jr, Lenkey C, Mitchell RJ. Microsurgical anatomy of the middle cerebral artery. J Neurosurg 1981; 54: 151–169. 31 Bouissou H, Emery MC, Sorbara R. Age related changes of the middle cerebral artery and a comparison with the radial and coronary artery. Angiology 1975; 26: 257– 268.
BLBK041-Kim
September 22, 2008
17:30
ANATOMY OF INTRACRANIAL ARTERIES
32 Donzelli R, Marinkovic S, Brigante L, et al. Territories of the perforating (lenticulostriate) branches of the middle cerebral artery. Surg Radiol Anat 1998; 20: 393– 398. 33 Grand W. Microsurgical anatomy of the proximal middle cerebral artery and the internal carotid artery bifurcation. Neurosurgery 1980; 7: 215–218. 34 Jain KK. Some observations on the anatomy of the middle cerebral artery. Can J Surg 1964; 7: 134–139. 35 Marinkovic SV, Milisavljevic MM, Kovacevic MS, Stevic ZD. Perforating branches of the middle cerebral artery. Microanatomy and clinical significance of their intracerebral segments. Stroke 1985; 16: 1022–1029. 36 Komiyama M, Nakajima H, Nishikawa M, Yasui T. Middle cerebral artery variations: duplicated and accessory arteries. AJNR Am J Neuroradiol 1998; 19: 45–49. 37 Lazar ML, Bland JE, North RR, Bringewald PR. Middle cerebral artery fenestration. Neurosurgery 1980; 6: 297– 300. 38 Yamamoto H, Marubayashi T, Soejima T, Matsuoka S, Matsukado Y, Ushio Y. Accessory middle cerebral artery and duplication of middle cerebral artery – terminology, incidence, vascular etiology, and developmental significance. Neurol Med Chir (Tokyo) 1992; 32: 262–267. 39 Perlmutter D, Rhoton AL, Jr. Microsurgical anatomy of the anterior cerebral-anterior communicating-recurrent artery complex. J Neurosurg 1976; 45: 259–272. 40 Pearce JM. Heubner’s artery. Eur Neurol 2005; 54: 112– 114. 41 Perlmutter D, Rhoton AL, Jr. Microsurgical anatomy of the distal anterior cerebral artery. J Neurosurg 1978; 49: 204–228. 42 Delcker A, Diener HC. [Various ultrasound methods for studying the vertebral artery – comparative evaluation]. Ultraschall Med 1992; 13: 213–220. 43 Touboul PJ, Bousser MG, LaPlane D, Castaigne P. Duplex scanning of normal vertebral arteries. Stroke 1986; 17: 921–923. 44 Park JH, Kim JM, Roh JK. Hypoplastic vertebral artery: frequency and associations with ischaemic stroke territory. J Neurol Neurosurg Psychiatry 2007; 78: 954– 958. 45 Jeng JS, Yip PK. Evaluation of vertebral artery hypoplasia and asymmetry by color-coded duplex ultrasonography. Ultrasound Med Biol 2004; 30: 605–609. 46 Lister JR, Rhoton AL, Jr, Matsushima T, Peace DA. Microsurgical anatomy of the posterior inferior cerebellar artery. Neurosurgery 1982; 10: 170–199. 47 Fine AD, Cardoso A, Rhoton AL, Jr. Microsurgical anatomy of the extracranial-extradural origin of the
48
49
50 51
52 53
54
55
56
57
58
59
60
61
62
63
posterior inferior cerebellar artery. J Neurosurg 1999; 91: 645–652. Lesley WS. and Dalsania HJ. Double origin of the posterior inferior cerebellar artery. AJNR Am J Neuroradiol 2004; 25: 425–427. Cullen SP, Ozanne A, Alvarez H, Lasjaunias P. The bihemispheric posterior inferior cerebellar artery. Neuroradiology 2005; 47: 809–812. Brassier G, Morandi X, Riffaud L and Mercier P. Basilar artery anatomy. J Neurosurg 2000; 93: 368–369. Kim JS, Lopez I, DiPatre PL, Liu F, Ishiyama A, Baloh RW. Internal auditory artery infarction: clinicopathologic correlation. Neurology 1999; 52: 40–44. Rhoton AL, Jr. The cerebellar arteries. Neurosurgery 2000; 47: S29–68. Kumral E, Kisabay A, Atac C. Lesion patterns and etiology of ischemia in the anterior inferior cerebellar artery territory involvement: a clinical – diffusion weighted – MRI study. Eur J Neurol 2006; 13: 395–401. Terao S, Miura N, Osano Y, et al. Multiple cerebellar infarcts: clinical and pathophysiologic features. J Stroke Cerebrovasc Dis 2005; 14: 193–198. Hardy DG, Peace DA, Rhoton AL, Jr. Microsurgical anatomy of the superior cerebellar artery. Neurosurgery 1980; 6: 10–28. Icardo JM, Ojeda JL, Garcia-Porrero JA, Hurle JM. The cerebellar arteries: cortical patterns and vascularization of the cerebellar nuclei. Acta Anat (Basle) 1982; 113: 108–116. Brandt T, von Kummer R, Muller-Kuppers M, Hacke W. Thrombolytic therapy of acute basilar artery occlusion. Variables affecting recanalization and outcome. Stroke 1996; 27: 875–881. Zeal AA. and Rhoton AL, Jr. Microsurgical anatomy of the posterior cerebral artery. J Neurosurg 1978; 48: 534– 559. Bisaria KK. Anomalies of the posterior communicating artery and their potential clinical significance. J Neurosurg 1984; 60: 572–576. Milisavljevic MM, Marinkovic SV, Gibo H, Puskas LF. The thalamogeniculate perforators of the posterior cerebral artery: the microsurgical anatomy. Neurosurgery 1991; 28: 523–529; Discussion 9–30. Fujii K, Lenkey C, Rhoton AL, Jr. Microsurgical anatomy of the choroidal arteries: lateral and third ventricles. J Neurosurg 1980; 52: 165–188. Carrera E, Michel P, Bogousslavsky J. Anteromedian, central, and posterolateral infarcts of the thalamus: three variant types. Stroke 2004; 35: 2826–2831. Percheron G. [Arteries of the thalamus in man. Choroidal arteries. III. Absence of the constituted thalamic territory of the anterior choroidal artery. IV. Arteries and thalamic
17
BLBK041-Kim
September 22, 2008
17:30
CHAPTER 1
territories of the choroidal and postero-median thalamic arterial system. V. Arteries and thalamic territories of the choroidal and postero-lateral thalamic arterial system]. Rev Neurol (Paris) 1977; 133: 547–558. 64 Gibo H, Marinkovic S, Brigante L. The microsurgical anatomy of the premamillary artery. J Clin Neurosci 2001; 8: 256–260. 65 Georgiadis AL, Yamamoto Y, Kwan ES, Pessin MS, Caplan LR. Anatomy of sensory findings in patients with
18
posterior cerebral artery territory infarction. Arch Neurol 1999; 56: 835–838. 66 Liebeskind DS, Hurst RW. Infarction of the choroid plexus. AJNR Am J Neuroradiol 2004; 25: 289–290. 67 Brandt T, Steinke W, Thie A, Pessin MS, Caplan LR. Posterior cerebral artery territory infarcts: clinical features, infarct topography, causes and outcome. Multicenter results and a review of the literature. Cerebrovasc Dis 2000; 10: 170–182.
BLBK041-Kim
August 9, 2008
2
16:16
Pathologic characteristics Xiang-Yan Chen and Mark Fisher
Atherosclerosis is a lifetime illness evolving slowly over many years.1 The course and maturation of atherosclerosis are influenced by cholesterol accumulation in the endothelial cells of the arterial wall.2 Atherosclerosis has traditionally been viewed to simply reflect the deposition of lipids. However, this concept has now been changed. It is currently understood that complex endothelial dysfunction is associated with atheroscerlsosis: elevated or modified low-density lipoproteins (LDLs), free radicals, infectious microorganisms, shear stress, hypertension, toxins derived from cigarette smoking, and associated compensatory inflammatory responses.3 Atherosclerosis involves multiple arteries throughout the body, including the aorta, coronary arteries, arteries of inner organs, or the limbs. Atherosclerosis may affect major intracranial and extracranial arteries. In intracranial vessels, atherosclerosis occurs in the setting of widespread vascular disease. Its onset is much later in life, and the severity of the lesions at various ages is consistently less than that of extracranial arteries in humans,4–9 non-human primates,10 rhesus and cynomolgus monkeys,11 spontaneously hypertensive rats,12,13 cholesterol-fed rabbits,11 and Watanabe heritable hyperlipidemic rabbits.14 However, in the recent years, it has been found that patients with intracranial atherosclerosis are at increased risk of stroke and heart disease. The occurrence of intracranial atherosclerosis seems to occur in two separate patterns: (1) In patients with severe extracranial and systemic atherosclerosis and (2) in some racial and ethnic groups who seem to have isolated intracranial disease with little extracranial, coronary, or systemic disease. Intracra-
nial severe atherosclerotic stenosis is thought to be more often accompanied by brain infarction than comparable extracranial disease.15–17
General features of atherosclerosis Atherosclerotic lesions begin with an inflammatory reaction followed by smooth muscle proliferation and thickening of the arterial wall. Histologically, atherosclerotic plaques have three principal components: (1) cells, including smooth muscle cells, and macrophages and other leukocytes; (2) connective tissue extracellular matrix, including collagen, elastin fibers, and proteoglycans; and (3) intracellular and extracellular lipid deposits. The proportion of these three components differs in different plaques, giving rise to a wide spectrum of lesions.18–20 Its development appears to be progressive, with well-recognized pathologic lesions that develop in a continuum (Fig. 2.1). The first observed pathologic change in the artery is a so-called fatty streak. It is characterized by the adhesion of monocytes to the endothelium and their migration to the subendothelial potions of the arterial wall. In this location, they form a foamy appearance microscopically.21 Fatty streaks can be found in the aorta and the coronary arteries of adolescents and young adults. Hemodynamic factors influence the location of initially developed plaques, and may contribute to their eventual destabilization. The most common locations for the developments of fatty streaks are the areas of vascular bifurcations or with turbulent blood flow. In cerebral arteries, plaques usually develop at the bifurcation of the common carotid
Intracranial Atherosclerosis Edited by Jong S Kim, Louis R Caplan and KS Lawrence Wong © 2008 Blackwell Publishing Ltd. ISBN: 978-1-405-17822-8
19
BLBK041-Kim
August 9, 2008
16:16
CHAPTER 2
A
B
Fig 2.1 Progression of atherosclerosis. (A) Endothelial dysfunction; (B) fatty-streak formation; (C) formation of an advanced, complicated lesion; (D) unstable fibrous plaques (From Ross R. Atherosclerosis – an inflammatory disease. N Engl J Med 1999; 340: 115–126, with permission).
artery where the internal carotid artery originates. Atherosclerosis of the middle cerebral artery (MCA) most commonly affects the first portion (M1 segment), which extends from the origin of the artery to its bifurcation in the sylvian fissure. In the vertebrobasilar system, plaques are most commonly found at the origin of the vertebral arteries and in the basilar artery at its origin. 20
With increasing age, the fatty streak is transformed into a fibrous plaque. A plaque is usually found in middle-aged or older adults. It consists of a core of cellular debris, free extracellular lipid, and cholesterol crystals under a “cap” consisting of foam cells, transformed smooth muscle cells, lymphocytes, and connective tissue.21 The most advanced stage of atherosclerosis is the complicated lesion, which contains
BLBK041-Kim
August 9, 2008
16:16
PATHOLOGIC CHARACTERISTICS
C
D
Fig 2.1 (Continued)
calcification, hemosiderin deposition, and luminal surface disruption.
Pathological characteristics of atherosclerosis in different arteries The pathological characteristics of atherosclerosis are different depending on arterial regions (coronaries,
carotids, or aorta). The pathology and pathogenesis of atherosclerosis in coronary arteries have been well studied in past years. Rupture-prone plaques in the coronary arteries, the so-called “vulnerable plaques”, tend to have a thin fibrous cap and a large lipid core. Acute coronary syndromes often result from rupture of a modestly stenotic vulnerable plaque.20 21
BLBK041-Kim
August 9, 2008
16:16
CHAPTER 2
The neuropatholgic features of extracranial or intracranial atherosclerosis are encountered in surgical specimens (i.e., derived from carotid endarterectomy) or at the time of necropsy. In contrast to coronary artery vulnerable plaques, high-risk plaques in carotid arteries are usually severely stenotic. Thus, the term “high-risk” has been used rather than the classic term “vulnerable,” which only implies the presence of a lipid-rich core. However, based on a large series in which the carotid endarterectomy specimen was carefully examined, it was found that carotid plaque morphology such as intraplaque hemorrhage or reparative neovascularization importantly influences plaque instability rather than the degree of stenosis.22,23 Fisher et al.24 reported that carotid plaque ulceration and thrombosis are more prevalent in symptomatic patients. Similarly, Barnett et al.25 investigated patients with cerebral embolic ischemia due to carotid artery atherosclerosis, and found that the dynamic state of the intimal surface in corresponding vessels is often associated with thrombus attached to de-endothelialized ulcerative plaque, intraluminal necrotic material, foamy histiocytes, and even foreign-body giant cells being shed on to the lumen. Any of the materials may act as the source of emboli to distal sites leading to subsequent ischemic events. In addition to emboli, hemodynamic conditions are consistently associated with the development of intimal atherosclerosis disease in carotid bifurcation arteries removed in autopsy.26 It is concluded that in the human carotid bifurcation, regions of moderate to high shear stress, where flow remains unidirectional and axially aligned, are relatively spared of intimal thickening. Intimal thickening and atherosclerosis develop largely in regions of relatively low wall shear stress, flow separation, and departure from axially aligned, unidirectional flow. It has been presumed that intracranial atherosclerosis may be similar to that found elsewhere, but this assumption should not be made lightly because of the epidemiologic differences between intra- and extracranial atherosclerotic disease.
Natural course of atherosclerosis Fatty streaks, fibrous plaques, and complicated plaques are the pathologic hallmarks of atheroscle22
rosis. These lesions insidiously progress, and symptoms develop when the plaque luminal surface destabilizes. Its evolution is a slowly progressive complex interaction of cellular events, intercellular messengers, hemodynamic factors, and vascular risk factors.21 The major cellular contributors to plaque development are monocytes/macrophages, endothelial cells, smooth muscle cells, and, to a lesser degree, lymphocytes and platelets. They interact in a complicated fashion. Circulating monocytes are recruited at a very early stage, enter the arterial wall, and become macrophages. Macrophages imbibe lipid, primarily LDL cholesterol, to form foam cells, a hallmark of early plaque formation.26 According to Dr. Russell Ross’s “response to injury” hypothesis, the initiating event for early plaque formation is functional or morphological endothelial injury induced by a variety of mechanical, biochemical, or physical stimuli. Monocytes/macrophages are then recruited, collecting in the arterial wall. Lipids accumulate, growth factors and cytokines are released, and smooth muscle cells and lymphocytes are recruited. As the process continues unimpeded, plaque slowly grows and matures. Platelets may gather at sites of endothelial disruption. As lipid-filled cells die, a central core is formed, leading to plaque remodeling and fibrosis. Macrophages, endothelial cells, smooth muscle cells, platelets, and different factors released by these cells (e.g., cytokines, growth factors, oxygen free radicals) promote the process of plaque development. Hemodynamic factors contribute to atherogenesis at preferential sites within the arterial vasculature, presumably by influencing the cellular mechanisms. Atherosclerotic plaques usually enlarge slowly over decades without any symptomatic presentations. The increase of a plaque over years leads to narrowing of the vessel and reduces blood flow.1 The narrowing may also lead to local turbulence of blood flow or sluggish perfusion. This turbulence and slow flow can activate platelets and clotting factors, which in turn promote thrombosis. Luminal surface disruption is probably the primary event in most cases, and leads to local thrombus formation. These thrombi may then embolize more distally to cause a particular stroke syndrome related to the occluded vascular territory. Alternatively, the compromised vessel may cause hemodynamic failure to produce ischemia in the distal areas.
BLBK041-Kim
August 9, 2008
16:16
PATHOLOGIC CHARACTERISTICS
Evidence from animal models To evaluate atherosclerosis in intracranial arteries, different animal models have been developed in many species, including swine, chickens, dogs, rabbits, rats, and monkeys.27–34 The models are very useful for studying morphological characteristics, the pathogenesis of cerebral atherosclerosis, and may be applied to the prevention and treatment of the human disease.30–32 Atherosclerosis can be produced in rabbits when they are fed an atherogenic diet.35 In this model, arterial lesions form rapidly, with accumulation of lipids in macrophages and formation of lesions associated with foam cells.36 In contrast, atherosclerosis occurs spontaneously in Watanabe heritable hyperlipidemic (WHHL) rabbits, are well known to develop severe atherosclerotic lesions in extracranial arteries.37 But it is difficult to induce atherosclerosis in the cerebral arteries, especially in intracranial arteries. To produce non-human models of cerebral atherosclerosis, additional application of hypertension is more effective than inducing hyperlipidemia alone.37–43 In a cynomolgus monkey, hypertension appears to accelerate cerebral atherosclerosis.40 In selectively bred homozygous WHHL rabbits that are known to show hypercholesterolemia and severe coronary atherosclerosis, Ito and Shiomi38 also demonstrated spontaneously developed cerebral atherosclerosis beginning at 9 months of age. These intracranial lesions occurred in the absence of hypertension in 24 of 25 animals at various sites, mainly along arteries at the base of the brain. Arterial findings were similar to those in human cerebral atherosclerosis, indicating that the coronary atherosclerosis-prone homozygous WHHL rabbit represents the first animal model for spontaneous cerebral atherosclerosis. In addition, there are other methods to produce cerebral atherosclerosis in animals. Yamori et al.44 successfully developed fat deposition in the posterior communicating arteries in normotensive rats, which were fed high-fat cholesterol (HFC) for 10 weeks after bilateral or unilateral carotid artery ligation or basilar artery ligation. These findings suggest that not only high blood pressure but also hemodynamic derangements are important factors for the development of fat deposition in cerebral arteries. Another model of cerebral arteriosclerosis was induced by intimal injury in rabbits.45 Intimal injury was produced by a silicone
rubber cylinder with nylon thread that was injected from the bifurcation of the right external and internal carotid arteries to embolize either to the intracranial internal carotid or middle cerebral artery. These findings suggest that enhancement of permeability of plasma constituents of the regenerated endothelium plays an important role in the atherogenesis of cerebral arteries. The animal models have demonstrated morphological characteristics of intracranial atherosclerosis and its development from different aspects. In hypertensive WHHL rabbits,37 atherosclerotic lesions developed near the vertebral–basilar arterial confluence and at the circle of Willis by 6 months after hypertensioninducing surgery (right nephrectomy and surgically induced stenoses of the left renal artery). Morphological studies showed that atherosclerotic lesions in cerebral arteries remained less severe than in the aorta and coronary arteries, and exhibited qualitative morphologic differences. Kato et al.41 also studied the development of cerebral atherosclerosis in rabbits. The earliest lesions developed at remarkably localized areas of the basilar artery–posterior cerebral artery Y-bifurcation (area A) and vertebral–basilar artery confluence (area B). By light microscopy, intimal lesions were mainly composed of accumulations of foam cells and smooth muscle cells. Foam cells that accumulated in the intima resembled those of monocyte–macrophage lineage. Early lesions involving only a few endothelial cells with adherent leukocytes occurred at the dividing and confluent portions of the endothelial arrays formed in areas A and B, respectively. Another study39 of experimental rabbits also demonstrated early lesions of intracranial atherosclerosis. By microscopy, widespread thickening and contraction were seen in almost all intracranial small arteries. Hyaline degeneration could be seen in some of the arteries. Most of the cerebral parenchymal capillary endothelia were swollen and some of these cells contained lipid. Imai and Thomas29 investigated cerebral atherosclerosis in swine and found necrosis in progression of diet-induced lesions from the proliferative to the atheromatous stage. Mechanisms of ischemic stroke induced by intracranial atherosclerosis has also been studied in animal models. Jeynes and Warren46 set up an animal model of cerebral atheroembolism by injecting human atheromatous material into the cerebral vasculature of rabbits via the left common carotid artery. 23
BLBK041-Kim
August 9, 2008
16:16
CHAPTER 2
Signs of neurologic deficit with motor dysfunction were seen in some surviving animals; occlusive vascular lesions were predominantly localized in ipsilateral cortical and subcortical vessels within the distribution territory of the middle cerebral artery. The occlusive lesions showed strong evidence of thrombosis. This experimental system may be useful as a model to study blood–atheroembolic vascular reactions, mechanism of cerebral infarction, and to test agents for preventing strokes or stabilizing the atheroma.
Human autopsy studies Investigating pathological characteristics of intracranial atherosclerosis have been particularly difficult because of the limitations of autopsy populations, time-consuming dissections of the arteries, and numerous technical problems associated with specimen preparation, shipment, and storage. Long-term repeated studies and grading systems and validation are also elements adding to the complexity of these studies. Nevertheless, autopsy study is still an important and valuable method to investigate intracranial atherosclerosis. The following is a procedure to obtain complete intracranial and extracranial arteries at autopsy: to facilitate removal of anterior extracranial vessels, bodies are routinely opened by U-shaped cervical incision. The cervical portion of the internal carotid artery is cut as close to the skull as possible and removed with the carotid sinus, the common carotid artery down to its origin in the aortic arch, and the innominate artery. For a patient who dies of ischemic stroke, examination of the complete internal carotid artery is necessary, and the vertebral arteries should be studied throughout their extraspinal length.47 The vessels are fixed in 10% formalin, and cross-sections cut at 5-mm intervals. Blocks are taken from the narrowest parts affected by atherosclerosis. The vessels in the circle of Willis are graded by gross examination using the method of Baker et al. 48 During grading, the vessels are crosssectioned at 5-mm intervals; the narrowest parts in the middle cerebral stem and the anterior cerebral arteries, posterior cerebral arteries, basilar and vertebral arteries are then taken for histological sectioning. The presence of thrombotic or embolic occlusion and ulceration are also recorded. During the process, caution should be taken to ensure perpendicular cutting 24
and embedding. Sections 6 μm thick are prepared and stained for microscopic histology. It is recommended that all basic studies of human atherosclerosis should include both macroscopic and microscopic description of the same arterial segments with the use of adequate terminology.49 According to a study on human coronary and cerebral atherosclerosis, the character of atherosclerotic lesions, the meaning of terms “normal intima”/“fatty streaks”/“fibrous plaques”/“complicated lesions,” the type of the early atherosclerotic lesions, the age of onset of these lesions, their sequence of development, their relationship to advanced lesions, all appear method-dependent. Gross inspection alone may lead us to have a distorted view on the natural history of atherosclerosis, because items such as intimal necrosis, incorporated microthrombi, fibromuscular plaques, mucoid plaques, and foam cell-rich plaques may be overlooked. By gross inspection, early stages of atherosclerotic involvement are frequently undetected as well. Within the same vascular segments, significant differences may occur between the number of atherosclerotic lesions recorded on microscopic and macroscopic examinations.
Risk factors In cerebral atherosclerosis, quantitative differences in severity exist among different age groups, races, and between males and females.50 Comparative neuropathologic features of cerebral atherosclerosis among ethnic groups have revealed that there are significant difference between North American and Asian populations. Autopsy studies in stroke patients have shown that African Americans and Japanese people tend to have intracranial vascular occlusion, whereas Caucasians more often have extracranial lesions.50,51 Atherosclerotic lesions were found primarily in large-caliber vessels of the circle of Willis in a Minnesota population; among Japanese subjects, atherosclerotic lesions were much more likely to occur also in smaller caliber vessels.50 The pathological data from an autopsy study of Hong Kong Chinese people showed that, by comparison with white and Japanese populations, the extent of intracranial atherosclerosis is much more severe; atherosclerotic narrowing of the extracranial carotid artery is less severe in Hong Kong Chinese people than in Caucasians.52
BLBK041-Kim
August 9, 2008
16:16
PATHOLOGIC CHARACTERISTICS
In addition to race, other risk factors for intracranial atherosclerosis include age, hypertension, cigarette smoking, diabetes mellitus, and lipid disorders.51–56 Atherosclerosis is a progressive disease with age.57–60 Moossy61 investigated development of cerebral atherosclerosis in various age groups and found that the earliest sites of deposition were the internal carotid and vertebral arteries, followed by the basilar artery and middle cerebral artery. Fatty steaks appear in the aorta in the first decade of life and in coronary arteries and extracranial carotid arteries in the second decade. The intracranial and extracranial vertebral arteries mainly have fibrous plaques by the third decade. In a New Orleans study, 1093 extracranial carotid and intracranial arteries were evaluated for black–white and male–female differences during a 10-year period. Raised lesions (fibrous plaques and complicated fibrous plaques) in the carotid arteries increased with age in both races but remained greater in black women. In the intracranial arteries fatty streaks and fibrous plaques start to form at the end of the second decade to the beginning of the third decade. A nationwide study62 of atherosclerosis in infants, children and young adults (from 1 month to 39 years old) in Japan found that atherosclerosis of aortas, coronary arteries, and cerebral arteries increased with age; the most severe lesions were seen in aortas, and then, with decreasing severity, in the coronary and cerebral arteries. Atherosclerosis occurred later and was less extensive in intracranial arteries than in extracranial arteries. Another study suggested that greater activity of antioxidant enzymes in intracranial arteries may contribute to their greater resistance to atherosclerosis and that with increasing age, accelerated atherosclerosis occurs in intracranial arteries secondary to decreased antioxidant protection.63 Hyperlipidemia, an important risk factor of coronary atherosclerosis and myocardial ischemia, is also linked to cerebral arterial atherosclerosis, as verified by a high correlation between increased cholesterol and Baker score.64 Another study65 using morphological methods to assess the severity of cerebral atherosclerosis also demonstrated that in subjects with elevated blood cholesterol levels, some features of advanced atherosclerosis (fibrous plaques, calcifications, stenoses, and occlusions of the vessel lumens) were encountered more frequently than in subjects with normal blood cholesterol level.
On the other hand, another study57 reported that blood pressure was the most important risk factor for cerebral atherosclerosis, even though serum cholesterol was also closely associated with the lesions. A study in Hisayama, Japan,6 investigating the relationship between cerebral atherosclerosis and cholesterol levels, reported that serum cholesterol level correlated better with the severity of aortic than with cerebral atherosclerosis. Studies from Oslo66,67 suggested that total serum cholesterol may be more important than systolic blood pressure in the development of coronary atherosclerosis. Intracranial advanced atherosclerotic lesions were more common in black people of both sexes at all ages.68 Regarding risk factors, black people consistently have higher rates of hypertension than white people, suggesting that hypertension or other unidentified factors may have an impact on the racial difference of intracranial atherosclerosis. A greater degree of blood pressure elevation may enhance intracranial plaque development and plaque destabilization. Cigarette smoking is another well-known risk factor for atherosclerosis in the aorta or coronary arteries.69 Smoking is known to injure endothelial cells and generate thrombi. According to a clinical study56 smoking may be the most significant independent predictor of the presence of atherosclerosis of the intracranial internal carotid artery.
Distribution of intracranial atherosclerosis Common locations for symptomatic cerebrovascular atherosclerosis are the origin of the internal carotid artery, the intracavernous portion of the internal carotid artery, the first segment of the middle cerebral artery, the origin and the distal portion of the vertebral artery, and mid-portion of the basilar artery. The origin of the internal carotid artery is the most frequent site for severe atherosclerosis in persons of European ancestry, whereas intracranial arteries, especially the middle cerebral artery, are most commonly affected among persons of African or Asian heritage.47,51,70–73 Fisher et al.,74 in a detailed autopsy study of the entire vertebrobasilar (including intraspinal) and carotid arterial systems in 178 patients (fourth through the ninth decade) demonstrated that (1) 40% of patients showed some degree of stenosis, whereas almost 10% of individuals had occlusion of a vessel in the neck 25
BLBK041-Kim
August 9, 2008
16:16
CHAPTER 2
and six patients had intracranial vascular occlusion; (2) symptomatic occlusion was more commonly extracranial in the carotid system but intracranial in the vertebral system; (3) stenosis in the carotid and vertebral arteries was asymptomatic; (4) hypertension aggravated cerebral atherosclerosis in general and basilar artery stenosis in particular; (5) the severity of intracranial atherosclerosis was similar in anterior and posterior portions of the circle of Willis. Another autopsy study75 carried out in Chinese subjects demonstrated that patients with cerebral infarction had arterial lesions at different levels, but the principal portions of cerebral artery lesions were the mediumsized intracranial arteries and their main branches. According to a study comparing Japanese people living in Hiroshima, Japan, with Japanese living Honolulu, Hawaii,76 atherosclerosis of the major branches of the circle of Willis was more severe in the Honolulu group whereas arteriosclerosis of penetrating arteries, with histologic features including intimal hyperplasia and subintima foam cells and cholesterol cleft deposition, was more common in men studied in the Hiroshima cohort. The latter group of the two cohorts also showed a higher incidence of cerebral infarcts, which may be attributed to the higher frequency of intraparenchymal arteriosclerosis among these men.76 Another clinical study, carried out among male participants in the Honolulu Heart Program, also showed association of severity of cerebral atherosclerosis with autopsy-verified cerebral infarcts and hemorrhage.77 The study also indicated a strong trend towards decreasing cerebral atherosclerosis in this population
A
Fig 2.2 Transverse paraffin sections of MCAs showing luminal stenosis and intraplaque neovasculature. (A) Stained with Victorial Blue (1.6×), showing 50.7% lumen stenosis. (B) Stained with H&E (10×) demonstrating intraplaque neovasculature (arrows). (From Chen XY,
26
over the years 1965–1983. The association of morphologically verified cerebral atherosclerosis with both cerebral infarcts and hemorrhage, especially in patients with large infarcts, was also confirmed by an autopsy investigation of cerebrovascular disease among 724 patients over the age of 40 who came to autopsy in Hisayama, Japan.78 Atherosclerosis of the middle cerebral artery most commonly affects the first portion (M-1 segment), which extends from the origin of the artery to its bifurcation in the sylvian fissure. The lenticulostriate vessels arise from this section, and the origins of these vessels can be affected by the development of an atherosclerotic plaque. Less commonly, the distal M1 segment or the proximal portions of the first major branches of the middle cerebral artery (M2 segment) can be involved.79 Advanced atherosclerosis of the middle cerebral artery also appears to be relatively common in diabetic patients. The majority of stenoses are less than 7 mm in length.80,81 Hemorrhage, ulceration, and calcification are found much less frequently in intracranial plaques compared with extracranial atherosclerotic plaques.53 Given the paucity of pathology data regarding middle cerebral artery atherosclerosis, an autopsy study was carried out in Hong Kong Chinese and reported that luminal stenosis caused by atherosclerotic plaque, percentage of lipid in lesion, and presence of intraplaque neovasculature in the MCA may play a key role in leading to ischemic stroke.82 The morphological features in middle cerebral artery atherosclerosis are shown in Figs 2.2 and 2.3.
B
Wong KS, Lam WW et al. Middle cerebral artery atherosclerosis: Histological comparison between plaques associated with and not associated with infarct in a postmortem study. Cerebrovasc Dis 2007; 25: 74–80, with permission.)
BLBK041-Kim
August 9, 2008
16:16
PATHOLOGIC CHARACTERISTICS
A
B
Fig 2.3 Transverse paraffin sections of the MCAs showing the immunostaining results of atherosclerotic plaques (40 × 40). (A) Numerous macrophages are shown when tissues are stained with antibodies for CD 68. (B) T lymphocytes are shown when tissues are stained with
antibodies for CD45RO. (From Chen XY, Wong KS, Lam WW et al. Middle cerebral artery atherosclerosis: Histological comparison between plaques associated with and not associated with infarct in a postmortem study. Cerebrovasc Dis 2007; 25: 74–80, with permission.)
Pathogenesis
flow or hypoperfusion. Severe stenosis or occlusion potentiates the effects of hypoperfusion leading to failure of perfusion to one or more portions of the brain. This turbulence and slow flow can also activate platelets and clotting factors, which in turn promote thrombosis. Although the degree of lumen obstruction is a relevant marker of the risk of stroke,86,87 the recognition of the role of the vulnerable plaque has opened new avenues in the understanding of atherothrombotic stroke. The vulnerability depends in part by plaque morphology, which in turn is influenced by pathophysiologic mechanisms at the cellular and molecular level. All types of atherosclerotic plaques with a high likelihood of thrombotic complications and rapid progression should be considered as vulnerable
Events within atherosclerotic artery walls leading to ischemic stroke may be similar to those that are hypothesized to occur within coronary arteries resulting in myocardial ischemia, which may include thrombosis and occlusion, thromboembolism, haemodynamic compromise, or the combination of these factors.70,83 Acute thrombosis begins with fracturing of the cap of the atherosclerotic plaque, which disrupts the endothelial surface of the artery. Local occlusion and secondary artery-to-artery embolism can result.84,85 Even without thrombosis, plaque gradually increases over years and slowly impinges on the vascular lumen; consequently, the blood flow becomes altered.51 The narrowing leads to local turbulence of blood
Fig 2.4 Biological factors supporting plaque vulnerability. (From Nighoghossian N, Derex L, Douek P. The vulnerable carotid artery plaque: current imaging methods and new perspectives. Stroke 2005; 36: 2764–2772. With permission)
27
BLBK041-Kim
August 9, 2008
16:16
CHAPTER 2
plaque underlying the cause of most clinical events.88 Ischemic stroke and transient ischemic attack are frequently caused by cerebral embolism from an atherothrombotic plaque or thrombosis at the site of plaque rupture.89 Figure 2.4 shows inter-related processes which account for the development of vulnerable atherosclerotic plaques.90,91 Conventional pathologic and imaging markers of plaque vulnerability in carotid artery include carotid artery intima/media thickness (IMT), erosion, ulceration, thrombus, intraplaque hemorrhage, calcification, status of fibrous cap, stratus of lipid core, extent of plaque inflammation, and microembolic signals on transcranial Doppler.91 A detailed histopathologic study92 of segments of thrombosed intracranial arteries performed on eight patients who died within 28 days of brain infarction showed occlusive thrombi in six instances and mural thrombi in two; thrombi had most commonly developed at or immediately distal to the sites of maximal stenosis. Arteries that had undergone thrombosis, showed plaque rupture (three cases), intramural hemorrhage (one) and ulceration (one). Thrombosis without plaque rupture or intramural hemorrhage was also observed in three cases. Two patients showed occlusive emboli distal to the site of thrombosis, indicating the occurrence of intracranial artery-to-artery thromboembolism. Intra-arterial embolism distal to atherosclerotic intracranial artery lesions was once thought to be an unusual occurrence but more recent transcranial Doppler studies have shown that microemboli are commonly found distal to intracranial stenotic lesions in symptomatic patients.83,92–94 A histopathologic study95 demonstrated atheromatous embolism in cerebral arteries with internal diameter of 50–300 μm in a variety of stroke patients. The presence of microembolic signals has been found to be associated with an increased risk of stroke.96 Caplan and Hennerici97 found that hypoperfusion and embolism often coexist and their pathophysiological features are interactive. Arterial luminal narrowing and endothelial abnormalities promote clot formation and subsequent embolization. Reduced perfusion limits clearance of emboli. Consequently, brain borderzones are a favored destination for microemboli that are not cleared. Impaired washout appears to be an important but neglected concept that combines hypoperfusion, embolization, and brain infarction. Until recently, the effect of emboli has 28
been confirmed when the means to detect emboli in cerebral arteries became available.96,98 Clinical studies using transcranial Doppler ultrasound have verified the association between the presence of microembolic signals and an increased risk of stroke.96 The consequences of severe atherosclerotic disease within individual major cerebral arteries have been reviewed.70,99,100 These clinical data highlight the importance of propagation of thrombotic material from the internal carotid artery to both the MCA and ACA. Moreover, the occurrence of lacunar infarcts in patients with large vessel atherosclerosis (e.g., affecting the MCA)70 highlights the probable importance of large vessel disease in the etiology of small areas of ischemia, which previously had been thought to result largely from intraparenchymal cerebral microvascular disease. Note, however, that the association of lacunae with atherosclerosis was commented on frequently by C. Miller Fisher in the 1970s.74,101–103
References 1 Fuster V, Badimon JJ, Chesebro JH. Atherothrombosis: mechanisms and clinical therapeutic approaches. Vasc Med 1998; 3: 231–239. 2 Yatsu FM, Fisher M. Atherosclerosis: Current concepts on pathogenesis and interventional therapies. Ann Neurol 1989; 26: 3–12. 3 Ross R. Atherosclerosis–an inflammatory disease. N Engl J Med 1999; 340: 115–126. 4 Gorelick PB, Mazzone T. Plasma lipids and stroke. J Cardiovasc Risk 1999; 6: 217–221. 5 Mathur KS, Kashyap SK, Kumar V. Correlation of the extent and severity of atherosclerosis in the coronary and cerebral arteries. Circulation 1963; 27: 929–934. 6 Sadoshima S, Kurozumi T, Tanaka K, et al. Cerebral and aortic atherosclerosis in Hisayama, Japan. Atherosclerosis 1980; 36: 117–126. 7 McGarry P, Solberg LA, Guzman MA, Strong JP. Cerebral atherosclerosis in New Orleans. Comparisons of lesions by age, sex, and race. Lab Invest 1985; 52: 533– 539. 8 Gorelick PB. Distribution of atherosclerotic cerebrovascular lesions. Effects of age, race, and sex. Stroke 1993; 24: 116–119; Discussion 120–121. 9 Napoli C, Witztum JL, de Nigris F, et al. Intracranial arteries of human fetuses are more resistant to hypercholesterolemia-induced fatty streak formation than extracranial arteries. Circulation 1999; 99: 2003– 2010.
BLBK041-Kim
August 9, 2008
16:16
PATHOLOGIC CHARACTERISTICS
10 Wissler RW, Vesselinovitch D. Atherosclerosis in nonhuman primates. Adv Vet Sci Comp Med 1977; 21: 351– 420. 11 Weber G. Delayed experimental atherosclerotic involvement of cerebral arteries in monkeys and rabbits (light, sem and tem observations). Pathol Res Pract 1985; 180: 353–355. 12 Weber G, Alessandrini C, Centi L, et al. Delayed development of intimal lesions in cerebral arteries of spontaneously hypertensive rats subjected to a short-term atherogenic diet (tem observations). Appl Pathol 1986; 4: 233–236. 13 Napoli C, Salomone S, Godfraind T, et al. 1,4dihydropyridine calcium channel blockers inhibit plasma and LDL oxidation and formation of oxidationspecific epitopes in the arterial wall and prolong survival in stroke-prone spontaneously hypertensive rats. Stroke 1999; 30: 1907–1915. 14 Wilson PW, Schaefer EJ, Larson MG, Ordovas JM. Apolipoprotein e alleles and risk of coronary disease. A meta-analysis. Arterioscler Thromb Vasc Biol 1996; 16: 1250–1255. 15 Craig DR, Meguro K, Watridge C, et al. Intracranial internal carotid artery stenosis. Stroke 1982; 13: 825– 828. 16 Marzewski DJ, Furlan AJ, St Louis P, et al. Intracranial internal carotid artery stenosis: Longterm prognosis. Stroke 1982; 13: 821–824. 17 Wechsler LR, Kistler JP, Davis KR, Kaminski MJ. The prognosis of carotid siphon stenosis. Stroke 1986; 17: 714–718. 18 Fuster V, Fayad ZA, Badimon JJ. Acute coronary syndromes: Biology. Lancet 1999; 353 Suppl 2: SII5–9. 19 Falk E, Shah PK, Fuster V. Coronary plaque disruption. Circulation 1995; 92: 657–671. 20 Fuster V, Lewis A. Conner memorial lecture. Mechanisms leading to myocardial infarction: Insights from studies of vascular biology. Circulation 1994; 90: 2126–2146. 21 Navab M, Fogelman AM, Berliner JA, et al. Pathogenesis of atherosclerosis. Am J Cardiol 1995; 76: 18C-23C. 22 Bornstein NM, Norris JW. The unstable carotid plaque. Stroke 1989; 20: 1104–1106. 23 Bornstein NM, Krajewski A, Lewis AJ, Norris JW. Clinical significance of carotid plaque hemorrhage. Arch Neurol 1990; 47: 958–959. 24 Fisher M, Paganini-Hill A, Martin A, Cosgrove M, Toole JF, Barnett HJ, Norris J. Carotid plaque pathology: Thrombosis, ulceration, and stroke pathogenesis. Stroke 2005; 36: 253–257. 25 Barnett HJ, Peerless SJ, Kaufmann JC. “stump” on internal carotid artery–a source for further cerebral embolic ischemia. Stroke 1978; 9: 448–456.
26 Zarins CK, Giddens DP, Bharadvaj BK, et al. Carotid bifurcation atherosclerosis. Quantitative correlation of plaque localization with flow velocity profiles and wall shear stress. Circ Res 1983; 53: 502–514. 27 Kahn SG, Siller WG. Absence of atherosclerosis in the cerebral arteries of chickens fed an atherogenic diet. Nature 1967; 213: 720–721. 28 Ratcliffe HL, Luginbuhl H, Pivnik L. Coronary, aortic and cerebral atherosclerosis in swine of 3 age-groups: Implications. Bull World Health Organ 1970; 42: 225–234. 29 Imai H, Thomas WA. Cerebral atherosclerosis in swine: Role of necrosis in progression of diet-induced lesions from proliferative to atheromatous stage. Exp Mol Pathol 1968; 8: 330–357. 30 Robertson AL, Jr, Butkus A, Ehrhart LA, Lewis LA. Experimental arteriosclerosis in dogs. Evaluation of anatomopathological findings. Atherosclerosis 1972; 15: 307–325. 31 Bhardwaj JR, Kukreja RS, Banerjee AK, et al. A morphological study of experimental cerebral atherosclerosis in rhesus monkeys. Indian J Med Res 1984; 79: 86– 92. 32 Suzuki M. Experimental cerebral atherosclerosis in the dog. I. A morphologic study. Am J Pathol 1972; 67: 387–402. 33 Suzuki M, Fukuuchi Y, Shimazu K, et al. Cerebral atherosclerosis in the dog. Ii. Cerebral circulation. Arch Pathol 1973; 96: 14–17. 34 Kato H. [experimental cerebral atherosclerosis in the rabbit. Scanning electron microscopic observation of initial lesion sites]. Fukuoka Igaku Zasshi 1987; 78: 532–546. 35 Ooboshi H, Rios CD, Chu Y, et al. Augmented adenovirus-mediated gene transfer to atherosclerotic vessels. Arterioscler Thromb Vasc Biol 1997; 17: 1786–1792. 36 Buja LM, Kita T, Goldstein JL, et al. Cellular pathology of progressive atherosclerosis in the WHHL rabbit. An animal model of familial hypercholesterolemia. Arteriosclerosis 1983; 3: 87–101. 37 Kong J, Tamaki N, Asada M. Early lesions of cerebral atherosclerosis from induced hypertension in watanabe heritable hyperlipidemic rabbits. Kobe J Med Sci 2000; 46: 87–101. 38 Ito T, Shiomi M. Cerebral atherosclerosis occurs spontaneously in homozygous WHHL rabbits. Atherosclerosis 2001; 156: 57–66. 39 Zhang T. [an experimental study on cerebral arteriosclerosis]. Zhonghua Shen Jing Jing Shen Ke Za Zhi 1991; 24: 228–230, 253. 40 Hollander W, Prusty S, Kemper T, et al. The effects of hypertension on cerebral atherosclerosis in the
29
BLBK041-Kim
August 9, 2008
16:16
CHAPTER 2
41
42
43
44
45
46 47
48
49
50
51
52
53
30
cynomolgus monkey. Stroke 1993; 24: 1218–1226; discussion 1226–1217. Kato H, Tokunaga O, Watanabe T, Sunaga T. Experimental cerebral atherosclerosis in the rabbit. Scanning electron microscopic study of the initial lesion site. Pathol Res Pract 1991; 187: 797–805. Kurozumi T, Tanaka K, Yae Y. Hypertension-induced cerebral atherosclerosis in the cholesterol-fed rabbit. Atherosclerosis 1978; 30: 137–145. Kurozumi T, Imamura T, Tanaka K, et al. Permeation and deposition of fibrinogen and low-density lipoprotein in the aorta and cerebral artery of rabbits– immuno-electron microscopic study. Br J Exp Pathol 1984; 65: 355–364. Yamori Y, Horie R, Sato M, Fukase M. Hemodynamic derangement for the induction of cerebrovascular fat deposition in normotensive rats on a hypercholesterolemic diet. Stroke 1976; 4: 385–389. Masuda J, Tanaka K. A new model of cerebral arteriosclerosis induced by intimal injury using a silicone rubber cylinder in rabbits. Lab Invest 1984; 51: 475–484. Jeynes BJ, Warren BA. Cerebral atheroembolism. An animal model. Stroke 1982; 13: 312–318. Feldmann E, Daneault N, Kwan E, rabbits. Chinesewhite differences in the distribution of occlusive cerebrovascular disease. Neurology 1990; 40: 1541– 1545. Baker AB, Flora GC, Resch JA, Loewenson R. The geographic pathology of atherosclerosis: A review of the literature with some personal observations on cerebral atherosclerosis. J Chronic Dis 1967; 20: 658– 706. Velican D, Anghelescu M, Petrescu C, Velican C. Method dependent limits in a study on the natural history of coronary and cerebral atherosclerosis. Med Interne 1982; 20: 215–229. Resch JA, Okabe N, Loewenson RB, Kimoto K, Katsuki S, Baker AB. Pattern of vessel involvement in cerebral atherosclerosis. A comparative study between a Japanese and Minnesota population. J Atheroscler Res 1969; 9: 239–250. Caplan LR, Gorelick PB, Hier DB. Race, sex and occlusive cerebrovascular disease: A review. Stroke 1986; 17: 648–655. Leung SY, Ng TH, Yuen ST, et al. Pattern of cerebral atherosclerosis in Hong Kong Chinese. Severity in intracranial and extracranial vessels. Stroke 1993; 24: 779–786. Moossy J. Cerebral infarcts and the lesions of intracranial and extracranial atherosclerosis. Arch Neurol 1966; 14: 124–128.
54 Moossy J. Pathology of cerebral atherosclerosis. Influence of age, race, and gender. Stroke 1993; 24: I22–123; I31–132. 55 Sacco RL, Kargman DE, Zamanillo MC. Race-ethnic differences in stroke risk factors among hospitalized patients with cerebral infarction: The northern Manhattan stroke study. Neurology 1995; 45: 659–663. 56 Ingall TJ, Homer D, Baker HL, Jr, et al. Predictors of intracranial carotid artery atherosclerosis. Duration of cigarette smoking and hypertension are more powerful than serum lipid levels. Arch Neurol 1991; 48: 687– 691. 57 Iwamoto M. [atherosclerosis. 1. Atherosclerotic changes with advancing age in the aorta, coronary artery and the arteries of the base of the brain]. Nippon Ronen Igakkai Zasshi 1972; 9: 133–143. 58 Bouissou H, Emery MC, Sorbara R. Age related changes of the middle cerebral artery and a comparison with the radial and coronary artery. Angiology 1975; 26: 257–268. 59 Flora G, Dahl E, Nelson E. Electron microscopic observations on human intracranial arteries. Changes seen with aging and atherosclerosis. Arch Neurol 1967; 17: 162–173. 60 Grunnet M. Changes in cerebral arteries with aging. Arch Pathol 1969; 88: 314–318. 61 Moossy J. Development of cerebral atherosclerosis in various age groups. Neurology 1959; 9: 569–574. 62 Tanaka K, Masuda J, Imamura T, et al. A nationwide study of atherosclerosis in infants, children and young adults in japan. Atherosclerosis 1988; 72: 143– 156. 63 D’Armiento FP, Bianchi A, de Nigris F, et al. Agerelated effects on atherogenesis and scavenger enzymes of intracranial and extracranial arteries in men without classic risk factors for atherosclerosis. Stroke 2001; 32: 2472–2479. 64 Nakamura M, Imaizumi K, Kikuchi Y, Kanaide H. Cerebral atherosclerosis in Japanese. Part 4: Relationship between lipid content and macroscopic severity of atherosclerosis. Stroke 1976; 7: 591–594. 65 Vavilova TI. [Atherosclerosis of the major arteries of the head and vessels of the base of the brain in persons with different serum cholesterol levels (biometric study)]. Zh Nevropatol Psikhiatr Im S S Korsakova 1979; 79: 1336–1340. 66 Holme I, Enger SC, Helgeland A, et al. Risk factors and raised atherosclerotic lesions in coronary and cerebral arteries. Statistical analysis from the Oslo study. Arteriosclerosis 1981; 1: 250–256. 67 Holme I, Helgeland A, Hjermann I, et al. Physical activity at work and at leisure in relation to coronary risk
BLBK041-Kim
August 9, 2008
16:16
PATHOLOGIC CHARACTERISTICS
68
69 70
71
72
73
74
75
76
77
78
79
80
81 82
factors and social class. A 4-year mortality follow-up. The Oslo study. Acta Med Scand 1981; 209: 277–283. Inzitari D, Hachinski VC, Taylor DW, Barnett HJ. Racial differences in the anterior circulation in cerebrovascular disease. How much can be explained by risk factors? Arch Neurol 1990; 47: 1080–1084. McGill HC, Jr. Cerebral artery atherosclerosis and diet. Stroke 1988; 19: 801. Bogousslavsky J, Barnett HJ, Fox AJ, et al. Atherosclerotic disease of the middle cerebral artery. Stroke 1986; 17: 1112–1120. Wityk RJ, Lehman D, Klag M, et al. Race and sex differences in the distribution of cerebral atherosclerosis. Stroke 1996; 27: 1974–1980. Wong KS, Li H, Chan YL, et al. Use of transcranial Doppler ultrasound to predict outcome in patients with intracranial large-artery occlusive disease. Stroke 2000; 31: 2641–2647. Huang YN, Gao S, Li SW, et al. Vascular lesions in Chinese patients with transient ischemic attacks. Neurology 1997; 48: 524–525. Fisher CM GI, Okabe N, White PD. Atherosclerosis of the carotid and vertebral arteries-extracranial and intracranial. J Neuropathol Exp Neurol 1965; 24: 455–476. Liu F, Zhang W, Zhou Y. [pathological changes of intracranial arteries in cerebral infarction]. Zhonghua Yi Xue Za Zhi 1999; 79: 607–609. Mitsuyama Y, Thompson LR, Hayashi T, et al. Autopsy study of cerebrovascular disease in Japanese men who lived in Hiroshima, Japan, and Honolulu, Hawaii. Stroke 1979; 10: 389–395. Reed DM, Resch JA, Hayashi T, et al. A prospective study of cerebral artery atherosclerosis. Stroke 1988; 19: 820–825. Masuda J, Tanaka K, Omae T, et al. Cerebrovascular diseases and their underlying vascular lesions in hisayama, japan–a pathological study of autopsy cases. Stroke 1983; 14: 934–940. Ueda S, Fujitsu K, Inomori S, Kuwabara T. Thrombotic occlusion of the middle cerebral artery. Stroke 1992; 23: 1761–1766. Hinton RC, Mohr JP, Ackerman RH, et al. Symptomatic middle cerebral artery stenosis. Ann Neurol 1979; 5: 152–157. Corston RN, Kendall BE, Marshall J. Prognosis in middle cerebral artery stenosis. Stroke 1984; 15: 237–241. Chen XY, Wong KS, Lam WW, et al. Middle cerebral artery atherosclerosis: Histological comparison between plaques associated with and not associated with infarct in a postmortem study. Cerebrovasc Dis 2007; 25: 74–80.
83 Wong KS, Gao S, Chan YL, et al. Mechanisms of acute cerebral infarctions in patients with middle cerebral artery stenosis: A diffusion-weighted imaging and microemboli monitoring study. Ann Neurol 2002; 52: 74–81. 84 Lafont A, Libby P. The smooth muscle cell: Sinner or saint in restenosis and the acute coronary syndromes? J Am Coll Cardiol 1998; 32: 283–285. 85 Sitzer M, Muller W, Siebler M, et al. Plaque ulceration and lumen thrombus are the main sources of cerebral microemboli in high-grade internal carotid artery stenosis. Stroke 1995; 26: 1231–1233. 86 Barnett HJ, Taylor DW, Eliasziw M, et al. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American symptomatic carotid endarterectomy trial collaborators. N Engl J Med 1998; 339: 1415–1425. 87 Randomised trial of endarterectomy for recently symptomatic carotid stenosis: Final results of the MRC European carotid surgery trial (ECST). Lancet 1998; 351: 1379–1387. 88 Naghavi M, Libby P, Falk E, et al. From vulnerable plaque to vulnerable patient: A call for new definitions and risk assessment strategies: Part i. Circulation 2003; 108: 1664–1672. 89 Bamford J, Sandercock P, Dennis M, et al. Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet 1991; 337: 1521–1526. 90 Faxon DP, Fuster V, Libby P, et al. Atherosclerotic vascular disease conference: Writing group iii: Pathophysiology. Circulation 2004; 109: 2617–2625. 91 Nighoghossian N, Derex L, Douek P. The vulnerable carotid artery plaque: Current imaging methods and new perspectives. Stroke 2005; 36: 2764–2772. 92 Ogata J, Masuda J, Yutani C, Yamaguchi T. Mechanisms of cerebral artery thrombosis: A histopathological analysis on eight necropsy cases. J Neurol Neurosurg Psychiatry 1994; 57: 17–21. 93 Gao S, Wong KS, Hansberg T, et al. Microembolic signal predicts recurrent cerebral ischemic events in acute stroke patients with middle cerebral artery stenosis. Stroke 2004; 35: 2832–2836. 94 Droste DW, Junker K, Hansberg T, et al. Circulating microemboli in 33 patients with intracranial arterial stenosis. Cerebrovasc Dis 2002; 13: 26–30. 95 Masuda J, Yutani C, Ogata J, et al. Atheromatous embolism in the brain: A clinicopathologic analysis of 15 autopsy cases. Neurology 1994; 44: 1231–1237. 96 Van Zuilen EV, Van Gijn J, Ackerstaff RG. The clinical relevance of cerebral microemboli detection by transcranial Doppler ultrasound. J Neuroimaging 1998; 8: 32–37.
31
BLBK041-Kim
August 9, 2008
16:16
CHAPTER 2
97 Caplan LR, Hennerici M. Impaired clearance of emboli (washout) is an important link between hypoperfusion, embolism, and ischemic stroke. Arch Neurol 1998; 55: 1475–1482. 98 Markus H. Monitoring embolism in real time. Circulation 2000; 102: 826–828. 99 Gacs G, Fox AJ, Barnett HJ, Vinuela F. Occurrence and mechanisms of occlusion of the anterior cerebral artery. Stroke 1983; 14: 952–959.
32
100 Lhermitte F, Gautier JC, Derouesne C. Nature of occlusions of the middle cerebral artery. Neurology 1970; 20: 82–88. 101 Mohr JP. Lacunes. Stroke 1982; 13: 3–11. 102 Miller VT. Lacunar stroke. A reassessment. Arch Neurol 1983; 40: 129–134. 103 Fisher CM. Capsular infarcts: The underlying vascular lesions. Arch Neurol 1979; 36: 65–73.
BLBK041-Kim
August 9, 2008
3
18:10
Epidemiology Philip Gorelick, Jinghao Han, Yining Huang and KS Lawrence Wong
Intracranial atherosclerosis (ICAS) is an important cause of stroke worldwide.1–5 Population groups that are at high risk for ICAS include black people in the USA, Asians, and Hispanics. In the USA, it has been estimated that of the 900 000 estimated stroke or transient ischemic attacks (TIAs) annually, up to 10% are caused by ICAS, and recurrence rates in these patients are 15% per year.6 The frequency of stroke attributable to ICAS in the USA is dwarfed by corresponding statistics from Asian countries. In Chinese populations, ICAS is estimated to account for 33–50% of stroke and >50% of TIAs, in Thailand 47% of stroke, in Korea about 28–60% of stroke, and in Singapore about 48% of stroke.7–10 The frequency of ICAS is also high in Japan, although there is increasing frequency of symptomatic extracranial carotid artery stenosis. In the USA, the relative rate of stroke associated with ICAS is about 5.0 for Hispanics (mostly from Puerto Rico and the Dominican Republic) and 5.85 for black people compared with white people. As the majority of the world’s population is Asian, African, or Hispanic, it seems that ICAS is the most common cerebral vascular lesion worldwide, whereas Caucasians may be a group predominantly predisposed to develop extracranial occlusive disease.7 Prior hypotheses to explain racial differences in the distribution of occlusive cerebrovascular disease lesions include, for example, low lipid levels and high blood pressure predisposing to intracerebral vascular disease; high lipids and high blood pressure predisposing to extracranial occlusive vascular lesions; and diabetes mellitus and metabolic syndrome for ICAS.1,2,8,11–13 However, the reason for racial
differences in the incidence of ICAS still remains unclear. Attempts to prevent recurrence of stroke events in ICAS have focused mainly on anticoagulant therapy, antiplatelet therapy, revascularization procedures, and other medical therapies.6,14,15 In this chapter, we review the epidemiology of ICAS in China, Japan, Korea, and the remainder of Asian countries in which ICAS is prevalent. Ethnic differences observed in the studies from North America and related regions will also be discussed.
China, Japan, Korea, and other Asian regions (Table 3.1) Autopsy studies For decades, it has been reported that patients of Asian, African, and Hispanic ancestry are at high risk of ICAS.1 Sufficient evidence from autopsy studies has shown that African Americans and Japanese have more ICAS, whereas Caucasians have more extracranial diseases.16–18 Masuda’s autopsy series of 724 patients aged 40 years or older, in the community of Hisayama, Japan, showed that ischemic stroke patients had more severe atherosclerosis of the major cerebral arteries than those without stroke or cerebral hemorrhage. In addition, a decline in frequency of cerebral hemorrhage was noted during the study period of 1961–81, with no definite change in the severity of cerebral atherosclerosis.19 However, a more recent study reported a marked decrease in ICAS in the recent 28 years, in contrast with unchanged incidence of coronary artery stenosis in Japanese elderly subjects.20 The authors pointed out that blood pressure lowering,
Intracranial Atherosclerosis Edited by Jong S Kim, Louis R Caplan and KS Lawrence Wong © 2008 Blackwell Publishing Ltd. ISBN: 978-1-405-17822-8
33
34 Study design Cross-sectional n = 2202 Cross-sectional n = 966 Community-based n = 590 Community-based n = 1068 Cross-sectional n = 3057 Prospective n = 156 Prospective n = 151 Retrospective n = 246 Retrospective n = 24 Prospective n = 21 Prospective n = 108
Prospective n = 96 Prospective n = 100
Study
Thomas et al., 200312
Thomas et al., 200413
Wong et al., 200724
Huang et al., 200725
Wong et al., 200729
Uehara et al., 199830
Uehara et al., 200131
Bae et al., 200611
Feldmann et al., 199036
Thajeb et al., 199337
Liu et al., 199645
Huang et al., 199746
Wong et al., 199847
Chinese
Chinese
Chinese
Chinese
Chinese Caucasian
Korean
Japanese
Japanese
Chinese
Chinese
Symptomatic ischemic stroke with adequate temporal windows (n = 66)
Symptomatic TIA
Symptomatic stroke
Symptomatic stroke
Symptomatic stroke
Asymptomatic in CABG patients
Asymptomatic in CABG patients
Asymptomatic
Asymptomatic in patients with vascular risk factors
Asymptomatic
Asymptomatic
Asymptomatic in DM patients
Asymptomatic in DM patients
Condition
TCD
TCD carotid duplex
MRA
DSA
DSA
TCD MRA
MRA
MRA
TCD
TCD
TCD
TCD
TCD
Assessment
Albuminuria may be related with ICAS in DM patients HT, glycosuria, IHD, family history of stroke Male, age, HT, and DM Age, HT, DM, and hyperlipidemia Age, HT No risk factor identified Age, male, HT, DM, and history of stroke/TIA
n = 137 (14.2) n = 41 (6.9) n = 63 (5.9) n = 385 (12.6)
n = 23 (14.7) n = 32 (21.1) n = 71 (28.9)
22 (33)
50 (51)
28 (26)
18 (85.7)
Intracranial occlusive disease is the most commonly found vascular lesion in our acute stroke patients
Most common in terminal internal carotid artery or proximal middle cerebral artery
No difference in vascular risk factors between patients with intracranial and extracranial lesions
HT, hyperfibrinogenemia, polycythemia, and low HDL cholesterol
Chinese had more intracranial lesions while white people had more extracranial lesions
HT, albuminuria
n = 217 (9.9)
White 2 (8) Chinese 6 (26)
Risk factors/results
Number (%)
August 9, 2008
Chinese
Chinese
Chinese
Racial
Table 3.1 Summary of clinical studies in asymptomatic and symptomatic ICAS in Asia regions.
BLBK041-Kim 18:10
Prospective n = 300
Retrospective n = 296
Retrospective n = 64
retrospective n = 279 Retrospective n = 268 Prospective n = 512
Retrospective n = 922 Prospective n = 392 Retrospective n = 100 Prospective n = 205
Zhou et al., 200444
Brust et al., 197534
Nishimaru et al., 198433
Takahashi et al., 199938
Suh et al., 200310
Bang et al., 20058
Nam et al., 2006 9
Kaul et al., 200240
Suwanwela et al., 200343
De Silva et al., 200741 South Asian
Thailand
Indian
Korean
Korean
Korean
Japanese
Japanese Caucasian
Japanese and other population groups in Hawaii
Chinese
Chinese
Symptomatic stroke
Symptomatic stroke or TIA
Symptomatic stroke
Symptomatic
Symptomatic stroke
Symptomatic stroke
Symptomatic stroke (n = 152) and others
Symptomatic carotid system TIA patients
Symptomatic stroke
Symptomatic stroke
Symptomatic stroke
TCCD MRA
TCD carotid duplex
TCD
DSA
DSA
DSA
MRA
DSA
DSA
MRA, DSA
TCD
93 (50)
51 (51)
11 (79) with TACI, 14 (47) PACI, 17 (65) POCI and 51 (44) LACI
DM and IHD
HT, DM, and smoking
Age, HT, smoking, IHD, history of stroke, and simple aortic plaques
n = 245 (48) 161 (41) LAD
Metabolic syndrome was independently associated with intracranial atherosclerosis
Korean patients with severe atherosclerotic stenosis tend to have more intracranial stenosis
HT and HbAlc
10 of 12 severe lesions in Japanese were located intracranially, 17 of 20 severe lesions present in the American group occurred in the extracranial portion of the internal or common carotid arteries
Significant difference between frequency of involvement of >50% stenosis in extracranial and intracranial vessels in Caucasian and that in the Hawaiian-born and Japan-born Japanese populations
The incidence of LAD in Chinese patients is higher than that of the other four subtypes of stroke due to TOAST criteria
The risk of vascular events or death increased rapidly with rising numbers of occlusive arteries
EC-LAA 77 (15.0) IC-LAA 143 (27.9) Non-atherosclerotic 292 (57.0)
Single lesion 37 (66) Multiple lesions 166 (50)
36 (12.9)
Mild lesion n = 25 (78.1) in Japanese n = 29 (90.6) in Caucasians
White 5 (5.4) Hawaii Japanese 8 (9.4) Japan Japanese 8 (34.8)
120 (40) LAD
258 (37)
August 9, 2008
CABG, coronary artery bypass grafting; DSA digital subtraction angiography; EC-LAA, extracranial portion of large artery atherosclerosis; DM, diabetes mellitus; HT, hypertension; IC-LAA, intracranial portion of large artery atherosclerosis; IHD, ischemic heart disease; LAD, large artery atherosclerosis; MRA, magnetic resonance angiography; TCD, transcranial Doppler; TCCD, transcranial color-coded doppler; TIA, transient ischemic attack; TOAST, Trial of ORG 10 172 in Acute Stroke Treatment. TACI, total anterior circulation infarction; PACI, partial anterior circulation infarction; POCI, posterior circulation infarction; LACI, lacunar infarction.
Prospective n = 705
Wong et al., 200048
BLBK041-Kim 18:10
35
BLBK041-Kim
August 9, 2008
18:10
CHAPTER 3
elevation of total cholesterol, and increased incidence of diabetes mellitus may be responsible for this trend. Compared with studies in Japanese populations, data in Chinese populations are relatively limited. In the early 1990s, among 114 consecutive Hong Kong Chinese patients who underwent autopsy, ICAS was found to be more severe than that of extracranial atherosclerosis.21 Both the proximal and distal branches of the intracranial arteries were involved. Hypertension and diabetes mellitus were identified as factors associated only with ICAS, whereas ischemic heart disease was associated with atherosclerosis in both the intracranial and extracranial vessels.21 In another autopsy study from mainland China, Liu et al.22 showed that atherosclerotic narrowing of medium-sized intracranial arteries and their primary branches was more severe than that found in the extracranial carotid arteries in stroke patients. A recent autopsy study in Hong Kong compared the detailed morphological characteristics of middle cerebral artery (MCA) atherosclerosis in patients with and without cerebral infarcts.23 Luminal stenosis caused by atherosclerotic plaques, the percentage of lipid area, and the presence of intraplaque neovasculature were independent risk factors of MCA territory infarcts.23 Prevalence of asymptomatic ICAS in community-based populations With the availability of transcranial Doppler ultrasound (TCD), intracranial stenosis can now be diagnosed easily and non-invasively. Wong et al.24 published the first door-to-door study of ICAS in middle-aged, asymptomatic subjects in rural China. Five hundred and ninety villagers aged 40 years or above were screened by TCD and 41 subjects (prevalence 6.9%) were found to have ICAS. In a multivariate analysis, the significant risk factors for ICAS were hypertension [odds ratio (OR) 2.53; 95% confidence interval (CI 1.12–5.72), glycosuria (OR 3; CI 1.19– 7.97), heart disease (OR 4; CI 1.39–11.6), and family history of stroke (OR 5.2; CI 1.38–20). In another community-based study using TCD in Southern China involving 1068 asymptomatic subjects over 50 years of age, MCA stenosis was evident in 63 subjects (prevalence 5.9%). Male sex, advanced age, hypertension, and diabetes mellitus were independent risk factors for MCA stenosis.25 In a substudy aiming to 36
determine the relationship between hyperhomocysteinemia and MCA stenosis, it was found that hyperhomocysteinemia was an independent risk factor for MCA stenosis.26 The prevalence of asymptomatic carotid stenosis in the white population has been estimated at about 2–8% in the middle-aged and elderly population.27 Therefore, the prevalence of ICAS in the Chinese population appears to be of a similar order of magnitude as the prevalence of asymptomatic carotid stenosis in the white population. Although the ICAS detected in these studies were asymptomatic ones, the presence of ICAS is of clinical significance because it is an independent predictor for survival and recurrent ischemic events.28 These study results provide an estimate of the burden of ICAS in the Chinese population and may be used as a basis for establishing future strategies for the prevention or the management of stroke in this population. Population-based studies have been rare in other Asian countries. However, some results from subjects undergoing health screening are available. Uehara et al.31 studied 156 Japanese subjects (37–83 years, mean age 63 years) with no evidence of stroke who had undergone magnetic resonance angiography (MRA) for other reasons such as non-specific dizziness, tension headache, or forgetfulness. They found that 14.7% had intracranial artery stenosis whereas 11.5% had cervical carotid artery stenosis.29 Multiple logistic regression analysis showed that age and hyperlipidemia were independent predictors for extracranial atherosclerosis, and that age and hypertension were predictors for ICAS. Park et al.30 studied 835 Korean subjects (29–85 years, mean age 53 years) who had visited a hospital for the purpose of routine health screening. MRA showed that 3% had ICAS and 0.48% had extracranial atherosclerosis. Old age and hypertension were independent risk factors for ICAS. The higher incidence of cerebral atherosclerosis in Japanese than in Korean subjects may be due to differences in age (higher mean age in Japanese than in Korean subjects), the criteria for MRA abnormality (>25% in the Japanese study and ≥50% in the Korean study), and subjects’ characteristics (subjects studied by Uehara et al.31 may have been the more risky group). Nevertheless, both results show that ICAS is more prevalent than extracranial atherosclerosis, perhaps more markedly in Korea than in Japan.
BLBK041-Kim
August 9, 2008
18:10
EPIDEMIOLOGY
Prevalence of asymptomatic ICAS in high-risk patients Population-based screening is the best scientific approach for epidemiological studies, but the yield among patients without vascular risk factors is low. Therefore, Wong et al.29 carried out a prevalence study of MCA stenosis among high-risk individuals who had vascular risk factors without history of stroke or TIA. Among 3057 subjects who had at least one vascular risk factor (hypertension, diabetes, hyperlipidemia), 385 (12.6%) had MCA stenosis. Old age, hypertension, diabetes, and hyperlipidemia were associated risk factors. The prevalence escalated quadratically with increasing number of associated factors: from 7.2% for one to 29.6% for four associated factors.29 Two studies from Hong Kong on type II diabetic patients12,13 also reported that blood pressure indices and albuminuria were closely associated with asymptomatic MCA stenosis. Patients scheduled for coronary artery bypass graft surgery (CABG) may have a high risk of cerebrovascular disease. In a study from Japan, 151 consecutive patients who were scheduled for CABG were evaluated with MRA. The results showed that cervical carotid artery narrowing of ≥50% was detected in 16.6%, and intracranial artery stenoses of ≥50% was detected in 21.2% of the subjects.32 This finding is not surprising as previous studies found ICAS was associated with aortic plaques and the metabolic syndrome, which in turn are closely related to coronary artery disease.9,33 However, it seems that extracranial atherosclerosis is more closely related to coronary heart disease than is ICAS, even in Asian countries; a Korean study in 246 consecutive CABG patients showed that the correlation of coronary atherosclerosis with extracranial carotid atherosclerosis was stronger than that of coronary artery atherosclerosis with ICAS, and that this difference was not explained by classic vascular risk factors.11
Symptomatic ICAS in stroke patients Conventional cerebral angiography-based studies There are a number of cerebral angiographic studies in Japan, Korea, and China showing the distribution and severity of ICAS in patients with ischemic stroke. In a case–control study of patients with symptomatic anterior circulation ischemia, 83% of severely stenotic le-
sions involved the intracranial arteries of 32 Japanese patients, whereas 85% of severe lesions involved the extracranial internal carotid artery in 32 American white subjects. For minor lesions, the frequency was similar in the two ethnic groups.34 Another angiogram study in 296 stroke patients living in Hawaii showed a more frequent involvement of the extracranial arteries in white people, and noticeably more frequent involvement of the intracranial arteries in the Hawaiianborn Japanese population.35 Based on the study by Suh et al.,10 Korean patients with severe atherosclerotic stenoses tend to have more intracranial than extracranial stenosis (52% versus 48%), and 59% of intracranial lesions were located in the anterior circulation. Nam et al.9 reported that among 922 Korean stroke patients intracranial or extracranial atherosclerosis was found in 511 patients (55%). Interestingly, simple aortic plaque assessed by transesophageal echocardiography was an independent predictor of ICAS. In an earlier angiographic study in Taiwan, Chinese patients with carotid territory TIAs reported that intracranial stenosis was present in 15% of 47 patients.36 In a case–control study comparing Chinese people living in the USA with American white people, Chinese patients had significantly higher rates of intracranial carotid artery and MCA stenosis.37 Of 24 Chinese patients with cerebral ischemia, 43% had symptomatic MCA stenosis, whereas the same lesion was present in only 14% of 24 age- and sex-matched white patients. In contrast, 50% of white patients had severe stenosis of the extracranial ICA, whereas only 9% of the Chinese patients had a similar lesion. A recent angiographic study of Chinese patients with acute capsular infarcts and prior ipsilateral TIA showed that intracranial stenosis was found in 67% of 21 patients.38 MR angiography and TCD studies Although cerebral angiography remains the gold standard for diagnosing large artery occlusive disease, recent advances in non-invasive diagnostic technologies such as MRA and TCD enable us to study a large number of patients. Studies from Korea, Japan, and China, and various regions of South Asia have shown that these racial groups are at high risk of developing ICAS. Kim et al.39 analyzed 1167 Korean stroke patients who had undergone MRI and MRA. A total of 491 patients (42%) showed large artery atherosclerosis that 37
BLBK041-Kim
August 9, 2008
18:10
CHAPTER 3
was responsible for the stroke. Excluding the patients with tandem vascular lesions, they found that symptomatic atherosclerotic lesions were most often located in the MCA (38%), followed by ICA (28%), vertebral artery (15%), posterior cerebral artery (9%) basilar artery (8%), and the anterior cerebral artery (2%). Among patients with symptomatic ICA disease proximal ICA slightly outnumbered distal ICA diseases. Thus, symptomatic ICAS seems to be more common than symptomatic extracranial atherosclerosis with an approximate ratio of 7:3. The ratio is greater than what was shown in the previous Korean study using conventional angiography,10 which may be explained by the presence of selection bias in conventional angiogram studies; patients with mild intracranial stenosis are likely to be under-represented in those studies. Features may be similar in Japan and other Asian countries. Takahashi et al.40 showed that 12.9% of Japanese stroke patients had MCA stenosis on MRA, and that hypertension and high serum HbAlc levels contributed to the development of MCA lesions. An MRA study from India showed that ICAS as a cause of strokes is probably more common in India than in Japan.41 Hospital-based stroke registry data from South India showed that among all ischemic stroke patients, 41%, 18%, 10%, 4%, and 27% were classified as large-artery atherosclerosis, lacunae, cardioembolism, other determined etiology, and undetermined etiology, respectively.42 The most notable difference between this and Western registries was the predominance of the intracranial rather than the extracranial location of large artery atherosclerosis in the southern Asia region. Similarly, a study from Singapore showed that significant ICAS was common among all Oxfordshire Community Stroke Project subtypes: 79% with total anterior circulation infarct, 47% partial anterior circulation infarct, 65% posterior circulation infarct, and 44% lacunar infarct.43 The finding is consistent with the ethnic Chinese data.44 A retrospective study in Thailand on patients with ischemic stroke or TIA found 98% of patients with extracranial stenosis had associated intracranial disease, whereas none of those with intracranial stenosis had more than 50% extracranial carotid stenosis.45 A study from mainland China suggested that largeartery atherosclerosis (40%) is the main cause of ischemic stroke according to the Trial of ORG 10172 in Acute Stroke Therapy (TOAST) criteria.46 The racial 38
difference between Chinese and white patients in the location of atherosclerotic lesions was also confirmed by an MRA study among 108 symptomatic Taiwan Chinese patients. In this study, approximately 24% of patients had only extracranial carotid disease, about 26% had only intracranial carotid tributary disease, and 17.6% had significant lesions in both extracranial and intracranial carotid artery tributaries.47 Ultrasonographical studies of Chinese subjects showed that ICAS occurred in 30–67% of stroke or TIA patients. One of these studies found ICAS in 51% of 96 TIA patients, whereas extracranial carotid disease occurred in 19% of all patients.48 Another TCD series showed that ICAS was the most common vascular lesion, which accounted for 33% of 66 ischemic stroke patients, whereas an extracranial carotid lesion was found only in 6%.49 Another study from Hong Kong on 705 Chinese stroke patients reported that ICAS only accounted for 37% of patients, and both intracranial and extracranial diseases accounted for 10% of patients, whereas 16 patients (2%) had extracranial carotid artery abnormality only. Overall, ICAS (47%) was nearly fourfold higher in frequency than extracranial carotid occlusive disease (12%).50 Recent data from the same research group was consistent with previous findings. Among the 345 patients who had TCD evidence of intracranial or carotid artery abnormalities, 75% had intracranial involvement only, 5% extracranial involvement only, and 20% had both intracranial and extracranial involvement.51
Symptomatic ICAS in Europe Most European studies have focused on extracranial carotid artery lesions, for this is the most common cause of ischemic stroke in Caucasians. However, there were still some studies investigating ICAS in acute stroke patients. The Group d’Etude ˆ des St´enoses Intra-Craniennes Ath´eromateuses symptomatiques (GESICA) study based in France included 102 stroke patients with ICAS; they found that ICAS involved the vertebral artery in 22.5%, the basilar artery in 25.5%, the MCA in 26.5%, and the internal carotid artery in 25.5%. This prospective study further suggested both a high 2-year recurrence rate of ischemic events in the stenotic cerebral artery territory (38.2%: stroke 13.7%, TIA 24.5%) and cardiovascular events (18.6%) with an 8.8% vascular death rate.52 Olsen et al.53 reported that 40% of
BLBK041-Kim
August 9, 2008
18:10
EPIDEMIOLOGY
patients with stroke in the carotid territory had MCA occlusion. MCA occlusion was responsible for 62% of the large or medium-sized infarcts on CT scan, whereas only 11% of the patients with small infarcts had significant MCA lesions. A Spanish study of 132 stroke patients found 50% had symptomatic intracranial stenosis, and only 26.5% had significant carotid atheromas. For the location of intracranial lesions, the vertebral artery accounted for 28%; MCA 27%; carotid siphon 21%; basilar artery 10%; anterior cerebral artery 5% and posterior cerebral artery 4%.54
North America and related regions Early autopsy studies The early history of ICAS in North America and related areas is replete with studies that have emphasized the importance of extracranial occlusive disease.55 In the early 1950s, for example, Fisher’s56 autopsy series of 200 patients with cerebrovascular disease did not include a single patient who had occlusion of the MCA. Yet, prior to this, patients with anterior circulation occlusive disease were routinely diagnosed as having MCA occlusion. In another autopsy study, Hutchinson and Yates57 emphasized that atherosclerosis of the vertebral artery was most prevalent in the proximal portion of this vessel, was contiguous with occlusive changes of the subclavian artery, and the severity of proximal vertebral artery occlusive disease often paralleled such disease in the proximal ICA. Baker and Iannone,58 in the late 1950s, described cerebral atherosclerosis at autopsy that not only involved the origin of the ICA but also included such areas as the distal, proximal, and mid-portions of the basilar artery and the MCA. Others such as Whisnant and colleagues in the USA confirmed the importance of proximal ICA occlusive disease, and Swartz and Mitchell in the UK and Torvik and Jorgenson in Norway corroborated the importance of occlusive ICA disease at the origin and in the intracranial portion at autopsy.1 Others such as Lhermitte and colleagues and Blackwood et al. suggested that intracranial MCA occlusion was predominantly embolic in origin.1 The studies cited above, however, included predominantly Caucasian patients. Later, Fisher59 elucidated the pathological lesions underlying lacunar infarcts within intracranial penetrating artery distributions. He described microscopic pathology in small blood vessels measuring less than
200 μm in diameter in some cases and that included fibrinoid degeneration of vessel walls and hyaline change within the vascular media (so-called lipohyalinosis). Racial differences in ICAS: autopsy studies In an autopsy study from the Charity Hospital in New Orleans in 1959, Moossy60 showed that cerebral atherosclerosis typically involved the ICA and vertebral arteries followed by the basilar artery and MCA. The youngest patient in that series was a black woman in her 20s. In a more extensive study of 2650 brain dissections, Moossy61 reported the importance of intracranial arterial thrombosis in those with recent ischemic stroke. In the International Atherosclerosis Project (IAP), black people in New Orleans had a higher extent of raised lesions than white people in New Orleans, and Jamaican black people had more raised lesions in the vertebral and other intracranial arteries. Later, McGarry et al.16 reported that in randomly selected autopsy subjects, black people in New Orleans had more advanced ICAS. A comparison among autopsy subjects from New Orleans, Oslo, and Kingston showed that black people had more atherosclerosis intracranially and as much or more cervical atherosclerosis, but white people had more occlusive disease in the aorta and coronary arteries.62 Sex differences in ICAS: autopsy study Whereas men have a higher risk of stroke overall, more women than men in the USA die of stroke. This has been attributed to the fact that women live longer than men and stroke risk is substantially linked to age. It has been suggested that women may have more intrinsic occlusive intracranial vascular disease.1 Flora et al.62 reported that the frequency of cerebral atherosclerosis increased more rapidly in women after the sixth decade; by the ninth decade it was more common than in men; and diabetic women were particularly at risk of cerebral atherosclerosis. Caplan1 has suggested that persons with medium-sized ICAS and major branch disease may be disproportionately more often women, black, or Asian, or hypertensive subjects. Conventional cerebral angiography-based studies of racial differences in ICAS There is a substantial history of cerebral angiographic studies showing racial differences in the distribution 39
BLBK041-Kim
August 9, 2008
18:10
CHAPTER 3
and severity of occlusive intracranial and extracranial arterial lesions. Caplan et al.1 and Gorelick2 have previously reviewed this literature. Overall, based on studies by Bauer et al., Fields et al., Russo, Heyden et al., and Heyman et al., there seems to be more surgically accessible extracranial lesions in white people than in black people and a higher frequency of intrinsic intracranial occlusive lesions among black people.63–67 We now review the findings from a series of angiographic studies among a hospital-based, racially mixed population of black and white people with symptomatic and asymptomatic occlusive cerebral vascular disease in Chicago, IL, which was carried out in the 1980s. We focus on the distribution, severity, and predictors of ICAS in this population. Chicago experience Symptomatic occlusive disease Gorelick et al. studied 26 white and 45 black subjects with symptomatic occlusive cerebrovascular disease of the anterior circulation.3 The patients had been entered into the Michael Reese Hospital Stroke Registry. Overall, white patients had more severe disease of the extracranial carotid artery at the origin, and a clinical history of more TIAs and carotid bruits, whereas black patients had more severe disease of the MCA stem and supraclinoid ICA. This study did not include multivariable analysis. However, in a companion conventional cerebral angiographic study that included 27 white and 24 black subjects predominantly from the Chicago area, white subjects had significantly more angina pectoris, more lesions of the origin of the left vertebral artery, and more severe lesions of the extracranial vertebral arteries, whereas black patients had significantly higher mean diastolic blood pressure, more diabetes mellitus, more lesions of the distal basilar artery, more severe lesions of intracranial branch vessels, and more symptomatic intracranial branch disease.4 Furthermore, logistic regression analysis showed that race was an independent predictor of the site of occlusive disease in the posterior circulation. Although the statistical power may have been low based on the small sample size in the study, there were significantly more intracranial lesions and symptomatic intracranial lesions among non-diabetic black people than among non-diabetic white people. Asymptomatic occlusive disease In a second companion conventional cerebral angiographic study, 40
Gorelick et al. compared clinical and arteriographic characteristics in 106 subjects who had symptomatic unilateral carotid territory occlusive disease to elucidate the frequency and distribution of occlusive arterial lesions in asymptomatic arterial vessels.5 Among the black patients, who were predominantly from Chicago, younger, and more often female than the white patients, there were fewer TIAs and myocardial infarctions and less claudication by medical history, but more asymptomatic lesions of the supraclinoid carotid artery, anterior cerebral artery stem, and MCA stem. Whereas the white patients, predominantly from New England, elderly, and men, had more frequent and severe occlusive asymptomatic disease of the extracranial carotid artery and vertebral artery sites. By stepwise logistic regression analysis, predictors of asymptomatic arterial sites included white race (extracranial carotid artery), black race (major intracranial artery sites), black race (major MCA sties), and black race and diabetes (anterior cerebral artery sites). Contemporary studies and perspectives The above autopsy and conventional cerebral angiographic studies from North America and related regions suggest that black people may have a propensity for ICAS, whereas white people may be more predisposed to extracranial occlusive disease. Circle of Willis ICAS has been linked to hypertension in an autopsy study.68 Interestingly, black populations, for example, in West Africa have been shown to have little atherosclerosis of the circle of Willis when the prevalence of hypertension is low. However, in urban West African populations, the prevalence of ICAS is believed to increase in conjunction with raised blood pressure. Furthermore, based on conventional cerebral angiographic studies outside of North America, black Zambian patients had been shown to have extracranial atherosclerosis rarely, and black South African patients with stroke had extracranial lesions infrequently.69 Caplan has set forth the following hypothesis to explain racial differences in the distribution and severity of intracranial and extracranial occlusive disease.69 He suggests that hypertension differs in black people and white people. For example, black people and Asians retain more sodium, and their hypertension responds to diuretics. Therefore, hypertension in these groups can be related to high volume states. In addition, diabetes is a disorder often accompanied by high blood
BLBK041-Kim
August 9, 2008
18:10
EPIDEMIOLOGY
volume, as are certain conditions in women, e.g., menstruation, pregnancy, and sex hormone use. These conditions associated with high blood volume, female sex, diabetes, and hypertension in black people and Asians, also are associated with intracranial occlusive disease. In contrast, hypertension in white people, for example, is associated with extracranial carotid artery and vertebral artery disease. It is possible that the medium of the blood vessel, which is more important in intracranial arteries, is more susceptible to high volume states that cause more stress on these vessels, whereas highresistance hypertension more commonly adversely affects the extracranial arteries. Several key studies based in North America have determined risk profiles for occlusive cerebrovascular disease. For example, in the international Extracranial/Intracranial Bypass Study entry characteristics were analyzed to determine whether there were differences in the site of the lesion on the basis of racial group.70 In this trial, black people more often had hypertension, diabetes, or smoked cigarettes, whereas white people had higher systolic blood pressure and hemoglobin levels. Asian subjects had the lowest prevalence of vascular risk factors. Keeping in mind the study limitations related to possible patient selection biases, multivariate analysis showed that race (black, Asian) was an independent predictor of the location of cerebrovascular lesions. In the Northern Manhattan Stroke Study (NoMASS), a greater prevalence of diabetes and hypercholesterolemia was noted among black and Hispanic people, accounting for a substantial proportion of the increased frequency of ICAS.71 In addition, in NoMASS the maximum internal carotid artery plaque thickness (MICPT) was measured among 526 racially mixed, stroke-free community residents.72 The mean MICPT was greater in white and black subjects than in Hispanic subjects. Independent predictors of MICPT included smoking, glucose, low-density lipoprotein (LDL) cholesterol, and hypertension. When covariates were controlled in statistical analyses, Hispanic race– ethnicity remained an independent predictor of less carotid plaque. In addition, there was a significant interaction between race–ethnicity and LDL cholesterol, with a greater effect with increasing LDL cholesterol in Hispanic sublects. Finally, in the Warfarin–Aspirin Symptomatic Intracranial Disease (WASID) trial, the metabolic syndrome was found in about 50% of subjects and was associated with higher risk of major vas-
cular events.33 In WASID, among persons with ICAS, the risk of subsequent stroke was predicted by stenosis ≥70%, the presence of recent symptoms (≤17 days), and being women.73 Burke and Howard74 provide a perspective regarding racial differences in the distribution and severity of asymptomatic extracranial atherosclerosis. Whereas clinical studies suggest a greater degree of atherosclerosis in white than in black patients, population studies [e.g., Atherosclerosis Risk in Communities (ARIC), Cardiovascular Health Study (CHS), Insulin Resistance Atherosclerosis Study,75 the Northern Manhatlan Stroke Study (NoMASS) suggest a similar extent of atherosclerosis amongst white and black people. They explain the disparity between clinical and population studies in the following manner: (1) black people have a large excess of stroke mortality at relatively young ages (e.g., 45–50 years) in which atherosclerosis is unlikely to play a major role in stroke etiology as the underlying causes are more likely to be hemorrhage, ICAS, embolism, etc.); and (2) because of a higher burden of stroke risk factors, black people have a higher risk of stroke at relatively lower levels of extracranial carotid artery stenosis, yet atherosclerosis remains an important factor.
Implication of racial distribution of cerebrovascular atherosclerosis ICAS is a common cause of stroke in Asian, black, and Hispanic patients but not in white patients. The cause of this disparity remains uncertain. Risk factors such as hypertension, diabetes, and hyperlipidemia are also prevalent in white subjects, so that vascular risk factors alone cannot explain this difference. Whether other environmental factors such as diet, lifestyle, or genetics play a role deserves further investigation. Other studies have suggested that genetic susceptibility may play a key role. black, Hispanic, and Asian people might be susceptible to ICAS.5,37 Laboratory work has shown that genes are highly associated with phenotypic variation in carotid artery occlusive disease76–78 as well as ICAS.79–82 There has been suggestion that the metabolic syndrome and related abnormalities may explain the high prevalence of ICAS in Asians. This aspect will be more thoroughly discussed in Chapter 4. Elucidating the factors responsible for the racial differences in the distribution of 41
BLBK041-Kim
August 9, 2008
18:10
CHAPTER 3
cerebrovascular atherosclerosis may provide important insights of the pathogenesis and may help to develop a better prevention and treatment strategy.
15
References 1 Caplan LR, Gorelick PB, Hier DB. Race, sex and occlusive cerebrovascular disease: a review. Stroke 1986; 17: 648– 655. 2 Gorelick PB. Distribution of atherosclerotic cerebrovascular lesions. Effects of age, race, and sex. Stroke 1993; 24: 116–19; discussion 120–121. 3 Gorelick PB, Caplan LR, Hier DB, et al. Racial differences in the distribution of anterior circulation occlusive disease. Neurology 1984; 34: 54–59. 4 Gorelick PB, Caplan LR, Hier DB, et al. Racial differences in the distribution of posterior circulation occlusive disease. Stroke 1985; 16: 785–790. 5 Gorelick PB, Caplan LR, Langenberg P, et al. Clinical and angiographic comparison of asymptomatic occlusive cerebrovascular disease. Neurology. 1988; 38: 852–858. 6 Chimowitz MI, Lynn MJ, Howlett-Smith H, et al. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med 2005; 352: 1305– 1316. 7 Wong LKS. Global burden of intracranial atherosclerosis. International Journal of Stroke. 2006; 1: 158–159. 8 Bang OY, Kim JW, Lee JH, et al. Association of the metabolic syndrome with intracranial atherosclerotic stroke. Neurology 2005; 65: 296–298. 9 Nam HS, Han SW, Lee JY, et al. Association of aortic plaque with intracranial atherosclerosis in patients with stroke. Neurology 2006; 67: 1184–1188. 10 Suh DC, Lee SH, Kim KR, et al. Pattern of atherosclerotic carotid stenosis in Korean patients with stroke: different involvement of intracranial versus extracranial vessels. AJNR Am J Neuroradiol 2003; 24: 239–244. 11 Bae HJ, Yoon BW, Kang DW, et al. Correlation of coronary and cerebral atherosclerosis: difference between extracranial and intracranial arteries. Cerebrovasc Dis 2006; 21: 112–119. 12 Thomas GN, Lin JW, Lam WW, et al. Middle cerebral artery stenosis in type II diabetic Chinese patients is associated with conventional risk factors but not with polymorphisms of the renin-angiotensin system genes. Cerebrovasc Dis 2003; 16: 217–223. 13 Thomas GN, Lin JW, Lam WW, et al. Albuminuria is a marker of increasing intracranial and extracranial vascular involvement in Type 2 diabetic Chinese patients. Diabetologia 2004; 47: 1528–1534. 14 Wong KS, Chen C, Ng PW, et al. Low-molecular-weight heparin compared with aspirin for the treatment of acute
42
16
17
18
19
20
21
22
23
24
25
26
27 28
ischaemic stroke in Asian patients with large artery occlusive disease: a randomised study. Lancet Neurol 2007; 6: 407–413. Kwon SU, Cho YJ, Koo JS, et al. Cilostazol prevents the progression of the symptomatic intracranial arterial stenosis: the multicenter double-blind placebo-controlled trial of cilostazol in symptomatic intracranial arterial stenosis. Stroke 2005; 36: 782–786. McGarry P, Solberg LA, Guzman MA, Strong JP. Cerebral atherosclerosis in New Orleans. Comparisons of lesions by age, sex, and race. Lab Invest 1985; 52: 533–539. Nakamura M, Yamamoto H, Kikuchi Y, et al. Cerebral atherosclerosis in Japanese. I. Age related to atherosclerosis. Stroke 1971; 2: 400–408. Resch JA, Okabe N, Loewenson RB, et al. Pattern of vessel involvement in cerebral atherosclerosis. A comparative study between a Japanese and Minnesota population. J Atheroscler Res 1969; 9: 239–250. Masuda J, Tanaka K, Omae T, et al. Cerebrovascular diseases and their underlying vascular lesions in Hisayama, Japan – a pathological study of autopsy cases. Stroke 1983; 14: 934–940. Koyama S, Saito Y, Yamanouchi H, et al. [Marked decrease of intracranial atherosclerosis in contrast with unchanged coronary artery stenosis in Japan]. Nippon Ronen Igakkai Zasshi 2003; 40: 267–273. Leung SY, Ng TH, Yuen ST, et al. Pattern of cerebral atherosclerosis in Hong Kong Chinese. Severity in intracranial and extracranial vessels. Stroke 1993; 24: 779– 786. Liu F, Zhang B, Tian Y. [Morphological changes in intracranial and extracranial arteries of autopsy cases of cerebrovascular diseases]. Zhonghua Yi Xue Za Zhi 1996; 76: 832–835. Chen XY, Wong KS, Lam WW, et al. Middle Cerebral artery atherosclerosis: histological comparison between plaques associated with and not associated with infarct in a postmortem study. Cerebrovasc Dis 2007; 25: 74–80. Wong KS, Huang YN, Yang HB, et al. A door-to-door survey of intracranial atherosclerosis in Liangbei County, China. Neurology 2007; 68: 2031–2034. Huang HW, Guo MH, Lin RJ, et al. Prevalence and risk factors of middle cerebral artery stenosis in asymptomatic residents in Rongqi County, Guangdong. Cerebrovasc Dis 2007; 24: 111–115. Huang HW, Guo MH, Lin RJ, et al. Hyperhomocysteinemia is a risk factor of middle cerebral artery stenosis. J Neurol 2007; 254: 364–367. Hill AB. Should patients be screened for asymptomatic carotid artery stenosis? Can J Surg 1998; 41: 208–213. Wong KS, Li H. Long-term mortality and recurrent stroke risk among Chinese stroke patients with predominant intracranial atherosclerosis. Stroke 2003; 34: 2361–2366.
BLBK041-Kim
August 9, 2008
18:10
EPIDEMIOLOGY
29 Wong KS, Ng PW, Tang A, et al. Prevalence of asymptomatic intracranial atherosclerosis in high-risk patients. Neurology 2007; 68: 2035–2038. 30 Park KY, Chung CS, Lee KH, et al. Prevalence and risk factors of intracranial atherosclerosis in an asymptomatic Korean population. J Clin Neurol 2006; 2: 29–33. 31 Uehara T, Tabuchi M, Mori E. Frequency and clinical correlates of occlusive lesions of cerebral arteries in Japanese patients without stroke. Evaluation by MR angiography. Cerebrovasc Dis 1998; 8: 267–272. 32 Uehara T, Tabuchi M, Kozawa S, Mori E. MR angiographic evaluation of carotid and intracranial arteries in Japanese patients scheduled for coronary artery bypass grafting. Cerebrovasc Dis 2001; 11: 341–345. 33 Ovbiagele B, Saver JL, Lynn MJ, Chimowitz M. Impact of metabolic syndrome on prognosis of symptomatic intracranial atherostenosis. Neurology 2006; 66: 1344– 1349. 34 Nishimaru K, McHenry LC, Jr, Toole JF. Cerebral angiographic and clinical differences in carotid system transient ischemic attacks between American Caucasian and Japanese patients. Stroke 1984; 15: 56–59. 35 Brust RW, Jr. Patterns of cerebrovascular disease in Japanese and other population groups in Hawaii: an angiographical study. Stroke 1975; 6: 539–542. 36 Ryu SJ. Angiographic features in Chinese patients with occlusive cerebrovascular disease. Stroke 1987; 18: 686. 37 Feldmann E, Daneault N, Kwan E, et al. Chinese-white differences in the distribution of occlusive cerebrovascular disease. Neurology 1990; 40: 1541–1545. 38 Thajeb P. Large vessel disease in Chinese patients with capsular infarcts and prior ipsilateral transient ischaemia. Neuroradiology 1993; 35: 190–195. 39 Kim JT, Yoo SH, Kwon J-H, Kwon SU, Kim JS. Subtyping of ischemic stroke based on vascular imaging: analysis of 1,167 acute, consecutive patients. J Clin Neurol 2006; 2: 225–230. 40 Takahashi K, Kitani M, Fukuda H, Kobayashi S. Vascular risk factors for atherosclerotic lesions of the middle cerebral artery detected by magnetic resonance angiography (MRA). Acta Neurol Scand 1999; 100: 395–399. 41 Padma MV, Gaikwad S, Jain S, et al. Distribution of vascular lesions in ischaemic stroke: a magnetic resonance angiographic study. Natl Med J India 1997; 10: 217– 220. 42 Kaul S, Sunitha P, Suvarna A, et al. Subtypes of Ischemic Stroke in a Metropolitan City of South India (One year data from a hospital based stroke registry). Neurol India 2002; 50 (Suppl): S8–S14. 43 De Silva DA, Woon FP, Pin LM, et al. Intracranial large artery disease among OCSP subtypes in ethnic South Asian ischemic stroke patients. J Neurol Sci 2007; 260: 147–149.
44 Li H, Wong KS. Racial distribution of intracranial and extracranial atherosclerosis. J Clin Neurosci 2003; 10: 30–34. 45 Suwanwela NC, Chutinetr A. Risk factors for atherosclerosis of cervicocerebral arteries: intracranial versus extracranial. Neuroepidemiology 2003; 22: 37–40. 46 Zhou H, Wang YJ, Wang SX, Zhao XQ. [TOAST subtyping of acute ischemic stroke]. Zhonghua Nei Ke Za Zhi 2004; 43: 495–498. 47 Liu HM, Tu YK, Yip PK, Su CT. Evaluation of intracranial and extracranial carotid steno-occlusive diseases in Taiwan Chinese patients with MR angiography: preliminary experience. Stroke 1996; 27: 650–653. 48 Huang YN, Gao S, Li SW, et al. Vascular lesions in Chinese patients with transient ischemic attacks. Neurology 1997; 48: 524–525. 49 Wong KS, Huang YN, Gao S, et al. Intracranial stenosis in Chinese patients with acute stroke. Neurology 1998; 50: 812–813. 50 Wong KS, Li H, Chan YL, et al. Use of transcranial Doppler ultrasound to predict outcome in patients with intracranial large-artery occlusive disease. Stroke 2000; 31: 2641–2647. 51 Li H, Wong KS, Kay R. Relationship between the Oxfordshire Community Stroke Project classification and vascular abnormalities in patients with predominantly intracranial atherosclerosis. J Neurol Sci 2003; 207: 65–69. 52 Mazighi M, Tanasescu R, Ducrocq X, et al. Prospective study of symptomatic atherothrombotic intracranial stenoses: the GESICA study. Neurology 2006; 66: 1187– 1191. 53 Olsen TS, Skriver EB, Herning M. Cause of cerebral infarction in the carotid territory. Its relation to the size and the location of the infarct and to the underlying vascular lesion. Stroke 1985; 16: 459–466. 54 Sanchez-Sanchez C, Egido JA, Gonzalez-Gutierrez JL, et al. [Stroke and intracranial stenosis: clinical profile in a series of 134 patients in Spain]. Rev Neurol 2004; 39: 305–311. 55 Caplan LR, Hennerici M. Impaired clearance of emboli (washout) is an important link between hypoperfusion, embolism, and ischemic stroke. Arch Neurol 1998; 55: 1475–1482. 56 Fisher M. Occlusion of the internal carotid artery. AMA Arch Neurol Psychiatry 1951; 65: 346–377. 57 Hutchinson EC, Yates PO. Carotico-vertebral stenosis. Lancet 1957; 272: 2–8. 58 Baker AB, Iannone A. Cerebrovascular disease. I. The large arteries of the circle of Willis. Neurology 1959; 9: 321–332. 59 Fisher CM. Lacunar strokes and infarcts: a review. Neurology 1982; 32: 871–876.
43
BLBK041-Kim
August 9, 2008
18:10
CHAPTER 3
60 Moossy J. Development of cerebral atherosclerosis in various age groups. Neurology 1959; 9: 569–574. 61 Moossy J. Cerebral infarction and intracranial arterial thrombosis. Necropsy studies and clinical implications. Arch Neurol 1966; 14: 119–123. 62 Flora GC, Baker AB, Loewenson RB, Klassen AC. A comparative study of cerebral atherosclerosis in males and females. Circulation 1968; 38: 859–869. 63 Fields WS, North RR, Hass WK, et al. Joint study of extracranial arterial occlusion as a cause of stroke. I. Organization of study and survey of patient population. JAMA 1968; 203: 955–960. 64 Heyden S, Heyman A, Goree JA. Nonembolic occlusion of the middle cerebral and carotid arteries – a comparison of predisposing factors. Stroke 1970; 1: 363– 369. 65 Heyman A, Karp HR, Heyden S, et al. Cerebrovascular disease in the biracial population of Evans County, Georgia. Arch Intern Med 1971; 128: 949–955. 66 Russo LS, Jr. Carotid system transient ischemic attacks: clinical, racial, and angiographic correlations. Stroke 1981; 12: 470–473. 67 Bauer RB, Sheehan S, Wechsler N, Meyer JS. Arteriographic study of sites, incidence, and treatment of arteriosclerotic cerebrovascular lesions. Neurology 1962; 12: 698–711. 68 Kuller LH. Introduction and overview commentary. In: Gillum R, Gorelick PB, Cooper ES (eds): Stroke in blacks. A guide to management and prevention. Basel: S. Karger AG, 1999, pp. 1–6. 69 Caplan LR. Cerebral ischemia and infarction in blacks. Clinical, autopsy and angiographic studies. In: Gillum R, Gorelick PB, Cooper ES (eds): Stroke in blacks. A guide to management and prevention. Basel: S. Karger AG, 1999, pp. 7–18. 70 Inzitari D, Hachinski VC, Taylor DW, Barnett HJ. Racial differences in the anterior circulation in cerebrovascular disease. How much can be explained by risk factors? Arch Neurol 1990; 47: 1080–1084. 71 Sacco RL, Kargman DE, Gu Q, Zamanillo MC. Raceethnicity and determinants of intracranial atherosclerotic cerebral infarction. The Northern Manhattan Stroke Study. Stroke 1995; 26: 14–20.
44
72 Sacco RL, Roberts JK, Boden-Albala B, et al. Raceethnicity and determinants of carotid atherosclerosis in a multiethnic population. The Northern Manhattan Stroke Study. Stroke 1997; 28: 929–935. 73 Kasner SE, Chimowitz MI, Lynn MJ, et al. Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis. Circulation 2006; 113: 555–563. 74 Burke GL, Howard G. Ethnic differences in cerebral atherosclerosis. In: Gillum R, Gorelick PB, Cooper ES (eds): Stroke in blacks. A guide to management and prevention. Basel: S. Karger AG 1999, pp. 94–105. 75 Oda K, Tanaka N, Arai T, et al. Polymorphisms in proand anti-inflammatory cytokine genes and susceptibility to atherosclerosis: a pathological study of 1503 consecutive autopsy cases. Hum Mol Genet 2007; 16: 592–599. 76 Robinet P, Vedie B, Chironi G, et al. Characterization of polymorphic structure of SREBP-2 gene: role in atherosclerosis. Atherosclerosis 2003; 168: 381–387. 77 Markus HS, Labrum R, Bevan S, et al. Genetic and acquired inflammatory conditions are synergistically associated with early carotid atherosclerosis. Stroke 2006; 37: 2253–2259. 78 Fiotti N, Altamura N, Fisicaro M, et al. MMP-9 microsatellite polymorphism and susceptibility to carotid arteries atherosclerosis. Arterioscler Thromb Vasc Biol 2006; 26: 1330–1336. 79 Wang L, Gu Y, Wu G, et al. [A case control study on the distribution of apolipoprotein AI gene polymorphisms in the survivors of atherosclerosis cerebral infarction]. Zhonghua Liu Xing Bing Xue Za Zhi 2000; 21: 22–25. 80 Sertic J, Hebrang D, Janus D, et al. Association between deletion polymorphism of the angiotensin-converting enzyme gene and cerebral atherosclerosis. Eur J Clin Chem Clin Biochem 1996; 34: 301–304. 81 Liu ZZ, Lv H, Gao F, et al. Polymorphism in the human C-reactive protein (CRP) gene, serum concentrations of CRP, and the difference between intracranial and extracranial atherosclerosis. Clin Chim Acta 2008; 389: 40– 44. 82 Abboud S, Karhunen PJ, Lutjohann D, et al. Proprotein convertase subtilisin/kexin type 9 (PCSK9) gene is a risk factor of large-vessel atherosclerosis stroke. PLoS ONE 2007; 2: e1043.
BLBK041-Kim
August 18, 2008
4
13:10
Risk factors Kazuo Minematsu, Oh Young Bang and Toshiyuki Uehara
Studies investigating risk factors for intracranial atherosclerosis (ICAS) have been rare compared with those for extracranial carotid atherosclerosis. This may be attributable to the limited availability of vascular imaging techniques assessing intracranial cerebral arteries. During the last decades, a variety of imaging technologies have become available to directly and non-invasively evaluate the status of the intracranial vascular system, including transcranial Doppler ultrasonography (TCD), magnetic resonance angiography (MRA), and computed tomography angiography (CTA). With these new techniques, we can assess the intracranial vascular system not only in stroke patients but also in asymptomatic individuals. These improvements in vascular imaging technologies have yielded a growing number of studies on risk factors for ICAS. It is well known that the distribution of atherosclerotic lesions in the cervicocephalic vascular systems varies among different race–ethnic groups.1–6 In Caucasians, atherosclerosis develops frequently in the extracranial carotid arteries, whereas ICAS is the common cause of stroke in Asians, Africans, and Hispanics. Several studies have demonstrated that hypercholesterolemia and ischemic heart disease (IHD) are more frequent, whereas hypertension and diabetes mellitus are less prevalent in Caucasians than in African Americans.4,5 It still remains elusive, however, whether the race–ethnicity is an independent risk factor of ICAS or is confounded by differences in stroke risk factors among different ethnic groups. Recently, it has been suggested that the metabolic syndrome, which refers to a constellation of metabolic risk factors linked to insulin resistance, is associated
with increased risks of coronary heart disease and stroke. The number of people with the metabolic syndrome has rapidly increased over the past two decades, in association with the global epidemics of obesity and diabetes.7 The Adult Treatment Panel III (ATP-III) defined this syndrome as the presence of three or more of the following: (1) abdominal obesity; (2) elevated triglyceride levels (≥150 mg/dL); (3) low high-density lipoprotein cholesterol levels (<40 mg/dL for men and <50 mg/dL for women); (4) hypertension (systolic blood pressure ≥130 mmHg or diastolic blood pressure ≥85 mmHg); and (5) impaired fasting glucose levels (≥110 mg/dL).8 The ATP-III recognized the metabolic syndrome as a secondary target for risk reduction therapy,8 and it was recently reported that the metabolic syndrome is associated with risks that are not accounted for entirely by conventional riskscoring paradigms.9 Numerous studies have addressed the independent association of the metabolic syndrome with heart disease-related mortality, with the relative hazard ratio reported to be 1.5 to 5.0.10 Stroke was considered as a combined co-morbidity in most studies. Several studies, however, reported that the metabolic syndrome or insulin resistance is associated with ischemic stroke across the study populations,11–16 especially with the atherosclerotic subtype of stroke.17–20 Since metabolic syndrome is almost three times as prevalent as diabetes mellitus, the population-attributable risk of stroke may be greater for the metabolic syndrome than for diabetes mellitus.21 In this chapter, various risk factors for ICAS, including the metabolic syndrome, are reviewed and discussed.
Intracranial Atherosclerosis Edited by Jong S Kim, Louis R Caplan and KS Lawrence Wong © 2008 Blackwell Publishing Ltd. ISBN: 978-1-405-17822-8
45
BLBK041-Kim
August 18, 2008
13:10
CHAPTER 4
Differences in risk factors between extra- and intracranial atherosclerosis Several studies have revealed that risk factors are different between extracranial carotid atherosclerosis and ICAS. Kuller et al.2 reported that the role of blood pressure may be greater than that of hyperlipidemia in major ICAS. In contrast, extracranial carotid and coronary atherosclerosis was more closely related to serum lipid levels than to blood pressure. Similarly, Caplan et al.1 reported that the extracranial internal carotid artery (ICA) lesions were closely related to hyperlipidemia and IHD, whereas middle cerebral artery (MCA) diseases were related to hypertension rather than hypercholesterolemia. Heyden et al.22 analyzed a group of patients with angiographically documented non-embolic MCA occlusion and noted that they had IHD and hypercholesterolemia less frequently than those with extracranial ICA lesions. A study evaluating stroke-free Japanese subjects using MRA found that risk factors for extracranial ICA disease were age and hyperlipidemia, whereas those for ICAS were age and hypertension.23 Thus, it seems that there are certain differences in risk factors between extracranial arterial diseases and ICAS. However, the results have not always been consistent. For instance, Inzitari et al.5 studied patients recruited in the EC/IC Bypass Study and found that Asians and black people more often had ICAS than did Caucasians. They then noticed that race was the only independent factor determining the location of atherosclerosis. Similarly, Wityk et al.24 found that the distribution of cerebral atherosclerosis was influenced by race and sex, but not other vascular risk factors. More recently, Kim and Choi-Kwon25 investigated risk factors and lifestyle factors in patients with cerebrovascular diseases. They meticulously evaluated atherosclerotic lesions at different levels of cerebral arteries using MRA and found that there were no risk factors that differentiate ICAS from extracranial arterial diseases. Therefore, there still remain controversies regarding whether there are risk factors preferentially affecting a specific level of cerebral vessels. Recently, several studies have reported that the metabolic syndrome, a constellation of a group of risk factors, may be more closely associated with ICAS than extracranial atherosclerosis.26–28 This issue
46
will be discussed in detail in the last sections of this chapter.
Intracranial atherosclerosis and coronary diseases Patients with IHD are more likely to have stroke than those without,29 and IHD is a frequent cause of death among stroke survivors.30 IHD shares risk factors with ischemic stroke. In Caucasians, the degree of extracranial carotid atherosclerosis has been shown to correlate with the extent of coronary atherosclerosis.31–34 On the other hand, although earlier autopsy-based studies reported a correlation between ICAS and coronary atherosclerosis,35,36 the relationship seems to be less clear. Uehara et al.37 evaluated atherosclerotic lesions in the extracranial and intracranial cerebral arteries using MRA in 67 Japanese patients who underwent selective coronary angiography to estimate the extent of IHD. Stenotic lesions >25% in diameter were found in 15 patients (22.4%) in the extracranial carotid artery and in 11 patients (16.4%) in the intracranial cerebral arteries. They compared the patients with IHD with age- and sex-matched control subjects without a history of IHD. The prevalence of carotid artery lesions was significantly higher in the IHD group than in the control group. Although the prevalence of ICAS was also higher in the IHD group than in the control group, the difference was not statistically significant. When the patients with IHD were divided into four groups as zero-, single-, two-, and three-vessel disease groups according to the number of affected major coronary branches, extracranial carotid artery lesions were significantly more common in the three-vessel group than in the zero- and single-vessel groups. A similar trend was also observed for ICAS, but the difference was not statistically significant. However, the failure to find an association between the severity of ICAS and that of coronary artery disease might be attributable to the small number of patients with ICAS who had two- or three-vessels disease. Recently, a study with a larger number of subjects found that the prevalence of ICAS as well as that of extracranial atherosclerosis increased significantly as coronary atherosclerosis became more severe, from zero- to three-vessel disease.38 The prevalence of ICAS
BLBK041-Kim
August 18, 2008
13:10
RISK FACTORS
Table 4.1 Studies on risk factors for intracranial atherosclerosis
Author (year)
Country
Sym/Asym
Evaluation method
Evaluation sites
Significant risk factors
Yasaka et al. (1993)43
Japan
Sym
CA
MCA, BA
MCA: advanced HT BA: DM, HL, IHD
Uehara et al. (1998)23 Kim et al. (1999)25 Takahashi et al. (1999)44 Arenillas et al. (2004)45
Japan Korea Japan Spain
Asym Sym Sym+Asym Sym
Korea Japan
Sym Asym
ICA, MCA, BA MCA, ACA, BA, PCA MCA ICA, MCA, ACA VA, BA, PCA MCA, VA, BA ICA, MCA, VA, BA
Age, HT HT, DM HT, HbA1c DM, Lp(a)
Bang et al. (2005)26 Uehara et al. (2005)46
MRA CA, MRA MRA MRA, CTA, TCD CA, MRA MRA
Bae et al. (2007)47
Korea
Asym
TCD
Park et al. (2007)27 Wong et al. (2007)48
Korea Hong Kong
Sym Asym
MRA TCD
Wong et al. (2007)49 Huang et al. (2007)50
Hong Kong Hong Kong
Asym Asym
TCD TCD
ICA, MCA, ACA VA, BA, PCA MCA, ACA, BA, PCA ICA, MCA, ACA VA, BA, PCA MCA MCA
MetS ICA: Age, HT, DM, IHD MCA: Age, HT BA: HT, DM VA: HL, IHD Age, HT, DM MetS HT, glycosuria, heart disease Family history of stroke Age, HT, DM, HL Age, male, HT, DM
Sym, symptomatic; Asym, asymptomatic. ACA, anterior cerebral artery; BA, basilar artery; CA, conventional angiography; CTA, CT angiography; DM, diabetes mellitus; IHD, ischemic heart disease; HL, hyperlipidemia; HT, hypertension; ICA, internal carotid artery; Lp(a), lipoprotein (a); MCA, middle cerebral artery; MetS, metabolic syndrome; MRA, MR angiography; PCA, posterior cerebral artery TCD, transcranial Doppler; VA, vertebral artery.
was high in patients who had severe coronary artery lesions or those scheduled for coronary artery bypass graft (CABG) surgery, although the relationship was less strong than in patients with extracranial carotid disease.39,40 Similarly, a more recent study41 analyzing 246 consecutive patients undergoing CABG surgery showed that the correlation of coronary atherosclerosis was stronger with extracranial carotid atherosclerosis than with ICAS. Finally, Arenillas et al.42 reported that the existence of symptomatic vertebral, basilar artery (BA), and intracranial ICA stenosis was an independent marker of myocardial perfusion abnormalities in single-photon emission computed tomography studies. These results, taken together, suggest that ICAS is closely associated with coronary atherosclerosis, but the association is weaker than in extracranial carotid atherosclerosis.
Conventional stroke risk factors in intracranial atherosclerosis A number of clinical studies have assessed conventional risk factors for ICAS mainly in Asian populations. Table 4.1 summarizes the results.23,25–28,43–50 Age It is well known that advanced age is a significant risk factor for ICAS. Solberg et al.51 suggested that atherosclerotic lesions develop in the intracranial cerebral arteries about one decade later in life than in the extracranial ICA. Gender The relationship of ICAS and gender remains controversial. Several studies have shown a female
47
BLBK041-Kim
August 18, 2008
13:10
CHAPTER 4
predominance in ICAS1 whereas others have reported that men are more likely to have ICAS than women.24 A clinical study in Chinese subjects50 and autopsy studies51,52 mainly on asymptomatic subjects also reported a male predominance in ICAS. Progression of atherosclerosis with age may also be different between men and women.53 In one study, ICAS developed earlier in men than in women with increasing age; however, it progressed faster in women than in men.1 It was speculated that hormonal changes secondary to the menopause may influence the progression rate of ICAS54 as in extracranial carotid atherosclerosis. Hypertension Early autopsy studies reported that hypertension may exert a strong influence on atherosclerosis in the intracranial cerebral arteries.51,55 Many clinical studies23,43,44,46–50 have also found a close correlation between hypertension and ICAS. Diabetes mellitus An autopsy-based study from Hong Kong demonstrated that the risk of ICAS was increased by the presence of diabetes mellitus.56 In clinical studies, diabetes mellitus has also been found to be a significant risk factor for ICAS. Bae et al.47 indicated that diabetes mellitus was a significant predictor of asymptomatic ICAS and might even be a more potent predictor than hypertension. This result was also supported by a few studies on symptomatic individuals.3,45,57 Diabetes mellitus was also found to be a significant risk factor in patients with combined extracranial and intracranial arterial diseases.58,59 Hyperlipidemia Hyperlipidemia is an established risk factor for carotid atherosclerosis. However, its role in ICAS remains unclear, because previous studies have shown controversial results. In the Northern Manhattan Stroke Study, the higher prevalence of diabetes mellitus and hypercholesterolemia among African Americans and Hispanics accounted for the much higher frequency of stroke related to ICAS when compared with white individuals.3 However, most of previous studies have shown that hyperlipidemia is a less important risk factor for ICAS than extracranial ICA diseases. Only a 48
few studies reported a positive correlation between serum cholesterol levels and ICAS.43,49 Cigarette smoking Cigarette smoking is an established risk factor for ischemic stroke.60 However, studies on smoking and ICAS have failed to prove a clear association between them.23,46
Risk factors in different vascular territories Several studies were carried out to examine and compare risk factors for occlusive lesions among different intracranial arteries, especially MCA, ICA, and BA. For example, in a study investigating risk factors for occlusive intracranial arterial lesions in stroke-free Japanese individuals, significant and independent predictors were age and hypertension for MCA lesions; age, hypertension, diabetes mellitus, and IHD for ICA lesions; and hypertension and diabetes mellitus for BA lesions.46 This observation suggests that the impact of risk factors may not be uniform throughout the intracranial arteries. Middle cerebral artery Caplan et al.1 reported that the high prevalence of hypertension and the relatively low prevalence of hypercholesterolemia could explain the high prevalence of MCA lesions in Japan. Yasaka et al.43 demonstrated that advanced hypertension was related to MCA atherosclerosis, whereas Takahashi and his colleagues44 reported that hypertension and high serum levels of glycosylated hemoglobin A1c were significant predictors of MCA disease. In a study on subjects who had vascular risk factors but without history of stroke or transient ischemic attack (TIA), advanced age, hyperlipidemia, hypertension, and diabetes mellitus were risk factors for MCA stenosis.49 In Chinese subjects, male sex, advanced age, hypertension, and diabetes mellitus were found to be risk factors for MCA stenosis.50 Intracranial internal carotid artery Little is known about the risk factors for intracranial ICA occlusive lesions. Ingall et al.61 demonstrated
BLBK041-Kim
August 18, 2008
13:10
RISK FACTORS
that age, hypertension, diabetes mellitus, and duration of cigarette smoking were significant and independent predictors. Intracranial ICA stenosis may be a marker for extensive cerebrovascular and systemic atherosclerotic diseases, especially coronary artery disease, and thus predicts poor prognosis.62
Basilar artery Previous studies yielded controversial results about risk factors for BA lesions. As mentioned above, a study on stroke-free subjects demonstrated that atherosclerosis of BA was associated with hypertension and diabetes mellitus.46 On the other hand, Caplan et al.1 and Yasaka et al.43 found that hyperlipidemia and IHD were closely related to extracranial ICA and BA atherosclerosis. This discrepancy might be attributable to the different study designs or relatively small numbers of subjects with BA stenosis in those studies.
Metabolic syndrome as a novel risk factor for intracranial atherosclerosis As discussed above, whether risk factors differentially affect different vascular system remains uncertain. Recently, two distinct studies suggested that metabolic syndrome, a constellation of risk factors, was independently associated with strokes with ICAS, whereas individual conventional risk factors were not.26,27 Patients with one or two, three, and four or five components of metabolic syndrome were about 2.5–3.8, 4.4, and 5.9–6.4 times, respectively, more likely to have ICAS than those who had no components.26 By contrast, such associations were not observed in patients with extracranial carotid atherosclerosis.26,27 A subgroup analysis of the Warfarin–Aspirin for Symptomatic Intracranial Disease (WASID) trial showed a high prevalence of metabolic syndrome in patients with ICAS; the metabolic syndrome was present in about half of individuals with symptomatic ICAS and was associated with a substantially higher risk of major vascular events.63 Supporting the role of metabolic syndrome on the development of ICAS, a dose–response relationship was observed: the frequency of multiple, tandem ICAS lesions increased as the number of syndrome components increased.26,27
Thus, treatment of the metabolic syndrome including lifestyle modifications, the use of insulinsensitizing drugs, and the management of associated risk factors could potentially be beneficial in preventing intracranial atherogenic progression and subsequent development of stroke. The Insulin Resistance Intervention After Stroke (IRIS) Trial is currently ongoing to determine whether reduction of insulin resistance by Pioglitazone (thiazolidinedione, an insulin sensitizer) prevents subsequent strokes or myocardial infarctions in patients with non-embolic ischemic strokes and insulin resistance.
Possible pathophysiologic interactions between metabolic syndrome and intracranial atherosclerosis There are several possible links explaining the high frequency of the metabolic syndrome in patients with ICAS. First, adiponectin may be one of the mediators connecting metabolic syndrome with ICAS. Adiponectin is one of abundant adipose tissue-specific cytokines that is closely linked to obesity.64 The level of adiponectin has been reported to be reduced in various conditions, including obesity, type 2 diabetes, insulin resistance, metabolic syndrome, dyslipidemia, oxidative stress, and cardiovascular disease.65 Adiponectin may have a protective effect against atherosclerosis through various mechanisms: suppression of neointimal formation, inhibiting the expression of inflammatory cytokines and adhesion molecules.65,66 Hypoadiponectinemia was also reported to be associated with endothelial dysfunction.67 The adiponectin level was found to be decreased in adults with early68 and advanced69,70 stages of atherosclerosis. It was recently reported that symptomatic ICAS was associated with the lower serum adiponectin level when compared with other ischemic stroke subtypes, regardless of the patients’ metabolic condition.28 Second, the metabolic syndrome is associated with several potentially harmful effects to the cerebrovascular system, which include endothelial dysfunction, increased oxidative stress, systemic inflammation, and sleep apnea. Oxidative stress, which is associated with this syndrome, has been suggested to play a role in endothelial dysfunction and subsequent atherosclerosis71,72 ; adults with metabolic 49
BLBK041-Kim
August 18, 2008
13:10
CHAPTER 4
syndrome had suboptimal concentrations of several antioxidants.73 An autopsy study revealed that intracranial arteries responded with accelerated atherogenesis to a greater degree than extracranial arteries when antioxidant protection was decreased.74 The authors suggested that the progression of atherosclerosis within intracranial arteries might be partly attributable to the failure of the intracellular defense system against free radical-mediated processes. Therefore, it is conceivable that intracranial arteries may become susceptible to oxidative stress, resulting in atherosclerotic changes, under the conditions of increased oxidative stress such as the metabolic syndrome. It was also suggested that inflammation within the vasculature might be an important pathogenic link between cardiovascular disease and the metabolic syndrome.75 Lastly, sleep apnea syndrome is another possible link between the metabolic syndrome and ICAS. The relationship between obstructive sleep apnea and the metabolic syndrome76–80 and chronic inflammation81 has been demonstrated. Vgontzas and colleagues82 summarized accumulating evidence that sleep apnea may be a manifestation of the metabolic syndrome: (a) there is a high prevalence of symptomatic sleep apnea in patients with insulin resistance78 and in women with polycystic ovarian syndrome (a disorder in which insulin resistance is the primary pathogenetic mechanism),83 (b) metabolic syndrome and insulin resistance are stronger determinants of sleepiness than the apnea/hypopnea index, (c) similar age distribution between symptomatic sleep apnea and the metabolic syndrome,84 and (d) the beneficial effect of exercise on both sleep apnea and insulin resistance.85 A growing line of evidence has shown that obstructive sleep apnea is a risk factor for ischemic heart disease and stroke in middle-aged or elderly populations.86,87 Thus, sleep apnea may be involved in the relationship between the metabolic syndrome and atherosclerotic stroke. The impact of the metabolic syndrome on the development of atherosclerotic stroke may differ according to the presence of obstructive sleep apnea. However, further studies are needed to elucidate the precise relationship between metabolic syndrome, sleep apnea and ICAS.
50
Metabolic syndrome and ethnic differences in the pattern of atherosclerosis As mentioned above, the distribution of atherosclerosis is different among different ethnicities. The metabolic syndrome and related conditions may at least in part explain the difference. First, adiponectin was reported to be a predictor of insulin sensitivity independent of visceral adipose tissue, leptin, and race.88 However, racial differences in insulin sensitivity and adipose secretion may exist. Despite the similar age, body mass index, and total adiposity, young African Americans have a lower adiponectin level and insulin sensitivity than young non-Hispanic white people, and the lower adiponectin level in the former may in part explain the lower insulin sensitivity.88 It was also reported that Indo-Asians have a lower adiponectin level than non-Hispanic white people.89 Such differences in adiponectin levels may be related with the ethnic differences in the distribution of atherosclerosis.27 In addition, race–ethnic difference in the levels of visceral adiposity, insulin resistance, and C-reactive protein may in part account for the difference in the patterns of disease presentation.90 Further studies on ethnic differences in adiponectin levels and adiponectin polymorphisms91 in both healthy individuals and patients with atherosclerotic stroke are warranted. Second, the estimated prevalence of insulin resistance syndrome, obesity, and obesity-related comorbidities may be different among race–ethnic groups. There was a higher prevalence of the obesityrelated hypertension in African-Americans, the obesity-related diabetes in Hispanics, and the predisposition to glucose intolerance in healthy lean young Asians, than in non-Hispanic white people.92 Certain genetic predisposition is likely to be involved in these observations.92 Third, race- and gender-based differences in the mechanisms of metabolic syndrome-induced atherosclerotic progression were reported.93,94 The race-specific impact of the metabolic syndrome on the distribution of atherosclerosis may be related to racespecific differences in the host response to the specific metabolic components (i.e., obesity and plasma lipid level) as well as by the differences in the prevalence of metabolic components. A study involving
BLBK041-Kim
August 18, 2008
13:10
RISK FACTORS
comprehensive work-ups in stroke patients with diverse race–ethnic backgrounds is currently underway to understand the possible race–ethnic differences in the impact of the metabolic syndrome on the different distribution of cerebral atherosclerosis. Lastly, obstructive sleep apnea syndrome was reported to be more prevalent or severe in certain ethnic groups. For instance, sleep apnea was found to be associated with a lesser degree of obesity in Asians than in white people.95 This different prevalence or severity of sleep apnea syndrome among different ethnic groups might play a role in ethnic differences in the manifestation of cerebral atherosclerosis. Further multicenter, multi-ethnic studies are needed to elucidate the relationship between ICAS and metabolic syndrome and related conditions. In addition, prospective trials focusing on the efficacy of modifying risk factors of metabolic syndrome in stroke patients with ICAS are warranted.
References 1 Caplan LR, Gorelick PB, Hier DB. Race, sex and occlusive cerebrovascular disease: a review. Stroke 1986; 17: 648– 655. 2 Kuller L, Reisler DM. An explanation for variations in distribution of stroke and arteriosclerotic heart disease among populations and racial groups. Am J Epidemiol 1971; 93: 1–9. 3 Sacco RL, Kargman DE, Gu Q, Zamanillo MC. Raceethnicity and determinants of intracranial atherosclerotic cerebral infarction: The Northern Manhattan Stroke Study. Stroke 1995; 26: 14–20. 4 Gorelick PB, Caplan LR, Hier DB, Parker SL, Patel D. Racial differences in the distribution of anterior circulation occlusive disease. Neurology 1984; 34: 54–57. 5 Inzitari D, Hachinski VC, Wayne Taylor D, Barnett HJM. Racial differences in the anterior circulation in cerebrovascular disease: how much can be explained by risk factors? Arch Neurol 1990; 47: 1080–1084. 6 Nishimaru K, McHenry LC Jr, Toole JF. Cerebral angiographic and clinical differences in carotid system transient ischemic attacks between American Caucasian and Japanese patients. Stroke 1984; 15: 56–59. 7 Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature 2001; 414: 782–787. 8 Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on
9
10 11
12
13
14
15
16 17
18
19
20
21
22
detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel iii). JAMA 2001; 285: 2486–2497. Girman CJ, Rhodes T, Mercuri M, et al. The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4s) and the air Force/TEXAS coronary atherosclerosis prevention study (AFCAPS/TEXCAPS). Am J Cardiol 2004; 93: 136–141. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 2005; 365: 1415–28. Isomaa B, Almgren P, Tuomi T, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001; 24: 683–689. Lakka HM, Laaksonen DE, Lakka TA, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002; 288: 2709– 2716. Pyorala M, Miettinen H, Halonen P, et al. Insulin resistance syndrome predicts the risk of coronary heart disease and stroke in healthy middle-aged men: The 22-year follow-up results of the Helsinki policemen study. Arterioscler Thromb Vasc Biol 2000; 20: 538–544. Kawamoto R, Tomita H, Oka Y, Kodama A. Metabolic syndrome as a predictor of ischemic stroke in elderly persons. Intern Med 2005; 44: 922–927. Kurl S, Laukkanen JA, Niskanen L, et al. Metabolic syndrome and the risk of stroke in middle-aged men. Stroke 2006; 37: 806–811. Kernan WN, Inzucchi SE, Viscoli CM, et al. Insulin resistance and risk for stroke. Neurology 2002; 59: 809–815. Milionis HJ, Rizos E, Goudevenos J, et al. Components of the metabolic syndrome and risk for first-ever acute ischemic nonembolic stroke in elderly subjects. Stroke 2005; 36: 1372–1376. Ninomiya JK, L’Italien G, Criqui MH, et al. Association of the metabolic syndrome with history of myocardial infarction and stroke in the third national health and nutrition examination survey. Circulation 2004; 109: 42–46. Ohira T, Shahar E, Chambless LE, et al. Risk factors for ischemic stroke subtypes: the atherosclerosis risk in communities study. Stroke 2006; 37: 2493–2498. Chen HJ, Bai CH, Yeh WT, et al. Influence of metabolic syndrome and general obesity on the risk of ischemic stroke. Stroke 2006; 37: 1060–1064. Najarian RM, Sullivan LM, Kannel WB, et al. Metabolic syndrome compared with type 2 diabetes mellitus as a risk factor for stroke: The Framingham offspring study. Arch Intern Med 2006; 166: 106–111. Heyden S, Heyman A, Goree JA. Nonembolic occlusion of the middle cerebral and carotid arteries: a comparison of predisposing factors. Stroke 1970; 1: 363–369.
51
BLBK041-Kim
August 18, 2008
13:10
CHAPTER 4
23 Uehara T, Tabuchi M, Mori E. Frequency and clinical correlates of occlusive lesions of cerebral arteries in Japanese patients without stroke: Evaluation by MR angiography. Cerebrovasc Dis 1998; 8: 267–272. 24 Wityk RJ, Lehman D, Klag M, et al. Race and sex differences in the distribution of cerebral atherosclerosis. Stroke 1996; 27: 1974–1980. 25 Kim JS, Choi-Kwon S. Risk factors for stroke in different levels of cerebral arterial disease. Eur Neurol 1999; 42: 150–156. 26 Bang OY, Kim JW, Lee JH, et al. Association of the metabolic syndrome with intracranial atherosclerotic stroke. Neurology 2005; 65: 296–298. 27 Park JH, Kwon HM, Roh JK. Metabolic syndrome is more associated with intracranial atherosclerosis than extracranial atherosclerosis. Eur J Neurol 2007; 14: 379– 386. 28 Bang OY, Saver JL, Ovbiagele B, et al. Adiponectin levels in patients with intracranial atherosclerosis. Neurology 2007; 68: 1931–1937. 29 Kannel WB, Wolf PA, Verter J. Manifestations of coronary disease predisposing to stroke. The Framingham study. JAMA 1983; 250: 2942–2946. 30 Hartmann A, Rundek T, Mast H, et al. Mortality and causes of death after first ischemic stroke. The Northern Manhattan Stroke Study. Neurology 2001; 57: 2000– 2005. 31 Crouse JR, Toole JF, McKinney WM, et al. Risk factors for extracranial carotid artery atherosclerosis. Stroke 1987; 18: 990–996. 32 Howard G, Ryu JE, Evans GW, et al. Extracranial carotid atherosclerosis in patients with and without transient ischemic attacks and coronary artery disease. Arteriosclerosis 1990; 10: 714–719. 33 Crouse JR, Harpold GH, Kahl FR, et al. Evaluation of a scoring system for extracranial carotid atherosclerosis extent with B-mode ultrasound. Stroke 1986; 17: 270– 275. 34 Craven TE, Ryu JE, Espeland MA, et al. Evaluation of the associations between carotid artery atherosclerosis and coronary artery stenosis. a case-control study. Circulation 1990; 82: 1230–1242. 35 Mathur KS, Kashyap SK, Kumar V. Correlation of the extent and severity of atherosclerosis in the coronary and cerebral arteries. Circulation 1963; 27: 929– 934. 36 Holme I, Enger SC, Helgeland A, et al. Risk factors and raised atherosclerotic lesions in coronary and cerebral arteries: Statistical analysis from the Oslo study. Atherosclerosis 1981; 1: 250–256. 37 Uehara T, Tabuchi M, Hayashi T, et al. Asymptomatic occlusive lesions of carotid and intracranial arteries in Japanese patients with ischemic heart disease: Evaluation
52
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
by brain magnetic resonance angiography. Stroke 1996; 27: 393–397. Uekita K, Hasebe N, Funayama N, et al. Cervical and intracranial atherosclerosis and silent brain infarction in Japanese patients with coronary artery disease. Cerebrovasc Dis 2003; 16: 61–68. Uehara T, Tabuchi M, Kozawa S, Mori E. MR angiographic evaluation of carotid and intracranial arteries in Japanese patients scheduled for coronary artery bypass grafting. Cerebrovasc Dis 2001; 11: 341–345. Yoon BW, Bae HJ, Kang DW, et al. Intracranial cerebral artery disease as a risk factor for central nervous system complications of coronary artery bypass graft surgery. Stroke 2001; 32: 94–99. Bae HJ, Yoon BW, Kang DW, et al. Correlation of coronary and cerebral atherosclerosis: difference between extracranial and intracranial arteries. Cerebrovasc Dis 2006; 21: 112–119. Arenillas JF, Candell-Riera J, Romero-Farina G, et al. Silent myocardial ischemia in patients with symptomatic intracranial atherosclerosis: associated factors. Stroke 2005; 36: 1201–1206. Yasaka M, Yamaguchi T, Shichiri M. Distribution of atherosclerosis and risk factors in atherothrombotic occlusion. Stroke 1993; 24: 206–211. Takahashi K, Kitani M, Fukuda H, Kobayashi S. Vascular risk factors for atherosclerotic lesions of the middle cerebral artery detected by magnetic resonance angiography (MRA). Acta Neurol Scand 1999; 100: 395–399. Arenillas JF, Molina CA, Chacon P, et al. High Lipoprotein (a), diabetes, and the extent of symptomatic intracranial atherosclerosis. Neurology 2004; 63: 27–32. Uehara T, Tabuchi M, Mori E. Risk factors for occlusive lesions of intracranial arteries in stroke-free Japanese. Er J Neurol 2005; 12: 218–222. Bae HJ, Lee J, Park JM, et al. Risk factors of intracranial cerebral atherosclerosis among asymptomatics. Cerebrovasc Dis 2007; 24: 355–360. Wong KS, Huang YN, Yang HB, et al. A door-to-door survey of intracranial atherosclerosis in Liangbei County, China. Neurology 2007; 68: 2031–2034. Wong KS, Ng PW, Tang A, et al. Prevalence of asymptomatic intracranial atherosclerosis in high-risk patients. Neurology 2007; 68: 2035–2038. Huang HW, Guo MH, Lin RJ, et al. Prevalence and risk factors of middle cerebral artery stenosis in asymptomatic residents in Rongqi County, Guangdong. Cerevrovasc Dis 2007; 24: 111–115. Solberg LA, McGarry PA. Cerebral atherosclerosis in Negroes and Caucasians. Atherosclerosis 1972; 16: 141– 154. Williams AO, Resch JA, Loewenson RB. Cerebral atherosclerosis: a comparative autopsy study between
BLBK041-Kim
August 18, 2008
13:10
RISK FACTORS
53 54
55
56
57
58
59
60
61
62
63
64
65
66
67
Nigerian Negroes and American Negroes and Caucasians. Neurology 1969; 19: 205–210. Resch JA, Baker AB. Etiologic mechanisms in cerebral atherosclerosis. Arch Neurol 1964; 10: 617–628. Joakimsen O, Bonaa KH, Stensland-Bugge E, Jacobsen BK. Population-based study of age at menopause and ultrasound assessed carotid atherosclerosis: the Tromso Study. J Clin Epdemiol 2000; 53: 525–530. Fisher CM, Gore I, Okabe N, White PD. Atherosclerosis of the carotid and vertebral arteries – extracranial and intracranial. J Neuropathol Exp Neurol 1965: 24: 455– 476. Leung SY, Ng THK, Yuen ST, et al. Pattern of cerebral atherosclerosis in Hong Kong Chinese: severity in intracranial and extracranial vessels. Stroke 1993; 24: 779– 786. Gorelick PB, Caplan LR, Langenberg P, et al. Clinical and angiographic comparison of asymptomatic occlusive cerebrovascular disease. Neurology 1988; 38: 852–858. Lee SJ, Cho SJ, Moon HS, et al. Combined extracranial and intracranial atherosclerosis in Korean patients. Arch Neurol 2003; 60: 1561–1564. Suwanwela NC, Chutinetr A. Risk factors for atherosclerosis of cervicocerebral arteries: intracranial versus extracranial. Neuroepidemiology 2003; 22: 37–40. Wolf A, D’Agostino RB, Kannel WB, et al. Cigarette smoking as a risk factor for stroke: The Framingham Study. JAMA 1988; 259: 1025–1029. Ingall TJ, Homer D, Baker, HL, Jr, et al. Predictors of intracranial carotid artery atherosclerosis. Duration of cigarette smoking and hypertension are more powerful than serum lipid levels. Arch Neurol 1991; 48: 687–691. Marzewski DJ, Furlan AJ, St. Louis P, et al. Intracranial internal carotid artery stenosis: Long-term prognosis. Stroke 1982; 13: 821–824. Ovbiagele B, Saver JL, Lynn MJ, Chimowitz M. Impact of metabolic syndrome on prognosis of symptomatic intracranial atherostenosis. Neurology 2006; 66: 1344– 1349. Arita Y, Kihara S, Ouchi N, et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999; 257: 79–83. Kadowaki T, Yamauchi T, Kubota N, et al. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest 2006; 116: 1784–1792. Matsuda M, Shimomura I, Sata M, et al. Role of adiponectin in preventing vascular stenosis. The missing link of adipo-vascular axis. J Biol Chem 2002; 277: 37487–37491. Shimabukuro M, Higa N, Asahi T, et al. Hypoadiponectinemia is closely linked to endothelial dysfunction in man. J Clin Endocrinol Metab 2003; 88: 3236–3240.
68 Pilz S, Horejsi R, Moller R, Almer G, et al. Early atherosclerosis in obese juveniles is associated with low serum levels of adiponectin. J Clin Endocrinol Metab 2005; 90: 4792–4796. 69 Kumada M, Kihara S, Sumitsuji S, et al. Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol 2003; 23: 85–89. 70 Pischon T, Girman CJ, Hotamisligil GS, et al. Plasma adiponectin levels and risk of myocardial infarction in men. JAMA 2004; 291: 1730–1737. 71 Cai H, Harrison DG. Endothelial dysfunction in cardiovascular diseases: The role of oxidant stress. Circ Res 2000; 87: 840–844. 72 Lee KU. Oxidative stress markers in Korean subjects with insulin resistance syndrome. Diabetes Res Clin Pract 2001; 54 (Suppl 2): S29–33. 73 Ford ES, Mokdad AH, Giles WH, Brown DW. The metabolic syndrome and antioxidant concentrations: Findings from the third national health and nutrition examination survey. Diabetes 2003; 52: 2346–2352. 74 D’Armiento FP, Bianchi A, de Nigris F, et al. Age-related effects on atherogenesis and scavenger enzymes of intracranial and extracranial arteries in men without classic risk factors for atherosclerosis. Stroke 2001; 32: 2472– 2479. 75 Ridker PM, Buring JE, Cook NR, Rifai N. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: An 8-year follow-up of 14 719 initially healthy American women. Circulation 2003; 107: 391– 397. 76 Young T, Palta M, Dempsey J, et al. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993; 328: 1230–1235. 77 Grunstein RR, Stenlof K, Hedner J, Sjostrom L. Impact of obstructive sleep apnea and sleepiness on metabolic and cardiovascular risk factors in the Swedish Obese Subjects (SOS) study. Int J Obes Relat Metab Disord 1995; 19: 410–418. 78 Ip MS, Lam B, Ng Mm, et al. Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med 2002; 165: 670–676. 79 Gruber A, Horwood F, Sithole J, et al. Obstructive sleep apnoea is independently associated with the metabolic syndrome but not insulin resistance state. Cardiovasc Diabetol 2006; 5: 22. 80 Coughlin SR, Mawdsley L, Mugarza JA, et al. Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome. Eur Heart J 2004; 25: 735–741. 81 Vgontzas AN, Papanicolaou DA, Bixler EO, et al. Relation to visceral obesity, insulin resistance, and hypercytokinemia. J Clin Endocrinol Metab 2000; 85: 1151– 1158.
53
BLBK041-Kim
August 18, 2008
13:10
CHAPTER 4
82 Vgontzas AN, Bixler EO, Chrousos GP. Sleep apnea is a manifestation of the metabolic syndrome. Sleep Med Rev 2005; 9: 211–224. 83 Vgontzas AN, Legro RS, Bixler EO, et al. Polycystic ovary syndrome is associated with obstructive sleep apnea and daytime sleepiness: Role of insulin resistance. J Clin Endocrinol Metab 2001; 86: 517– 520. 84 Park YW, Zhu S, Palaniappan L, et al. The metabolic syndrome: Prevalence and associated risk factor findings in the US population from the third national health and nutrition examination survey, 1988–1994. Arch Intern Med 2003; 163: 427–436. 85 Peppard PE, Young T. Exercise and sleep-disordered breathing: An association independent of body habitus. Sleep 2004; 27: 480–484. 86 Yaggi HK, Concato J, Kernan WN, et al. Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med 2005; 353: 2034–2041. 87 Munoz R, Duran-Cantolla J, Martinez-Vila E, et al. Severe sleep apnea and risk of ischemic stroke in the elderly. Stroke 2006; 37: 2317–2321. 88 Lee S, Bacha F, Gungor N, Arslanian SA. Racial differences in adiponectin in youth: Relationship to visceral fat and insulin sensitivity. Diabetes Care 2006; 29: 51–56.
54
89 Valsamakis G, Chetty R, McTernan PG, et al. Fasting serum adiponectin concentration is reduced in Indo-Asian subjects and is related to HDL cholesterol. Diabetes Obes Metab 2003; 5: 131–135. 90 Forouhi NG, Sattar N. CVD risk factors and ethnicity– a homogeneous relationship? Atheroscler Suppl 2006; 7: 11–19. 91 Ukkola O, Santaniemi M, Rankinen T, et al. Adiponectin polymorphisms, adiposity and insulin metabolism: heritage family study and Oulu diabetic study. Ann Med 2005; 37: 141–150. 92 Cossrow N, Falkner B. Race/ethnic issues in obesity and obesity-related comorbidities. J Clin Endocrinol Metab 2004; 89: 2590–2594. 93 Fan AZ. Metabolic syndrome and progression of atherosclerosis among middle-aged US adults. J Atheroscler Thromb 2006; 13: 46–54. 94 Li S, Chen W, Srinivasan SR, Tang R, Bond MG, Berenson GS. Race (black–white) and gender divergences in the relationship of childhood cardiovascular risk factors to carotid artery intima-media thickness in adulthood: the Bogalusa Heart Study. Atherosclerosis 2007; 194: 421– 425. 95 Villaneuva AT, Buchanan PR, Yee BJ, Grunstein RR. Ethnicity and obstructive sleep apnoea. Sleep Med Rev 2005; 9: 419–436.
BLBK041-Kim
August 12, 2008
19:56
PART TWO
Stroke mechanism and clinical consequence
Intracranial Atherosclerosis Edited by Jong S Kim, Louis R Caplan and KS Lawrence Wong © 2008 Blackwell Publishing Ltd. ISBN: 978-1-405-17822-8
BLBK041-Kim
August 12, 2008
5
19:56
Stroke mechanisms KS Lawrence Wong, Louis R Caplan and Jong S Kim
Atherosclerotic disease of the intracranial large arteries, especially the middle cerebral artery (MCA), is the commonest cause of stroke and transient ischemic attack (TIA) in most parts of the world, apart from Europe and North America. The pathology of intracranial atherosclerosis (ICAS) is not much different from atherosclerosis in other parts of the circulation such as the aorta and the coronary and carotid arteries. Lipidladen plaques with various thickness of capsule are commonly found in ICAS. The details of the pathological features are covered in Chapter 2. Yet, the stroke mechanisms may vary in different patients. Artery-to-artery embolism, hemodynamic insufficiency, branch occlusive diseases or the combination of these mechanisms leads to brain ischemia. Coexisting causes such as small vessel disease and cardioembolism are also found in the same patient. Recently, advances in neuroimaging technologies such as microembolic signal (MES) detection, diffusion weighted imaging (DWI), and various blood flow measurements have provided insights into various aspects of stroke mechanism in patients with ICAS. It is important to delineate the stroke mechanism since treatment and prevention strategies should be based on the correct understanding of pathophysiological mechanism in an individual patient.
Neuroimaging investigations to study stroke mechanisms Advances in neuroimaging have provided new insights into the stroke mechanisms of ICAS. Newer generation
CT angiography and MR angiography easily depict the location and severity of intracranial stenosis. DWI is the most sensitive tool to detect tiny, symptomatic, or asymptomatic cerebral ischemic lesions and can differentiate recent infarcts from old ones.1–3 Using DWI, the characteristic topographic patterns of cerebral infarcts may be individually assessed. On the other hand, fluid-attenuated inversion recovery (FLAIR) sequences offer advantages in detection of infarcts affecting the cortical ribbon, because cortical infarcts may be hard to detect given the similarly high signal of cortical gray matter and adjacent cerebrospinal fluid, and the complex convolutional geometry of the surface of the brain.4 In addition, transcranial Doppler ultrasound (TCD) can non-invasively identify narrowing and collateralization of major intracranial large arteries in patients with good temporal windows. MES detected by TCD is likely to represent an embolus passing through the insonated artery,5–8 and helps us to identify the mechanism of stroke or TIA in patients with ICAS. The application of these advanced imaging technologies is described in detail in other chapters (Chapters 10–12).
Stroke mechanisms in intracranial atherosclerosis Possible mechanisms for brain infarction or TIA arising from ICAS include thrombosis leading to complete occlusion, artery-to-artery embolism, hemodynamic compromise (hypoperfusion), local branch occlusion of the orifice of a deep perforator, or the combination of these mechanisms9,10 (Table 5.1).
Intracranial Atherosclerosis Edited by Jong S Kim, Louis R Caplan and KS Lawrence Wong © 2008 Blackwell Publishing Ltd. ISBN: 978-1-405-17822-8
57
BLBK041-Kim
August 12, 2008
19:56
CHAPTER 5
Table 5.1 Mechanisms of brain infarction and TIA in patients with intracranial atherosclerosis Stroke mechanism
Frequency
Pattern of infarcts
Number of infarcts
In situ thrombotic occlusion
Uncommon
Large subcortical Sometimes with borderzone Rarely, whole territory
Single Sometimes enlarging
Artery-to-artery embolism∗
Common
Small cortical and subcortical
Multiple
Impaired clearance of emboli∗
Common
Small, scattered, alongside the borderzone region
Multiple
Branch occlusive disease
Common
Small subcortical, lacune-like
Single
Hemodynamic
Uncommon
Borderzone May be without lesion
Multiple None
∗ These
mechanisms frequently coexist.
In situ thrombotic occlusion Acute thrombosis begins with fissuring of the fibrous cap of the atherosclerotic plaque, which disrupts the endothelial surface of the artery. Release of tissue factors promotes the development of a clot adjacent to the plaque.11 Local occlusion and secondary artery-to-artery embolism can then result.12,13 Lammie et al.14 reported that coronary-type rupture of an unstable atherosclerotic plaque is the usual cause of fatal occlusion of the carotid sinus, but other causes usually underlie intracranial carotid occlusion. Plaque instability can be related to factors such as inflammation, autoimmunity, or genetic predisposition, and these conditions may play a role in acceleration of atherosclerosis in addition to traditional risk factors.15 In patients with ICAS, in situ thrombotic occlusion usually produces infarcts that are larger than those caused by other mechanisms. However, unlike patients with cardiogenic embolism, the in situ thrombotic occlusion rarely produces whole territory infarction because of the relatively well-developed collateral circulation in patients with chronic atherosclerotic disease. In patients with MCA steno-occlusion, the initial lesions are usually restricted to the striatocapsular area, borderzone area or the combination of both. Occasionally, an initial infarct evolves to a larger lesion along with progressive neurological worsening (Fig. 5.1). Thus, the ultimate size of the infarct may vary according to the development of collateral 58
circulation, the speed of arterial occlusion and hemodynamic stability after the occurrence of stroke. With sufficient collaterals, total thrombotic intracranial occlusion may remain asymptomatic, or produce only minor brain infarcts or TIAs.
Artery-to-artery embolism Apart from occlusion at the site of thrombosis, forceful blood flow can break up a portion of the thrombus and carry it to distal branches. Besides, ulceration of the surface of the plaque can be the source of atherosclerotic debris (cholesterol embolism) that migrates to distal vessels. Blockage of the distal branches by embolism causes cerebral infarction. MES monitoring is now an established method to detect symptomatic or asymptomatic embolism in patients with MCA disease.5,16 For MCA occlusion, particularly cardiac diseases, atrial fibrillation is the most frequent cause. The resultant stroke is usually quite large and disabling.17,18 Internal carotid artery (ICA) atherosclerotic disease is another important source of embolism, leading to MCA occlusion and brain infarcts.19 Cerebral angiography within the first 6 hours after the onset of ischemic symptoms shows intracranial occlusion in about 80% of the cases that are usually caused by emboli.20,21 Cardioembolic stroke is commonly associated with a bigger infarct than an embolic stroke of arterial origin partly because the clots are larger and
BLBK041-Kim
August 12, 2008
19:56
STROKE MECHANISMS
Fig 5.1 A 64-year-old hypertensive man developed mild right hemiparesis and sensory aphasia. Diffusion weighted magnetic resonance imaging (A–D) at the time of admission showed acute infarcts in the left lenticulocapsular and borderzone area between middle cerebral artery (MCA) and
posterior cerebral artery. MR angiography showed thrombotic occlusion of the left MCA (E). The patient’s neurologic symptoms gradually worsened to have severe right hemiparesis and global aphasia. Follow-up MRI 4 days later showed enlarged size of the lesion (F–J).
partly because of the insufficient development of collateral circulation. In patients with ICAS, artery-to-artery embolism (i.e., proximal MCA to distal MCA) is also an important mechanism of stroke. DWI is particularly useful in assessing the embolic mechanism of stroke because it can reliably detect small, scattered, cortical embolic infarcts (see Chapter 11 for details). According to previous studies, artery-to-artery embolism is usually associated with a more severe degree of intracranial stenosis than found in patients having branch occlusion.22 Moreover, the artery-to-artery embolism is often associated with perfusion deficits in the territory of the stenosed vessel. Perhaps, underlying perfusion deficits may contribute to the development of embolic infarction through impaired clearance of emboli (Fig. 5.2).
media of small vessels. Lipohyalinosis causes segmental disorganization of penetrating arteries along the course of the vessel, whereas atheromatous branch disease affects the vessel orifice. Pathological features of this type of branch occlusion have previously been described by Lhermitte et al.24 and Fisher.25–27 The pathology includes microdissection, plague hemorrhage, and platelet and platelet–fibrin materials. The concept of atheromatous branch occlusive disease has broadened our understanding on the pathogenesis of deep, subcortical (lacunar) infarcts. Traditionally accepted pathological hallmarks of lacunar infarction are 15–20 mm, irregular cavities deep in the cerebral hemisphere, brain stem, and cerebellum. 25,28–34 However, true lacunar infarcts are usually smaller than 0.5–1 cm when they are detected by brain imaging studies. If the lesion is larger than 1 cm, the diagnosis of small artery occlusive disease may have to be questioned. Although lipohyalinosis or fibrinoid necrosis of a small artery is still an important cause of these small, deep subcortical infarcts,35 Caplan23 argued that (1) deep infarcts may also be caused by large cerebral artery diseases or even embolization from proximal artery or the heart;36,37 (2) the clinical diagnosis of lacune is difficult to make
Branch occlusive disease Atherosclerotic plaque in the intracranial artery can protrude into the orifice of the perforators and occlude the lumen, causing a subcortical infarct.23 This so-called atheromatous branch occlusion is different from lipohyalinosis, a hypertensive change in the
59
BLBK041-Kim
August 12, 2008
19:56
CHAPTER 5
Fig 5.2 A 55 year-old-man with hypertension and diabetes mellitus developed recurrent, brief episodes of speech disturbances. Diffusion-weighted magnetic resonance imaging (MRI) showed several tiny, scattered, embolic infarcts in the left middle cerebral artery (MCA) territory
(left, thin arrows). Perfusion weighted MRI showed decreased perfusion in the whole left MCA territory (middle). MR angiography showed severe atherosclerotic narrowing of the left MCA (right, short arrow).
and not easily be differentiated from symptoms caused by large artery occlusive disease; and (3) many patients with lacunar infarction do not have hypertension nor have a history of high blood pressure. Thus, lacunar infarcts are actually caused by intracranial branch atheromatous disease in many patients.23 Nevertheless, atheromatous branch disease has been uncommonly documented because of the rarity of careful neuropathologic studies of intracranial arteries. Branch pathology can be accurately assessed only by meticulous analysis of serial sections of intracranial vascular specimens at necropsy. Although branch disease is a pathologic entity that can only be diagnosed with certainty at postmortem, the following clinical or imaging features may support the diagnosis of atheromatous branch disease: (1) the infarcts are small, deep, and confined to the territory of one or a few penetrating branches; (2) gradual or stepwise progression or fluctuation of symptoms and signs suggesting intrinsic “thrombotic” disease rather than embolism; (3) vascular studies and cardiac evaluation show no significant extracranial large artery occlusive disease or emboligenic heart disease; and (4) there is no past or present hypertension and no evidence of end organ damage from hypertension such as retinopathy or left ventricular cardiac hypertrophy.23 With the advances of imaging technologies such as magnetic resonance (MR) angiogram or computerized tomography (CT) angiogram, ICAS producing branch
occlusion is nowadays more easily recognized. Recent literatures from Asian countries that used such imaging tools have shown that perforating branch occlusion is an important stroke mechanism of intracranial atherosclerosis and that many of the socalled lacunar infarcts are actually caused by intracranial large artery disease rather than lipohyalinosis38–41 (Fig. 5.3). The infarction resulting from occlusion of the orifice of the branch tends to extend to the basal surface whereas a lacune caused by lipohyalinosis usually produces an island of ischemic tissue within the parenchyma. The subcortical infarcts caused by branch atheromatous disease are expected to be larger in size and associated with a more unstable clinical course than those caused by lipohyalinosis.38,39 However, other studies argued that the size and clinical presentations are not different between these two groups of subcortical infarction.41 One of the problems in investigating this issue is the sensitivity and specificity of existing imaging techniques in detecting mild atherosclerosis. As discussed above, the arterial stenosis producing branch occlusion is usually less severe than that producing arteryto-artery embolism or hemodynamic stroke22 (see Figs 5.2 and 5.3). In patients with very mild intracranial stenosis, the stenotic lesion cannot be detected by TCD, and often remains questionable even when MR angiography is used. Moreover, because the imaging
60
BLBK041-Kim
August 12, 2008
19:56
STROKE MECHANISMS
Fig 5.3 A 75-year-old hypertensive woman developed left hemiparesis and dysarthria. Diffusion-weighed MRI showed a small subcortical infarct in the right lenticulocapsular area. MR angiography showed a moderate, focal stenosis that probably occluded the orifice of the perforating artery (arrow).
diagnosis of atherosclerosis is based on findings of luminal narrowing of an artery, atherosclerotic thickening of the vessel walls without causing intraluminal narrowing cannot be identified with current technologies. In this sense, it seems likely that atheromatous branch disease is still underestimated even in this era of MRI and MR angiography. Application of technologies that can image the abnormal vessel wall will further improve our understanding of branch atheromatous disease in the future.42 Hypoperfusion Before the onset of acute thromboembolism formation, atherosclerotic plaque gradually increases over years. The vessel can remodel to expand outward initially43 but later the plaque grows slowly and impinges on the vascular lumen; consequently, blood flow becomes disturbed.44 The narrowing leads to turbulence of blood flow and finally hypoperfusion distal to the stenosis. Severe stenosis or occlusion leads to failure of perfusion to one or more regions of the brain. In addition, turbulence and fast flow velocity increase the shear stress on the endothelium and encourage fissuring of the plaque, which in turn activates platelets and clotting factors. Recent observations45,46 have shown a close correlation between the recurrence of ischemic stroke and the severity of occlusive disease producing hypoperfusion. In clinical practice, hypoperfusion caused by a process occurring at a distance from the brain (for example, the heart or neck arteries) rarely produces major
brain infarction.47 In contrast, decreased blood flow caused by a lesion directly at the site of vulnerable brain tissue is not so benign. Occlusion of penetrating arteries by a lipohyalinotic process or by atheromatous branch disease23,25,39,41 often causes an infarct directly in the center of perfusion of the obstructed artery. Similarly, severe intracranial arterial occlusive disease seems more likely to cause brain infarction than extracranial occlusive disease.48–50 Although the circle of Willis serves as a collateral supply in patients with extracranial diseases, it may take more time to develop cortical collaterals in those with intracranial arterial diseases. Although hypoperfusion to a specific region of the brain is clearly an important factor for the development of infarct, the status of the collateral circulation can influence the size of the lesion. Insufficient collaterals and blood flow may be a factor predicting future strokes as well. According to Han et al.,51 who measured the extracranial arterial blood flow volume by color velocity imaging quantification ultrasound (CVIQ) in a cohort of 210 acute stroke patients, total cerebral blood flow was an independent predictor for future ischemic events; the mean extracranial blood flow volume was significantly lower for patients who had a recurrent stroke than for those without. In patients with insufficient collaterals, so-called hemodyamic strokes or TIAs may occur. Typically, TIA symptoms such as hemiparesis, dysarthria, aphasia (in anterior circulation disease) or dizziness, diplopia, visual disturbances (in posterior circulation disease) occur briefly and stereotypically when the patients are 61
BLBK041-Kim
August 12, 2008
19:56
CHAPTER 5
Fig 5.4 A 74-year-old woman with hypertension and diabetes mellitus developed brief and stereotypical episodes of right hemiparesis that developed when she stood up suddenly or when she was exhausted and dehydrated. Diffusion-weighted magnetic resonance imaging (MRI) showed no lesions (A) while perfusion weighted MRI showed decreased perfusion in the left middle cerebral artery (MCA) territory (B). MR angiography showed severe stenosis of the left MCA (C, white arrow). Angiography showed severe MCA stenosis and downward shift of MCA–ACA (anterior cerebral artery) borderzone area (D, dark arrow). After angioplasty and stenting, the stenosis improved and the borderzone area ascended (E, dark arrow). The patient no longer developed neurological symptoms afterwards.
dehydrated or exhausted or at the time when they suddenly stand up. When stroke occurs, the symptoms may fluctuate widely according to the degree of hydration and head position. Adequate hydration and cerebral blood flow maintenance is important in the management of these patients. Occasionally, interventional revascularization therapies such as bypass surgery or angiography/stenting relieve the patients’ symptoms dramatically (Fig. 5.4). Traditionally, hypoperfusion and embolism are considered independent mechanisms of stroke in patients with arterial occlusive diseases. However, very often they coexist in patients with severe occlusive lesions. This is explained in part by the fact that both mechanisms are related to shared pathologic features: a complicated atherosclerotic plaque easily protrudes into the lumen leading to a hypoperfused status in the distal area and also tends to produce plaque fissuring resulting in embolism to distal arteries. In addition, recent imaging studies have shown that hypoperfusion and embolism interacts complementarily. For instance, Sedlaczek et al.52 described patients with arterial occlusive diseases who had subcortical em62
bolization within the borderzone areas. Caplan and Hennerici53 analyzed the pattern of small infarcts detected by DWI in patients with large artery occlusive disease, and realized that many of these tiny infarcts were located in the borderzone regions. They proposed that in the region with poor perfusion (borderzone area), emboli cannot be washed out and therefore ultimately result in small infarcts. Thus, embolism and hypoperfusion synergistically contribute to development of stroke in patients with severe large artery occlusive disease,17 including ICAS disease (Fig. 5.2). Finally, there is a phenomenon called Bernoulli’s principle, which may contribute to low flow to the perforating artery even without actual branch occlusion. This principle states that for any flow, an increase in the velocity occurs simultaneously with a decrease in pressure. Progressive narrowing in arterial stenosis invariably increases the flow velocity in the MCA, which is the hallmark for diagnosis of stenosis by Doppler. Sometimes the flow velocity in the MCA exceeds 300 m/sec. According to the Bernoulli’s principle, the higher the flow velocity in the MCA, the
BLBK041-Kim
August 12, 2008
19:56
STROKE MECHANISMS
A
B
C
Fig 5.5 Lesion pattern shown in middle cerebral artery (MCA) atherosclerosis. MR angiogram shows moderately severe left MCA stenosis (A). Diffusion-weighted imaging
shows the typical pattern of multiple small infarcts along the borderzone regions (B) and also multiple small infarcts in the cortical region (C).
lower the pressure in the perforating arteries, which often arise from the MCA perpendicularly. The potential importance of this mechanical cause of low perfusion remains unknown clinical.
with moderate to severe MCA stenosis, Wong et al.10 found that common stroke mechanisms in these patients are the occlusion of a single penetrating artery to produce a small subcortical infarction and arteryto-artery embolism with impaired clearance of emboli producing multiple, small cerebral infarcts especially along the borderzone region. Thus, small scattered infarcts along the border zone are common with severe MCA stenosis (Fig. 5.5). Other studies using DWI and MR angiography, also showed that perforating artery infarcts, whether single or occurring in addition to pial or borderzone infarcts, are the most common lesion pattern in patients with MCA stenosis22,58 (Fig. 5.6). Another report54 indicated that concomitant small cortical or subcortical lesions are commonly associated findings in diverse patterns of MCA territory infarction, which could mostly be explained by probable embolic mechanism. The severity of MCA stenosis is an independent predictor of future stroke, suggesting the importance of hypoperfusion in the pathogenesis of infarction.59 Droste et al.60 also reported that more severe MCA stenosis, as evidenced by very high flow velocity (>210 cm/s) in TCD, was associated with detection of MES and clinical symptoms. The presence and the frequency of MES predicts further risk of stroke and TIAs.61 In addition, Wong et al.62 reported that involvement of multiple vessels is more likely to cause further strokes both in the short term and the long term.63
Stroke mechanisms in different vascular territories Anterior circulation disorders MCA atherosclerosis Although embolic occlusion of MCA either from the heart or the atherosclerotic ICA has been considered the main cause of MCA territory infarction, intrinsic atherosclerosis is an important cause of stroke at least in Asian population (see Chapter 6). Relatively little was known about the frequency and stroke mechanisms of intrinsic MCA stenosis before the advances in neuroimaging. MCA atherosclerosis produces diverse topographic patterns of infarction depending on the variability in blood supply, degree of primary and secondary collateralization, and pathogenesis of infarcts.54 Secondary ischemic lesions visualized by brain imaging include small deep infarcts, large striatocapsular lesions, branch cortical strokes, or a combination of these lesions.10,22,54–56 Histopathologically observed fibrin–platelet microembolism has been found in patients with MCA stenosis presenting with TIA.57 Using MES detection by TCD together with DWI to explore the pathophysiology of cerebral infarct in acute stoke patients
63
BLBK041-Kim
August 12, 2008
19:56
CHAPTER 5
A
B
C
Fig 5.6 MR angiogram shows moderate stenosis of left middle cerebral artery (A). Diffusion-weighted imagining reveals a solitary infarct in the corona radiate region (B) and in the cortical region as well (C).
On the other hand, in subjects with chronic, asymptomatic MCA stenosis (lasting more than 12 months), MESs are rarely detectable regardless of the patients’ medication.60,64,65 Therefore, chronic, asymptomatic MCA stenosis does not seem to representa significant embolic source. Follow-up studies of patients with asymptomatic stenosis also confirmed the low risk of stroke in these patients.49 However, as discussed earlier, severe MCA occlusive disease with insufficient collateralization may produce recurrent hemodynamc TIAs. In addition, the patients with severe MCA occlusive disease may have disabling cognitive impairment, especially when they have bilateral MCA diseases (see Chapter 8 for further detail). Finally, sudden thrombotic MCA occlusion may produce relatively large infarction in the MCA territory. However, compared with cardiogenic infarction the so-called malignant MCA territory infarction involving the whole MCA territory is definitely uncommon in patients with intrinsic MCA atherosclerotic disease, probably due to relatively well-developed collateral circulation in these patients. Thus, even in patients with acute thrombotic occlusion, the infarct may be limited to the part of the MCA territory, usually at the striatocapsular region or borderzone areas. In some of these patients, however, a relatively small initial lesion may progressively enlarge along with neurological deterioration (Fig. 5.1). Revascularization procedures such as stenting and angioplasty, if performed early enough, may be of help in these patients.
64
Anterior cerebral artery atherosclerosis Compared with MCA territory infarction, anterior cerebral artery (ACA) territory infarction is rare, occurring in less than 3% of all strokes.66–70 As in patients with MCA territory infarction, embolism either from the heart or the proximal ICA atherosclerotic disease has been considered the most important cause of ACA territory infarction.66,67 However, intrinsic atherosclerotic disease seems to be the more important cause of ACA territory infarction in Asian populations.68,70 According to Kang and Kim,70 intrinsic ACA atherosclerosis is the cause of ACA territory infarction in 61 of 100 Korean patients with ACA territory infarction. As in intrinsic MCA disease, ACA atherosclerosis produces infarction by way of in situ thrombotic occlusion, local branch occlusion, arteryto-artery embolization, and the combination of these mechanisms. Collateral circulation and hemodynamic factors also play a role in determining the location and size of the final infarct (for details, see Chapter 6). Unlike MCA territory infarction, however, embolism from the diseased heart or ICA disease does not necessarily produce massive ACA territory infarction, probably due to the presence of abundant collaterals connecting both ACA systems. Posterior circulation disorders Vertebral artery atherosclerosis The most common location for atherosclerosis of the vertebral artery (VA) is the extracranial first
BLBK041-Kim
August 12, 2008
19:56
STROKE MECHANISMS
segment. Less commonly, atherosclerotic disease can cause stenosis of the second and third segments of the VA or the distal intracranial segment adjacent to the origin of the posterior inferior cerebellar artery.71,72 Atherosclerosis in the intracranial portion of the VA can produce occlusion of the branches supplying the medulla, which is the most important pathogenic mechanism for medullary (either lateral or medial) infarction.73,74 In patients with relatively severe atherosclerosis, either at the extracranial or extracranial VA, mural thrombosis can lead to artery-to-artery emboli that cause occlusion of distal branches such as the posterior cerebral artery, the superior cerebellar artery, the posterior inferior cerebellar artery, the basilar artery, or a combination of some of these.75–78 In patients with bilateral, severe atherosclerosis or in those with unilateral VA disease with contralateral hypoplasic VA, hemodynamic disturbances may contribute to ischemic symptoms. However, the lesion pattern of hemodynamic stroke is less well established in posterior circulation diseases than in anterior circulation diseases. It seems that both distal embolization and hemodynamic insufficiency play a role in development of ischemic stroke in many patients. Although rare, patients have repeated episodes of hemodynamic TIAs, which may be improved by revascularization such as angioplasty and stenting (see Fig. 7.5). In patients with severe and long-standing hemodynamic compromise, MRI may reveal atrophic changes in the posterior fossa. Basilar artery atherosclerosis The middle portion of the basilar artery (BA) is a relatively common site for advanced atherosclerosis. Patients with high-grade BA stenosis are at risk of a local thrombosis. Acute BA thrombotic occlusion may occlude multiple perforators producing bilateral pontine infarcts, resulting in coma, quadriparesis, and ocular motor disturbances. In many cases, the patients’ neurological deficits progress from unilateral to bilateral as the steno-occlusive process continues. The resultant stroke and consequent neuralgic deficits (lockedin syndrome) are one of the most devastating sequelae of stroke (see Fig 7.3). However, chronic occlusion in the presence of sufficient collaterals, especially from the posterior communicating arteries, may not produce any significant neurologic deficits (see Fig. 7.4).
More commonly, a milder degree of BA stenosis and resultant local thrombus produces occlusion of one or a few perforating branches producing more benign unilateral pontine infarction. In these cases, patients usually present with lacunar syndromes. Occlusion of the anterior inferior cerebellar artery also results from BA atherothrombosis. In addition, embolization arising from the clot formed in the BA can migrate to the distal BA, the posterior cerebral artery, the superior cerebellar arteries, or some of these vessels, resulting in relevant clinical syndromes. Combined branch artery occlusion and artery-to-artery embolization is also commonly observed. Acute, multiple brain infarcts due to distal embolization are more clearly observed when DWI is used, which helps us understand the embolic nature of strokes.79 Finally, basilar artery dolichoectesia is a vascular anomaly related to atherosclerosis, which may cause brainstem ischemia by multiple mechanisms, including thrombosis, embolism, and occlusion of deep penetrating arteries.80 Posterior cerebral artery atherosclerosis The frequency and stroke mechanism of intrinsic posterior cerebral artery (PCA) atherosclerosis has been rarely studied. Literatures have shown that the leading etiology of PCA territory infarcts is the embolism from the heart or proximal vertebrobasilar atherosclerotic disease, whereas intrinsic atherosclerosis of the PCA has been considered an uncommon occurrence.81–84 As in anterior circulation disease, however, the importance of intrinsic PCA atherosclerotic disease as a cause of PCA territory infarction seems to greater in Asians than in Caucasians. In a recent study from Korea using DWI and MR angiography (Lee E. et al., unpublished data), out of 205 patients with PCA territory infarction, large artery atherosclerosis was the cause of stroke in 87 patients, of whom 38 patients had intrinsic PCA atherosclerotic disease. In these patients, the most frequent stroke mechanism was atheromatous branch occlusion (19 patients) followed by in situ thromboocclusion (11 patients), and artery-to-artery embolism (eight patients). Although embolic PCA occlusion most frequently damages the occipital lobe, intrinsic PCA atherothrombosis produces subcortical lesions (i.e., ventrolateral thalamus) more frequently. Branch occlusion due to atheromatous PCA disease is an
65
BLBK041-Kim
August 12, 2008
19:56
CHAPTER 5
important mechanism of stroke occurring in the midbrain and thalamus.85 Although uncommon, patients with PCA stenosis may have recurrent TIAs as happens in patients with MCA stenosis.86
References 1 Warach S, Gaa J, Siewert B, Wielopolski P, Edelman RR. Acute human stroke studied by whole brain echo planar diffusion-weighted magnetic resonance imaging. Ann Neurol 1995; 37: 231–241. 2 Lutsep HL, Albers GW, DeCrespigny A, et al. Clinical utility of diffusion-weighted magnetic resonance imaging in the assessment of ischemic stroke. Ann Neurol 1997; 41: 574–580. 3 Lovblad KO, Pluschke W, Remonda L, et al. Diffusionweighted MRI for monitoring neurovascular interventions. Neuroradiology 2000; 42: 134–138. 4 Brant-Zawadzki M, Atkinson D, Detrick M, et al. Fluidattenuated inversion recovery (FLAIR) for assessment of cerebral infarction. Initial clinical experience in 50 patients. Stroke 1996; 27: 1187–1191. 5 Markus H. Transcranial Doppler detection of circulating cerebral emboli. A review. Stroke 1993; 24: 1246– 1250. 6 Levi CR, O’Malley HM, Fell G, et al. Transcranial Doppler detected cerebral microembolism following carotid endarterectomy. High microembolic signal loads predict postoperative cerebral ischaemia. Brain 1997; 120: 621–629. 7 Vachaspati T. Production of vortices by scattering particles. Phys Rev D Part Fields 1994; 49: R4985–R4989. 8 Droste DW, Dittrich R, Hermes S, et al. Four-gated transcranial Doppler ultrasound in the detection of circulating microemboli. Eur J Ultrasound 1999; 9: 117–125. 9 Bogousslavsky J, Barnett HJ, Fox AJ, Hachinski VC, Taylor W. Atherosclerotic disease of the middle cerebral artery. Stroke 1986; 17: 1112–1120. 10 Wong KS, Gao S, Chan YL, et al. Mechanisms of acute cerebral infarctions in patients with middle cerebral artery stenosis: a diffusion-weighted imaging and microemboli monitoring study. Ann Neurol 2002; 52: 74– 81. 11 Badimon JJ, Lettino M, Toschi V, et al. Local inhibition of tissue factor reduces the thrombogenicity of disrupted human atherosclerotic plaques: effects of tissue factor pathway inhibitor on plaque thrombogenicity under flow conditions. Circulation 1999; 99: 1780–1787. 12 Lafont A, Libby P. The smooth muscle cell: sinner or saint in restenosis and the acute coronary syndromes? J Am Coll Cardiol 1998; 32: 283–285.
66
13 Sitzer M, Muller W, Siebler M, et al. Plaque ulceration and lumen thrombus are the main sources of cerebral microemboli in high-grade internal carotid artery stenosis. Stroke 1995; 26: 1231–1233. 14 Lammie GA, Sandercock PA, Dennis MS. Recently occluded intracranial and extracranial carotid arteries. Relevance of the unstable atherosclerotic plaque. Stroke 1999; 30: 1319–1325. 15 Rothwell PM, Villagra R, Gibson R, et al. Evidence of a chronic systemic cause of instability of atherosclerotic plaques. Lancet 2000; 355: 19–24. 16 Caplan LR. Brain embolism, revisited. Neurology 1993; 43: 1281–1287. 17 Caplan LR, Wong KS, Gao S, Hennerici MG. Is hypoperfusion an important cause of strokes? If so, how? Cerebrovasc Dis 2006; 21: 145–153. 18 Fisher cm. Reducing risks of cerebral embolism. Geriatrics 1979; 34: 59–61, 65–56. 19 Ringelstein EB, Zeumer H, Angelou D. The pathogenesis of strokes from internal carotid artery occlusion. Diagnostic and therapeutical implications. Stroke 1983; 14: 867–875. 20 Fieschi C, Argentino C, Lenzi GL, et al. Clinical and instrumental evaluation of patients with ischemic stroke within the first six hours. J Neurol Sci 1989; 91: 311– 321. 21 Furlan A, Higashida R, Wechsler L, et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in acute cerebral thromboembolism. JAMA 1999; 282: 2003–2011. 22 Lee DK, Kim JS, Kwon SU, et al. Lesion patterns and stroke mechanism in atherosclerotic middle cerebral artery disease: early diffusion-weighted imaging study. Stroke 2005; 36: 2583–2588. 23 Caplan LR. Intracranial branch atheromatous disease: a neglected, understudied, and underused concept. Neurology 1989; 39: 1246–1250. 24 Lhermitte F, Gautier JC, Derouesne C. Nature of occlusions in the middle cerebral artery. Neurology 1970; 20: 82–88. 25 Fisher cm, Caplan LR. Basilar artery branch occlusion: a cause of pontine infarction. Neurology 1971; 21: 900– 905. 26 Fisher CM. Bilateral occlusion of basilar artery branches. J Neurol Neurosurg Psychiatry 1977; 40: 1182–1189. 27 Fisher CM. Capsular infarcts. The underlying vascular lesions. Arch Neurol 1979; 36: 65–73. 28 Fisher CM. Lacunes: Small, Deep Cerebral Infarcts. Neurology 1965; 15: 774–784. 29 Fisher CM. A lacunar stroke. The dysarthria – clumsy hand syndrome. Neurology 1967; 17: 614–617. 30 Fisher CM. Lacunar strokes and infarcts: a review. Neurology 1982; 32: 871–876.
BLBK041-Kim
August 12, 2008
19:56
STROKE MECHANISMS
31 Fisher CM. Ataxic hemiparesis. A pathologic study. Arch Neurol 1978; 35: 126–128. 32 Fisher CM, Curry HB. Pure motor hemiplegia. Trans Am Neurol Assoc 1964; 89: 94–97. 33 Fisher CM, Cole M. Homolateral ataxia and crural paresis: a vascular syndrome. J Neurol Neurosurg Psychiatry 1965; 28: 48–55. 34 Fisher CM. Pure sensory stroke involving face, arm, and leg. Neurology 1965; 15: 76–80. 35 Mohr JP. Lacunes. Stroke 1982; 13: 3–11. 36 Sacco SE, Whisnant JP, Broderick JP, et al. Epidemiological characteristics of lacunar infarcts in a population. Stroke 1991; 22: 1236–1241. 37 Mast H, Thompson JL, Voller H, et al. Cardiac sources of embolism in patients with pial artery infarcts and lacunar lesions. Stroke 1994; 25: 776–781. 38 Adachi T, Kobayashi S, Yamaguchi S, Okada K. MRI findings of small subcortical ‘lacune-like’ infarction resulting from large vessel disease. J Neurol 2000; 247: 280–285. 39 Bang OY, Heo JH, Kim JY, et al. Middle cerebral artery stenosis is a major clinical determinant in striatocapsular small, deep infarction. Arch Neurol 2002; 59: 259– 263. 40 Mok VCT, Fan YH, Lam WWM, et al. Small subcortical infarct and intracranial large artery disease in Chinese. J Neurol Sci 2003; 216: 55–59. 41 Cho AH, Kang DW, Kwon SU, Kim JS. Is 15 mm size criterion for lacunar infarction still valid? A study on strictly subcortical middle cerebral artery territory infarction using diffusion-weighted MRI. Cerebrovasc Dis. 2006; 23: 14–19. 42 Klein IF, Lavallee PC, Schouman-Claeys E, Amarenco P. High-resolution MRI identifies basilar artery plaques in paramedian pontine infarct. Neurology 2005; 64: 551– 552. 43 Lam WW, Wong KS, So NM, et al. Plaque volume measurement by magnetic resonance imaging as an index of remodeling of middle cerebral artery: correlation with transcranial color Doppler and magnetic resonance angiography. Cerebrovasc Dis 2004; 17: 166–169. 44 Caplan LR, Gorelick PB, Hier DB. Race, sex and occlusive cerebrovascular disease: a review. Stroke 1986; 17: 648– 655. 45 Chambers BR, Norris JW. Outcome in patients with asymptomatic neck bruits. N Engl J Med 1986; 315: 860– 865. 46 North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med 1991; 325: 445–453. 47 Halliday A, Mansfield A, Marro J, et al. Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms:
48
49
50
51
52
53
54
55
56
57 58
59
60
61
62
randomised controlled trial. Lancet 2004; 363: 1491– 1502. Thijs VN, Albers GW. Symptomatic intracranial atherosclerosis: outcome of patients who fail antithrombotic therapy. Neurology 2000; 55: 490–497. Kern R, Steinke W, Daffertshofer M, et al. Stroke recurrences in patients with symptomatic vs asymptomatic middle cerebral artery disease. Neurology 2005; 65: 859– 864. Klijn CJ, Kappelle LJ, Algra A, van Gijn J. Outcome in patients with symptomatic occlusion of the internal carotid artery or intracranial arterial lesions: a meta-analysis of the role of baseline characteristics and type of antithrombotic treatment. Cerebrovasc Dis 2001; 12: 228–234. Han JH, Ho SS, Lam WW, Wong KS. Total cerebral blood flow estimated by color velocity imaging quantification ultrasound: a predictor for recurrent stroke? J Cereb Blood Flow Metab 2007; 27: 850–856. Sedlaczek O, Caplan L, Hennerici M. Impaired washout– embolism and ischemic stroke: further examples and proof of concept. Cerebrovasc Dis 2005; 19: 396–401. Caplan LR, Hennerici M. Impaired clearance of emboli (washout) is an important link between hypoperfusion, embolism, and ischemic stroke. Arch Neurol 1998; 55: 1475–1482. Min WK, Park KK, Kim YS, et al. Atherothrombotic middle cerebral artery territory infarction: topographic diversity with common occurrence of concomitant small cortical and subcortical infarcts. Stroke 2000; 31: 2055–2061. Caplan L, Babikian V, Helgason C, et al. Occlusive disease of the middle cerebral artery. Neurology 1985; 35: 975– 982. Lyrer PA, Engelter S, Radu EW, Steck AJ. Cerebral infarcts related to isolated middle cerebral artery stenosis. Stroke 1997; 28: 1022–1027. Adams HP, Jr, Gross CE. Embolism distal to stenosis of the middle cerebral artery. Stroke 1981; 12: 228–229. Lee PH, Oh SH, Bang OY, et al. Isolated middle cerebral artery disease: clinical and neuroradiological features depending on the pathogenesis. J Neurol Neurosurg Psychiatry 2004; 75: 727–732. Kasner SE, Chimowitz MI, Lynn MJ, et al. Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis. Circulation 2006; 113: 555–563. Droste DW, Junker K, Hansberg T, et al. Circulating microemboli in 33 patients with intracranial arterial stenosis. Cerebrovasc Dis 2002; 13: 26–30. Gao S, Wong KS, Hansberg T, et al. Microembolic signal predicts recurrent cerebral ischemic events in acute stroke patients with middle cerebral artery stenosis. Stroke 2004; 35: 2832–2836. Wong KS, Li H, Chan YL, et al. Use of transcranial Doppler ultrasound to predict outcome in patients with
67
BLBK041-Kim
August 12, 2008
19:56
CHAPTER 5
63
64
65
66
67
68
69
70
71
72
73
74
68
intracranial large-artery occlusive disease. Stroke 2000; 31: 2641–2647. Wong KS, Li H. Long-term mortality and recurrent stroke risk among Chinese stroke patients with predominant intracranial atherosclerosis. Stroke 2003; 34: 2361–2366. Sliwka U, Klotzsch C, Popescu O, et al. Do chronic middle cerebral artery stenoses represent an embolic focus? A multirange transcranial Doppler study. Stroke 1997; 28: 1324–1327. Wong KS, Gao S, Lam WW, et al. A pilot study of microembolic signals in patients with middle cerebral artery stenosis. J Neuroimaging 2001; 11: 137–140. Gacs G, Fox AJ, M. Barnett HJM, Vinuela F. Occurrence and mechanisms of occlusion of the anterior cerebral artery. Stroke 1983; 14: 952–959. Bogousslavsky J, Franco R. Anterior cerebral artery territory infarction in the Lausanne stroke registry. Arch Neurol 1990; 1: 144–150. Kazui S, Sawada T, Naritomi H, Kuriyama Y. Angiographic evaluation of brain infarction limited to the anterior cerebral artery territory. Stroke 1993; 24: 549–53. Kumral E, Bayulkem B, Evyapan D, Yunten N. Spectrum of anterior cerebral artery territory infarction: clinical and MRI findings. Eur J Neurol 2002; 9: 615–24. Kang SY, Kim JS. Anterior cerebral artery infarction: Stroke mechanism and clinical-imaging study in 100 patients. Neurology 2008; 70: 2386–2393. Muller-Kuppers M, Graf KJ, Pessin MS, et al. Intracranial vertebral artery disease in the New England Medical Center Posterior Circulation Registry. Eur Neurol 1997; 37: 146–156. Shin HK, Yoo KM, Chang HM, Caplan LR. Bilateral intracranial vertebral artery disease in the New England Medical Center, Posterior Circulation Registry. Arch Neurol 1999; 56: 1353–1358. Kim JS, Kim HK, Chung CS. Medial medullary syndrome: report of 18 new patients and a review of the literature. Stroke 1995; 26: 1548–1552. Kim JS. Pure lateral medullary infarction: clinicalradiological correlation of 130 acute, consecutive patients. Brain 2003; 126: 1864–1872.
75 Wityk RJ, Chang HM, Rosengart A, et al. Proximal extracranial vertebral artery disease in the New England Medical Center Posterior Circulation Registry. Arch Neurol 1998; 55: 470–478. 76 Pessin MS, Daneault N, Kwan ES, et al. Local embolism from vertebral artery occlusion. Stroke 1988; 19: 112– 115. 77 Caplan LR, Amarenco P, Rosengart A, et al. Embolism from vertebral artery origin occlusive disease. Neurology 1992; 42: 1505–1512. 78 Levine SR, Quint DJ, Pessin MS, et al. Intraluminal clot in the vertebrobasilar circulation: clinical and radiologic features. Neurology 1989; 39: 515–522. 79 Koch S, Amir M, Rabinstein AA, et al. Diffusionweighted magnetic resonance imaging in symptomatic vertebrobasilar atherosclerosis and dissection. Arch Neurol 2005; 62: 1228–1231. 80 Kumral E, Kisabay A, Atac C, et al. The mechanism of ischemic stroke in patients with dolichoectatic basilar artery. Eur J Neurol 2005; 12: 437–444. 81 Steinke W, Mangold J, Schwartz A, Hennerici M. Mechanisms of infarction in the superficial posterior cerebral artery territory. J Neurol 1997; 244: 571–578. 82 Yamamoto Y, Georgiadis AL, Chang HM, Caplan LR. Posterior cerebral artery territory infarcts in the New England Medical Center Posterior Circulation Registry. Arch Neurol 1999; 56: 824–832. 83 Brandt T, Steinke W, Thie A, Pessin MS, Caplan LR. Posterior cerebral artery territory infarcts: Clinical features, infarct topography, causes and outcome. Multicenter results and a review of the literature. Cerebrovasc Dis 2000; 10: 170–182. 84 Kumral E, Bayulkem G, Atac C, Alper Y. Spectrum of superficial posterior cerebral artery territory infarcts. Eur J Neurol 2004; 11: 237–246. 85 Kim JS, Kim JY. Pure midbrain infarction: clinical, radiological and pathophyiological findings. Neurology 2005; 64: 1227–1232. 86 Kim JS. Pure or predominantly sensory transient ischemic attacks associated with posterior cerebral artery stenosis. Cerebrovasc Dis 2002; 14: 136–138.
BLBK041-Kim
August 18, 2008
6
10:38
Anterior circulation disorders Jong S Kim
Intracranial atherosclerosis is an important cause of stroke occurring in the anterior circulation. The stroke mechanisms of intracranial atherosclerosis in general are amply described in the previous chapter (Chapter 5). Based on diverse stroke mechanisms, stroke patterns and clinical syndromes manifest diversely also. In this chapter, strokes caused by atherosclerosis in the middle cerebral artery (MCA), anterior cerebral artery (ACA), and intracranial internal carotid artery (ICA) are reviewed.
resonance angiography (MRA), and computerized angiography (CTA), MCA atherosclerosis is now being increasingly recognized as a cause of MCA territory infarction. The role of MCA atherosclerosis as a cause of MCA territory infarction is especially important in Asians, black people, and Hispanics. Recent studies performed in these populations have suggested that the resultant lesion patterns, clinical syndromes, and prognosis are different between infarction due to intrinsic atherosclerosis and infarction due to embolism.
Middle cerebral artery infarction
MCA territory infarction due to intrinsic MCA atherosclerosis
General features MCA territory infarction is the most commonly encountered stroke subtype in our clinical practice. Occlusion of the main MCA trunk produces contralateral hemiparesis, hemisensory deficit, deviation of eyes towards the side of the infarct, and hemianopia. Global aphasia occurs when the dominant hemisphere is severely damaged, whereas hemineglect occurs when the infarct develops in the right hemisphere. Divisional or branch occlusion induces partial or minor neurological deficits. Occlusion of perforating arteries produces subcortical infarction sparing the cortex and typically yields lacunar syndromes such as pure motor, sensorimotor, ataxic-hemiparesis, or dysarthria clumsy syndromes. Occlusion of the MCA because of embolism arising from the atherosclerotic ICA or the diseased heart has been regarded as the most important cause of MCA territory infarction. However, with the advent of techniques such as transcranial Doppler (TCD), magnetic
MCA atherosclerosis has been considered a rare cause of MCA territory infarction. About 40 years ago, Lhermitte et al.1 studied 122 patients with MCA territory infarction, 94 assessed by cardiac and angiographic examination and 28 patients by post-mortem examination. MCA occlusion was identified in 40 cases (41.7%). However, atherosclerotic MCA occlusive disease accounted for only 11 cases (27.5% of MCA occlusion). Moreover, in six of them, there remained the possibility of embolic occlusion from an atherosclerotic proximal ICA. Thus, there were only five cases in which firm evidence of atherosclerotic MCA occlusion was documented. When two patients with MCA stenosis were added, atherosclerosis of MCA disease with sufficient evidence was found in only seven (16.6%) patients with MCA territory infarction. In a subsequent study,2 they reported postmortem findings in 47 infarcts in the MCA territory from 41 patients. Again, intrinsic MCA atherosclerosis was rare; only two patients were considered
Intracranial Atherosclerosis Edited by Jong S Kim, Louis R Caplan and KS Lawrence Wong © 2008 Blackwell Publishing Ltd. ISBN: 978-1-405-17822-8
69
BLBK041-Kim
August 18, 2008
10:38
CHAPTER 6
to have atherosclerotic thrombotic occlusion, in the proximal MCA in one and in the inferior branch of the MCA in the other. The findings from autopsy3 and angiogram studies4–8 by subsequent authors have also revealed that MCA atherosclerosis is a much less common cause of MCA territory infarction than embolism. However, it is likely that the findings of post-mortem or angiogram studies are from patients who had severe symptoms. Therefore, the results may not be generalizable to all MCA territory infarction. With the advances of techniques such as TCD, MRA, and CTA, we can now more easily detect stenosis of intracranial vessels that produces milder clinical symptoms. More importantly, subsequent studies have clearly illustrated that there is an ethnic difference in the etiology of MCA territory infarction: MCA atherosclerosis as a cause of MCA territory infarction is more important in Asians, black people’ and Hispanics than in Caucasians.9–13 Recent series of studies from Asian countries using advanced imaging technologies have confirmed this and suggested that the characteristics of lesion patterns and clinical outcomes are different from those produced by embolism. Min et al.14 studied 42 Korean patients with MCA territory infarction who underwent MRI and angiographic studies (either conventional angiogram or MRA). Patients with potential cardiogenic embolism were excluded. They found that intrinsic MCA atherosclerosis was the cause of infarction in as many as 30 patients (71%). In another study,15 107 stroke patients with isolated MCA disease (stenosis of >50% or occlusion) were studied, all of whom underwent diffusion-weighted MRI (DWI) and angiogram (conventional or MRA). Patients with significant ICA disease were excluded. There were 76 patients with intrinsic MCA atherosclerosis, whereas only 31 patients had a potential source of cardiac embolism. This result suggests that MCA atherosclerosis may be the more important cause of MCA territory infarction than cardiac embolism in Asians. However, embolic infarcts with recanalized vessels were not included in this study, and therefore cardiogenic embolism might have been underestimated. More recently, Lee et al.16 studied 185 Korean patients with MCA territory infarction diagnosed by DWI and MRA. Vascular disease was considered significant when there was stenosis of ≥50% or occlusion. There were 63 patients with MCA atheroscle70
rotic disease (34%), 38 with ICA disease (21%), and 84 with cardiac embolism (45%). Thus, this result suggests that even in Asian countries, cardiac embolism may still be the most important etiology of MCA territory infarction. In this study, however, MCA atherosclerosis might have been underestimated, since mild (<50%) stenosis was not included. There are other limitations in the above studies: echocardiogram was not performed in every case, and MCA stenosis shown by angiography might potentially represent a partial recanalization of an embolus from an unknown source rather than intrinsic atherosclerosis. More importantly, these are hospitalbased studies with a relatively small number of patients. Therefore, the results should be interpreted with caution. Nevertheless, based on the above series of reports, it seems clear that MCA atherosclerosis is one of the main causes of MCA territory infarction in Asian populations. Lesion pattern and clinical syndrome in patients with MCA atherosclerosis Studies have shown that demography, lesion pattern, and consequent stroke syndrome of MCA territory infarction are different according to different etiologies. The difference was elegantly suggested by Caplan et al.17 more than 20 years ago. They compared 20 patients with angiographically proven MCA atherosclerotic disease with 25 patients with MCA territory infarction caused by embolism from proximal ICA disease. They reported that patients with MCA atherosclerosis were more often black, female, and younger, more often had hypertension, and had fewer transient ischemic attacks (TIAs) and a lower incidence of subsequent cardiac death. In the following year, Bogousslavsky et al.18 analyzed 352 patients with intrinsic MCA disease recruited from the patient pool of the EC/IC Bypass Study, and suggested that there may be characteristic lesion patterns in these patients: approximately 30% of the strokes were deep infarcts in the lenticulostriate artery territory. A more detailed lesion pattern analysis was performed by Lyrer et al.,19 who studied 22 stroke patients with intrinsic MCA stenosis. CT scan showed small deep infarcts in 10 (46%), large striatocapsular infarcts in 2 (9%), pial MCA branch infarction in 3 (14%), and striatocapsular plus pial in 4 patients (18%). Only one patient (5%) had large territorial infarction. Clinical features included
BLBK041-Kim
August 18, 2008
10:38
ANTERIOR CIRCULATION DISORDERS
lacunar syndrome in 10 (46%), whereas 12 (54.4%) had non-lacunar syndrome such as aphasia, neglect, or visual field defect. Subsequently, Yoo et al.12 analyzed 89 patients with MCA territory infarction from the New England Stroke Registry. There were 28 patients with intrinsic MCA diseases, 17 with embolism (either cardiogenic or unknown), and 44 patients with significant ICA diseases. Infarcts in patients with intrinsic MCA disease mostly involved the striatocapuslar area (61%), whereas those due to embolism from the heart or ICA disease most often involved the parietal lobe (75% and 43%, respectively). With the advent of MRI, the lesion pattern of MCA territory infarction could be analyzed more precisely. Excluding the patients with cardiogenic embolism, Min et al.14 analyzed lesion patterns in 42 patients with MCA territory infarction. They found that the topographic patterns seen on MRI could be divided into following four groups: (1) cortical borderzone infarcts (n = 6); among them, four had concomitant small cortical or subcortical multiple lesions. Angiography showed intrinsic MCA disease in four. patients. (2) Pial territory infarcts without insular infarct (n = 3); two also had small, multiple centrum ovale lesions. All had intrinsic MCA disease. (3) Pial territory infarcts with insular infarct (n = 14); five had additional multiple cortical or subcortical lesions. Ten patients had intrinsic MCA disease. (4) Large subcortical infarcts (n = 19); 10 had concomitant small cortical or subcortical lesions, and six patients had intrinsic MCA disease. Although the results are complex, what they underscored was that similar MCA lesions may produce diverse topographic lesion patterns, which appears to be related to individual variations of vascular territory, degree of collateralization, and etio-pathogenesis of infarcts. One of the disadvantages in using CT or conventional MRI in stroke research is that we cannot assess the age of infarcts precisely enough. Recently developed DWI has an advantage in that it can identify small, early infarcts more reliably.20–22 Studies using DWI have provided further insights into the stroke patterns in patients with MCA territory infarction. The aforementioned study by Lee et al.15 used DWI in all the patients and compared the stroke patterns between 76 lesions due to intrinsic MCA atherosclerosis and 31 due to cardiac embolism. The lesion patterns produced by MCA atherosclerosis were subcortical in 53 (83%) patients, cortical (involving one
M2 branch territory) in eight (13%), and territorial (involving more than one M2 territories) in three (5%) patients. On the other hand, locations of MCA infarcts associated with cardiac embolism were subcortical in six (19%), cortical in 10 (32%), and territorial in 15 (48%) patients. In addition, borderzone infarction was more common in the atherosclerosis group than in the embolism group (24 vs 1). Clinical features were also different between the two groups. In patients with MCA atherosclerosis, there were lacunar syndromes in 31 (48%), partial MCA syndromes in 25 (39%), and total MCA syndromes in eight (13%), whereas those with cardiac embolism included lacunar syndromes in six (20%), partial syndromes in three (10%), and total syndromes in 21 (70%). In addition, the patients with embolism showed more abrupt onset of disease, higher initial National Institutes of Health Stroke Score (NIHSS) (9.7 vs 4.6), and shorter onsetto-admission time than those with MCA atherosclerosis. Although this study has elegantly demonstrated different lesion patterns according to different etiologies, it was unfortunate that patients with ICA disease were excluded in this study. A subsequent study from another center16 including patients with ICA disease presented more comprehensive results. The study involved 185 patients with MCA territory infarction assessed by DWI and MRA who showed corresponding MCA disease (stenosis of ≥50% or occlusion), ICA disease (stenosis of ≥50% or occlusion), or cardiac embolism. There were 63 (34%) patients with MCA disease, 38 (21%) with ICA disease, and 84 (45%) cardiac embolism. Among the 63 patients with MCA atherosclerosis, single perforator infarction occurred in 17 patients, perforator + pial in 14, and perforator + pial + borderzone in nine patients. On the other hand, among 84 patients with cardiac embolism, pial territory infarction occurred in 27 patients, and large territorial infarction in 23. The most frequent lesion pattern of ICA disease (n = 38) was the pial territory + borderzone (n = 13) pattern. The DWI lesion patterns due to MCA atherosclerosis are shown in other chapters (Figs 5.1, 5.2, and 5.3; Fig. 11.2). Thus, in line with the previous studies with CT scan,19 subcortical infarcts are significantly more common in MCA atherosclerosis than in the embolism group, whereas cortical or territorial infarcts are more common in patients with embolism. The frequent sparing of the cortex in patients with MCA atherosclerosis 71
BLBK041-Kim
August 18, 2008
10:38
CHAPTER 6
Table 6.1 Differences in MCA territory infarction according to difference etiologies Intrinsic MCA disease
Cardiac embolism
ICA disease
Ethnicities Onset Precedence by TIAs Important risk factors
Asian, Black, Hispanics Gradual ++ Advanced hypertension Metabolic syndrome
Variable Abrupt + Emboligenic heart disease
Caucasian Variable +++ Hyperlipidemia
Degree of arterial stenosis Coronary heart disease Peripheral artery disease Lesion pattern
Either severe or mild ++ ++ Subcortical Combined cortical and subcortical +++ + +++ +
none ++ + Cortical Territorial
Usually severe +++ +++ Cortical Internal borderzone
+ +++ + +++
+ ++ ++ ++
Lacunar syndrome Cortical symptoms Neurological progression Acute herniation
ICA, internal carotid artery; MCA, middle cerebral artery; TIA, transient ischemic attack; +, less frequent; ++, moderately frequent; + + +, frequent.
is probably related to pre-existing, well-developed collateral circulation. The less frequent cortical damage in patients with MCA atherosclerosis explains less frequent cortical symptoms such as aphasia, neglect, eyeball deviation, and post-stroke seizures (2% according to Bogousslavsky et al.18 ). Owing to the sparing of the cortex, malignant, whole territory MCA infarction is rare in MCA atherosclerosis. Indeed, embolism was a presumed cause of stroke in all the 55 patients with malignant MCA infarction.23 Accordingly, we rarely observe fatal herniation in patients with intrinsic MCA disease, although progressive worsening of motor symptoms are not infrequent (see Fig. 5.1). Table 6.1 summarizes the differences in MCA territory infarction according to difference etiologies.
Subcortical infarction associated with MCA atherosclerosis Importance of MCA atherosclerosis as a cause of subcortical infarction Because subcortical infarction sparing the cortex is one of the important stroke patterns caused by MCA atherosclerosis, this topic deserves a separate description. Subcortical infarction in the territory of 72
perforating arteries has long been described as lacunar infarction caused by small vessel occlusion due to lipohyalinosis.24,25 However, other etiologies such as embolism from the heart or ICA disease have also been found to be associated with strictly subcortical infarction.26 In addition, strictly subcortical infarction due to MCA atherosclerosis has been identified; Lhermtte et al.2 and Fisher27 described autopsy findings of patients with lacunar infarction caused by perforator occlusion due to atherosclerotic plaque of the MCA trunk. Such patients have also been identified in a study using angiography.28 However, subcortical infarcts due to intrinsic MCA disease appear to be uncommon in Caucasians. Rather, there have been arguments regarding the role of ICA disease or cardiac disease as a cause of subcortical infarction. In a prospective study using CT scan and conventional angiography, 14 of 45 patients with lacunar infarction were found to have ipsilateral ICA stenosis.29 However, the authors thought that the ICA diseases were likely to be a general marker for atherosclerosis rather than a specific cause of lacunar infarction, since the stenosis was severe only in six patients and a half of them had concurrent stenosis on the contralateral ICA. Although Waterston et al.30 agreed to this, they raised the possibility that hemodynamic
BLBK041-Kim
August 18, 2008
10:38
ANTERIOR CIRCULATION DISORDERS
failure caused by ICA disease might have contributed to at least some of the small subcortical infarction. However, Mead et al.31 recently found that the prevalence of severe ICA disease was not different between the symptomatic (5%) and asymptomatic (4%) side in 259 patients with lacunar infarction, and stated that ICA disease seems to be a mere coincidental finding. There also have been arguments regarding the role of cardiogenic embolism in the subcortical infarction. Horowitiz et al.26 studied 108 patients with CT-based subcortical infarction who presented clinically with lacunar syndrome, and identified a potential source of cardiogenic embolism in 18%. Donnan et al.32 prospectively studied 50 patients with striatocapsular infarction identified by CT scan with the longest diameter greater than 1.5 cm. Among them, 43 patients could be divided into four subgroups: cardiac emboli to the origin of the MCA (n = 17), severe ICA disease with artery-to-artery embolism with or without associated hemodynamic factors (n = 12), subjects with normal angiogram (n = 11), and intrinsic MCA disease (n = 3). Thus, they underscored the importance of potential cardiogenic embolism in patients with relatively large subcortical infarction. These results suggest that embolism either from the heart or ICA disease may produce subcortical infarction, especially when the size of the lesion is large.33 In these series studying Caucasian patients, MCA atherosclerosis as a cause of subcortical infarction has largely been neglected. However, results from studies in Asian countries have been quite different. Studies from Japan,34,35 Korea,36,37 or Hong Kong38 have illustrated that MCA atherosclerotic disease is an important cause of infarction occurring in the subcortical area. It seems clear that the importance of MCA atherosclerosis as a cause of subcortical infarction in these countries is significantly greater than the importance of ICA disease as a cause of subcortical infarction in Caucasians (see Fig. 5.3). Bang et al.36 studied 102 Korean patients with lacunar syndromes and relevant small (<1.5 cm), MRIidentified subcortical infarction. Angiograms (conventional or MRA) were performed in all the patients. They detected MCA atherosclerotic disease responsible for the infarction in as many as 37 (36%) patients. Embolic sources from the ICA, aorta, or heart were found in 25 patients (25%), whereas small vessel occlusion was considered to be the cause of infarcts in the rest of the patients. Thus, MCA disease may
be an important cause of lacune-like small, subcortical infarction in this population. A study from Hong Kong, China also confirmed that MCA disease is an important cause of small, subcortical infarction.38 The authors studied 257 patients with ischemic stroke, in whom DWI was performed in 226 patients. Among them, 71 patients (27.6%) had small (0.2–2.0 cm in diameter) subcortical infarction, which was related to relevant intracranial large artery disease in 12 (16.9%) and ipsilateral ICA disease in three patients (4.2%). None had cardiac embolism. Thus, although 1.5 cm or 2.0 cm in diameter has been traditionally considered a criteria for lacunar infarction due to small perforating artery occlusion,39 studies described above have shown that these small lesions can still be caused by etiologies other than